DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
Thiopurine S-methyltransferase (TPMT)
|
OTFOX70W
|
TPMT_HUMAN
|
Decreases Expression
|
[141] |
Gamma-glutamyl hydrolase (GGH)
|
OTL71J7T
|
GGH_HUMAN
|
Decreases Expression
|
[174] |
Dihydrofolate reductase (DHFR)
|
OT3DVIGM
|
DYR_HUMAN
|
Decreases Response To Substance
|
[175] |
Solute carrier family 22 member 7 (SLC22A7)
|
OTKTNH1W
|
S22A7_HUMAN
|
Increases Expression
|
[141] |
ATP-binding cassette sub-family C member 4 (ABCC4)
|
OTO27PAL
|
MRP4_HUMAN
|
Decreases Expression
|
[174] |
ATP-binding cassette sub-family C member 2 (ABCC2)
|
OTJSIGV5
|
MRP2_HUMAN
|
Increases Expression
|
[174] |
Broad substrate specificity ATP-binding cassette transporter ABCG2 (ABCG2)
|
OTW8V2V1
|
ABCG2_HUMAN
|
Increases Expression
|
[143] |
Multidrug resistance-associated protein 1 (ABCC1)
|
OTGUN89S
|
MRP1_HUMAN
|
Decreases Expression
|
[174] |
ATP-dependent translocase ABCB1 (ABCB1)
|
OTEJROBO
|
MDR1_HUMAN
|
Increases Expression
|
[176] |
ATP-binding cassette sub-family C member 5 (ABCC5)
|
OT34G4US
|
MRP5_HUMAN
|
Decreases Expression
|
[174] |
Solute carrier organic anion transporter family member 1B1 (SLCO1B1)
|
OTNEN8QK
|
SO1B1_HUMAN
|
Increases Response To Substance
|
[177] |
Proton-coupled folate transporter (SLC46A1)
|
OT049V7Y
|
PCFT_HUMAN
|
Increases Response To Substance
|
[177] |
Reduced folate transporter (SLC19A1)
|
OTWB0BTO
|
S19A1_HUMAN
|
Decreases Response To Substance
|
[178] |
Solute carrier family 22 member 6 (SLC22A6)
|
OTKRCBVM
|
S22A6_HUMAN
|
Increases Response To Substance
|
[179] |
ATP-binding cassette sub-family C member 3 (ABCC3)
|
OTC3IJV4
|
MRP3_HUMAN
|
Affects Response To Substance
|
[180] |
Organic anion transporter 3 (SLC22A8)
|
OT8BY933
|
S22A8_HUMAN
|
Increases Response To Substance
|
[179] |
Cellular tumor antigen p53 (TP53)
|
OTIE1VH3
|
P53_HUMAN
|
Decreases Expression
|
[137] |
Sulfotransferase 1E1 (SULT1E1)
|
OTGPJ517
|
ST1E1_HUMAN
|
Increases Expression
|
[181] |
Sulfotransferase 1A1 (SULT1A1)
|
OT0K7JIE
|
ST1A1_HUMAN
|
Increases Expression
|
[181] |
Arylamine N-acetyltransferase 1 (NAT1)
|
OTCCNQ3H
|
ARY1_HUMAN
|
Decreases Activity
|
[182] |
Cytochrome P450 3A4 (CYP3A4)
|
OTQGYY83
|
CP3A4_HUMAN
|
Decreases Expression
|
[183] |
TANK-binding kinase 1-binding protein 1 (TBKBP1)
|
OTXTU37H
|
TBKB1_HUMAN
|
Decreases Expression
|
[137] |
Alternative prion protein (PRNP)
|
OTE85L1Q
|
APRIO_HUMAN
|
Decreases Expression
|
[137] |
AH receptor-interacting protein (AIP)
|
OTDJ3OSV
|
AIP_HUMAN
|
Increases Expression
|
[137] |
Toll-like receptor 4 (TLR4)
|
OTP7ML3S
|
TLR4_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 21 (CCL21)
|
OT7DOXEM
|
CCL21_HUMAN
|
Decreases Expression
|
[137] |
Peroxisomal targeting signal 2 receptor (PEX7)
|
OTM7VBRC
|
PEX7_HUMAN
|
Increases Expression
|
[137] |
Acetyl-CoA carboxylase 2 (ACACB)
|
OT96UIP1
|
ACACB_HUMAN
|
Increases Expression
|
[137] |
Stearoyl-CoA desaturase (SCD)
|
OTB1073G
|
SCD_HUMAN
|
Increases Expression
|
[137] |
AP-3 complex subunit delta-1 (AP3D1)
|
OTJLI0IM
|
AP3D1_HUMAN
|
Decreases Expression
|
[137] |
C-X-C motif chemokine 11 (CXCL11)
|
OT353XE3
|
CXL11_HUMAN
|
Decreases Expression
|
[137] |
Syntaxin-16 (STX16)
|
OTM7TAOE
|
STX16_HUMAN
|
Increases Expression
|
[137] |
Phytanoyl-CoA dioxygenase, peroxisomal (PHYH)
|
OTUG4BWA
|
PAHX_HUMAN
|
Increases Expression
|
[137] |
Long-chain fatty acid transport protein 2 (SLC27A2)
|
OT7JEG5F
|
S27A2_HUMAN
|
Increases Expression
|
[137] |
Synaptojanin-2 (SYNJ2)
|
OTLRHXP1
|
SYNJ2_HUMAN
|
Increases Expression
|
[137] |
FYN-binding protein 1 (FYB1)
|
OT6345CH
|
FYB1_HUMAN
|
Decreases Expression
|
[137] |
Phospholipid scramblase 1 (PLSCR1)
|
OTGY9B5T
|
PLS1_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 25 (CCL25)
|
OTLWJ8CJ
|
CCL25_HUMAN
|
Decreases Expression
|
[137] |
DNA-directed RNA polymerase I subunit RPA34 (POLR1G)
|
OTEGR9C2
|
RPA34_HUMAN
|
Decreases Expression
|
[137] |
Plexin-B1 (PLXNB1)
|
OTCA7JIT
|
PLXB1_HUMAN
|
Increases Expression
|
[137] |
Hypocretin neuropeptide precursor (HCRT)
|
OTQ4FGI9
|
OREX_HUMAN
|
Decreases Expression
|
[137] |
Transcription factor 21 (TCF21)
|
OT393IMA
|
TCF21_HUMAN
|
Decreases Expression
|
[137] |
Acyl-CoA (FADS1)
|
OTUYOYHX
|
FADS1_HUMAN
|
Increases Expression
|
[137] |
Long-chain-fatty-acid--CoA ligase 4 (ACSL4)
|
OTI71MUJ
|
ACSL4_HUMAN
|
Increases Expression
|
[137] |
Target of Myb1 membrane trafficking protein (TOM1)
|
OT30QA56
|
TOM1_HUMAN
|
Decreases Expression
|
[137] |
Receptor activity-modifying protein 1 (RAMP1)
|
OT7UT2XB
|
RAMP1_HUMAN
|
Decreases Expression
|
[137] |
Receptor activity-modifying protein 2 (RAMP2)
|
OTGQXLH5
|
RAMP2_HUMAN
|
Decreases Expression
|
[137] |
Low affinity immunoglobulin gamma Fc region receptor III-B (FCGR3B)
|
OTSLSPZG
|
FCG3B_HUMAN
|
Decreases Expression
|
[137] |
ICOS ligand (ICOSLG)
|
OTAD976B
|
ICOSL_HUMAN
|
Decreases Expression
|
[137] |
Leucine-rich repeat-containing G-protein coupled receptor 5 (LGR5)
|
OTMVHF9E
|
LGR5_HUMAN
|
Decreases Expression
|
[137] |
Protein XRP2 (RP2)
|
OTK050I3
|
XRP2_HUMAN
|
Increases Expression
|
[137] |
Diacylglycerol O-acyltransferase 1 (DGAT1)
|
OTL104WL
|
DGAT1_HUMAN
|
Increases Expression
|
[137] |
DnaJ homolog subfamily B member 5 (DNAJB5)
|
OT7WDJ5C
|
DNJB5_HUMAN
|
Decreases Expression
|
[137] |
Cystatin-F (CST7)
|
OTQWZUVQ
|
CYTF_HUMAN
|
Decreases Expression
|
[137] |
SUN domain-containing protein 1 (SUN1)
|
OTIU8V4U
|
SUN1_HUMAN
|
Increases Expression
|
[137] |
Nuclear factor of activated T-cells 5 (NFAT5)
|
OTKIE59S
|
NFAT5_HUMAN
|
Increases Expression
|
[137] |
Interleukin-18 receptor accessory protein (IL18RAP)
|
OTCUB1EV
|
I18RA_HUMAN
|
Decreases Expression
|
[137] |
Tumor necrosis factor alpha-induced protein 8 (TNFAIP8)
|
OT1G9297
|
TFIP8_HUMAN
|
Decreases Expression
|
[137] |
Fibroblast growth factor 19 (FGF19)
|
OT2DVJWY
|
FGF19_HUMAN
|
Decreases Expression
|
[137] |
Putative lipid scramblase CLPTM1 (CLPTM1)
|
OT14QP7N
|
CLPT1_HUMAN
|
Decreases Expression
|
[137] |
Mitochondrial import receptor subunit TOM40 homolog (TOMM40)
|
OTZDQ29F
|
TOM40_HUMAN
|
Increases Expression
|
[137] |
Hypoxanthine-guanine phosphoribosyltransferase (HPRT1)
|
OTOEEEXG
|
HPRT_HUMAN
|
Decreases Expression
|
[137] |
Prothrombin (F2)
|
OTNFSM49
|
THRB_HUMAN
|
Increases Expression
|
[137] |
Complement C3 (C3)
|
OTCH5GS0
|
CO3_HUMAN
|
Increases Expression
|
[137] |
Complement C5 (C5)
|
OTSL3OIC
|
CO5_HUMAN
|
Increases Expression
|
[137] |
Myc proto-oncogene protein (MYC)
|
OTPV5LUK
|
MYC_HUMAN
|
Decreases Expression
|
[137] |
Platelet-derived growth factor subunit B (PDGFB)
|
OTMFMFC3
|
PDGFB_HUMAN
|
Decreases Expression
|
[137] |
Transforming growth factor beta-1 proprotein (TGFB1)
|
OTV5XHVH
|
TGFB1_HUMAN
|
Decreases Expression
|
[137] |
Beta-nerve growth factor (NGF)
|
OTOLABJT
|
NGF_HUMAN
|
Increases Expression
|
[137] |
Prolactin (PRL)
|
OTWFQGX7
|
PRL_HUMAN
|
Decreases Expression
|
[137] |
Insulin (INS)
|
OTZ85PDU
|
INS_HUMAN
|
Decreases Expression
|
[137] |
Interferon gamma (IFNG)
|
OTXG9JM7
|
IFNG_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-1 alpha (IL1A)
|
OTPSGILV
|
IL1A_HUMAN
|
Decreases Expression
|
[137] |
HLA class II histocompatibility antigen, DR alpha chain (HLA-DRA)
|
OT7KZMP2
|
DRA_HUMAN
|
Decreases Expression
|
[137] |
Myelin basic protein (MBP)
|
OTFZCEDB
|
MBP_HUMAN
|
Increases Expression
|
[137] |
Complement C1q subcomponent subunit B (C1QB)
|
OT2G1IOX
|
C1QB_HUMAN
|
Decreases Expression
|
[137] |
Fibronectin (FN1)
|
OTB5ZN4Q
|
FINC_HUMAN
|
Increases Expression
|
[137] |
Platelet factor 4 (PF4)
|
OTEMJU68
|
PLF4_HUMAN
|
Decreases Expression
|
[137] |
Plasma kallikrein (KLKB1)
|
OTGSEISX
|
KLKB1_HUMAN
|
Increases Expression
|
[137] |
Catalase (CAT)
|
OTHEBX9R
|
CATA_HUMAN
|
Increases Expression
|
[137] |
Glucocorticoid receptor (NR3C1)
|
OTCI2YDI
|
GCR_HUMAN
|
Decreases Expression
|
[137] |
Amyloid-beta precursor protein (APP)
|
OTKFD7R4
|
A4_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-4 (IL4)
|
OTOXBWAU
|
IL4_HUMAN
|
Decreases Expression
|
[137] |
Insulin receptor (INSR)
|
OTTY341H
|
INSR_HUMAN
|
Increases Expression
|
[137] |
Protein S100-A9 (S100A9)
|
OTOARHCS
|
S10A9_HUMAN
|
Decreases Expression
|
[137] |
T-cell surface antigen CD2 (CD2)
|
OTLYO0DB
|
CD2_HUMAN
|
Decreases Expression
|
[137] |
Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5)
|
OTREV92I
|
CEAM5_HUMAN
|
Increases Expression
|
[137] |
Fatty acid-binding protein, liver (FABP1)
|
OTR34ETM
|
FABPL_HUMAN
|
Increases Expression
|
[137] |
Vitamin K-dependent protein S (PROS1)
|
OTXQWNOI
|
PROS_HUMAN
|
Increases Expression
|
[137] |
Macrophage colony-stimulating factor 1 receptor (CSF1R)
|
OTDYTB9C
|
CSF1R_HUMAN
|
Decreases Expression
|
[137] |
Complement component C8 alpha chain (C8A)
|
OTIJ65J4
|
CO8A_HUMAN
|
Increases Expression
|
[137] |
Pulmonary surfactant-associated protein B (SFTPB)
|
OTOHS07E
|
PSPB_HUMAN
|
Decreases Expression
|
[137] |
Thrombospondin-1 (THBS1)
|
OT0ECWK3
|
TSP1_HUMAN
|
Decreases Expression
|
[137] |
Cathepsin G (CTSG)
|
OT85ZMQG
|
CATG_HUMAN
|
Decreases Expression
|
[137] |
Receptor-type tyrosine-protein phosphatase C (PTPRC)
|
OT6KOR77
|
PTPRC_HUMAN
|
Decreases Expression
|
[137] |
Integrin alpha-5 (ITGA5)
|
OT3RCI67
|
ITA5_HUMAN
|
Increases Expression
|
[137] |
Interleukin-3 (IL3)
|
OT0CQ35N
|
IL3_HUMAN
|
Decreases Expression
|
[137] |
Glutathione S-transferase A2 (GSTA2)
|
OTW7UB1H
|
GSTA2_HUMAN
|
Increases Expression
|
[137] |
CD48 antigen (CD48)
|
OT83ZNPP
|
CD48_HUMAN
|
Decreases Expression
|
[137] |
Macrophage colony-stimulating factor 1 (CSF1)
|
OT68M7RD
|
CSF1_HUMAN
|
Decreases Expression
|
[137] |
Heat shock 70 kDa protein 1A (HSPA1A)
|
OTKGIE76
|
HS71A_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 3 (CCL3)
|
OTW2H3ND
|
CCL3_HUMAN
|
Decreases Expression
|
[137] |
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (DLAT)
|
OT9LBJVN
|
ODP2_HUMAN
|
Increases Expression
|
[137] |
T-cell-specific surface glycoprotein CD28 (CD28)
|
OTT5XJST
|
CD28_HUMAN
|
Decreases Expression
|
[137] |
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADM)
|
OTA4P0FC
|
ACADM_HUMAN
|
Increases Expression
|
[137] |
Steroid hormone receptor ERR1 (ESRRA)
|
OTTDTUSP
|
ERR1_HUMAN
|
Decreases Expression
|
[137] |
Aromatase (CYP19A1)
|
OTZ6XF74
|
CP19A_HUMAN
|
Increases Expression
|
[137] |
Cytochrome c oxidase subunit 6A1, mitochondrial (COX6A1)
|
OT77MV8G
|
CX6A1_HUMAN
|
Decreases Expression
|
[137] |
Inosine-5'-monophosphate dehydrogenase 2 (IMPDH2)
|
OTPG0K7E
|
IMDH2_HUMAN
|
Decreases Expression
|
[137] |
Low affinity immunoglobulin gamma Fc region receptor II-a (FCGR2A)
|
OT0OUDUT
|
FCG2A_HUMAN
|
Increases Expression
|
[137] |
Granzyme A (GZMA)
|
OT43R33L
|
GRAA_HUMAN
|
Decreases Expression
|
[137] |
Proto-oncogene tyrosine-protein kinase Src (SRC)
|
OTETYX40
|
SRC_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 2 (CCL2)
|
OTAD2HEL
|
CCL2_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 5 (CCL5)
|
OTSCA5CK
|
CCL5_HUMAN
|
Decreases Expression
|
[137] |
L-selectin (SELL)
|
OT6RAJZR
|
LYAM1_HUMAN
|
Decreases Expression
|
[137] |
Phospholipase A2, membrane associated (PLA2G2A)
|
OT1NY7BF
|
PA2GA_HUMAN
|
Increases Expression
|
[137] |
Interleukin-2 receptor subunit beta (IL2RB)
|
OT6M0F70
|
IL2RB_HUMAN
|
Decreases Expression
|
[137] |
Cytochrome c oxidase subunit 6B1 (COX6B1)
|
OTNKXYQI
|
CX6B1_HUMAN
|
Decreases Expression
|
[137] |
B-lymphocyte antigen CD19 (CD19)
|
OTCPF9NF
|
CD19_HUMAN
|
Decreases Expression
|
[137] |
15-hydroxyprostaglandin dehydrogenase (HPGD)
|
OTYZI6JB
|
PGDH_HUMAN
|
Increases Expression
|
[137] |
Antigen-presenting glycoprotein CD1d (CD1D)
|
OT3ROU4J
|
CD1D_HUMAN
|
Increases Expression
|
[137] |
SH2/SH3 adapter protein NCK1 (NCK1)
|
OTKYZ4OP
|
NCK1_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 3-like 1 (CCL3L1)
|
OTQXCYB1
|
CL3L1_HUMAN
|
Decreases Expression
|
[137] |
HLA class I histocompatibility antigen, alpha chain G (HLA-G)
|
OTMLK1KN
|
HLAG_HUMAN
|
Decreases Expression
|
[137] |
Polyunsaturated fatty acid lipoxygenase ALOX12 (ALOX12)
|
OTFL5KR5
|
LOX12_HUMAN
|
Decreases Expression
|
[137] |
Lipopolysaccharide-binding protein (LBP)
|
OTQXAH4L
|
LBP_HUMAN
|
Increases Expression
|
[137] |
Lymphocyte function-associated antigen 3 (CD58)
|
OTIUGMGS
|
LFA3_HUMAN
|
Increases Expression
|
[137] |
Spermidine synthase (SRM)
|
OT4N5MDP
|
SPEE_HUMAN
|
Decreases Expression
|
[137] |
L-serine dehydratase/L-threonine deaminase (SDS)
|
OT5WTJ2M
|
SDHL_HUMAN
|
Increases Expression
|
[137] |
Integrin alpha-L (ITGAL)
|
OTCUQAIS
|
ITAL_HUMAN
|
Increases Expression
|
[137] |
Mimecan (OGN)
|
OTKP5S4L
|
MIME_HUMAN
|
Decreases Expression
|
[137] |
Inosine-5'-monophosphate dehydrogenase 1 (IMPDH1)
|
OT6QGM5Y
|
IMDH1_HUMAN
|
Decreases Expression
|
[137] |
T-cell surface glycoprotein CD3 zeta chain (CD247)
|
OT45FGUX
|
CD3Z_HUMAN
|
Decreases Expression
|
[137] |
fMet-Leu-Phe receptor (FPR1)
|
OTFF9I6W
|
FPR1_HUMAN
|
Decreases Expression
|
[137] |
Kit ligand (KITLG)
|
OTB9AVQ4
|
SCF_HUMAN
|
Decreases Expression
|
[137] |
C5a anaphylatoxin chemotactic receptor 1 (C5AR1)
|
OT58QDI9
|
C5AR1_HUMAN
|
Decreases Expression
|
[137] |
Tumor necrosis factor ligand superfamily member 4 (TNFSF4)
|
OTOCBX7P
|
TNFL4_HUMAN
|
Increases Expression
|
[137] |
Trans-acting T-cell-specific transcription factor GATA-3 (GATA3)
|
OTGP7D5Y
|
GATA3_HUMAN
|
Increases Expression
|
[137] |
Interleukin-32 (IL32)
|
OT3FHZ81
|
IL32_HUMAN
|
Decreases Expression
|
[137] |
Myeloblastin (PRTN3)
|
OT72MHP7
|
PRTN3_HUMAN
|
Decreases Expression
|
[137] |
Tenascin (TNC)
|
OTK4FSHR
|
TENA_HUMAN
|
Increases Expression
|
[137] |
Deoxyribonuclease-1 (DNASE1)
|
OTM4KWB3
|
DNAS1_HUMAN
|
Increases Expression
|
[137] |
C-X-C chemokine receptor type 2 (CXCR2)
|
OTISGW7L
|
CXCR2_HUMAN
|
Decreases Expression
|
[137] |
N-formyl peptide receptor 2 (FPR2)
|
OTEZ2THZ
|
FPR2_HUMAN
|
Decreases Expression
|
[137] |
Cathepsin S (CTSS)
|
OT3PXIPM
|
CATS_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-1 receptor type 2 (IL1R2)
|
OT0G7E35
|
IL1R2_HUMAN
|
Decreases Expression
|
[137] |
ATP-binding cassette sub-family D member 3 (ABCD3)
|
OT2PITLX
|
ABCD3_HUMAN
|
Increases Expression
|
[137] |
T-cell surface glycoprotein CD1b (CD1B)
|
OT4D5EG7
|
CD1B_HUMAN
|
Decreases Expression
|
[137] |
Enoyl-CoA hydratase, mitochondrial (ECHS1)
|
OTS0593S
|
ECHM_HUMAN
|
Increases Expression
|
[137] |
High affinity immunoglobulin epsilon receptor subunit gamma (FCER1G)
|
OTBZBL9Y
|
FCERG_HUMAN
|
Decreases Expression
|
[137] |
Coronin-1A (CORO1A)
|
OTVAZOHC
|
COR1A_HUMAN
|
Decreases Expression
|
[137] |
Protein S100-A11 (S100A11)
|
OTI57KDN
|
S10AB_HUMAN
|
Decreases Expression
|
[137] |
Low affinity immunoglobulin gamma Fc region receptor II-b (FCGR2B)
|
OTCJD51H
|
FCG2B_HUMAN
|
Decreases Expression
|
[137] |
G-protein coupled receptor 183 (GPR183)
|
OTRILX7G
|
GP183_HUMAN
|
Decreases Expression
|
[137] |
ETS-related transcription factor Elf-1 (ELF1)
|
OTV5LKIA
|
ELF1_HUMAN
|
Decreases Expression
|
[137] |
Lymphocyte-specific protein 1 (LSP1)
|
OTSPSIFO
|
LSP1_HUMAN
|
Increases Expression
|
[137] |
ATP-binding cassette sub-family D member 1 (ABCD1)
|
OT3FL9W0
|
ABCD1_HUMAN
|
Decreases Expression
|
[137] |
Heat shock 70 kDa protein 4 (HSPA4)
|
OT5HR0AR
|
HSP74_HUMAN
|
Increases Expression
|
[137] |
Gap junction alpha-4 protein (GJA4)
|
OTUPCT1V
|
CXA4_HUMAN
|
Decreases Expression
|
[137] |
Pro-adrenomedullin (ADM)
|
OT7T0TA4
|
ADML_HUMAN
|
Decreases Expression
|
[137] |
Histamine H1 receptor (HRH1)
|
OT8F9FV6
|
HRH1_HUMAN
|
Increases Expression
|
[137] |
Phosphoenolpyruvate carboxykinase, cytosolic (PCK1)
|
OTNWEJ5Y
|
PCKGC_HUMAN
|
Increases Expression
|
[137] |
Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3)
|
OTZG1W8W
|
CEAM3_HUMAN
|
Decreases Expression
|
[137] |
Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6)
|
OTQOUHVK
|
CEAM6_HUMAN
|
Increases Expression
|
[137] |
Trifunctional enzyme subunit alpha, mitochondrial (HADHA)
|
OTO557N2
|
ECHA_HUMAN
|
Increases Expression
|
[137] |
Kappa-type opioid receptor (OPRK1)
|
OTXCZF4L
|
OPRK_HUMAN
|
Increases Expression
|
[137] |
Regulator of G-protein signaling 2 (RGS2)
|
OT0FSRW7
|
RGS2_HUMAN
|
Decreases Expression
|
[137] |
Patatin-like phospholipase domain-containing protein 4 (PNPLA4)
|
OT5CVDJM
|
PLPL4_HUMAN
|
Decreases Expression
|
[137] |
Neuroblastoma suppressor of tumorigenicity 1 (NBL1)
|
OTT37U4O
|
NBL1_HUMAN
|
Decreases Expression
|
[137] |
Tumor necrosis factor ligand superfamily member 9 (TNFSF9)
|
OTV9L89D
|
TNFL9_HUMAN
|
Decreases Expression
|
[137] |
T-lymphocyte activation antigen CD86 (CD86)
|
OTJCSBPC
|
CD86_HUMAN
|
Decreases Expression
|
[137] |
Signal transducer and activator of transcription 5A (STAT5A)
|
OTBSJGN3
|
STA5A_HUMAN
|
Decreases Expression
|
[137] |
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2)
|
OTGLVWOP
|
THIM_HUMAN
|
Increases Expression
|
[137] |
Stromal cell-derived factor 1 (CXCL12)
|
OT2QX5LL
|
SDF1_HUMAN
|
Increases Expression
|
[137] |
Paxillin (PXN)
|
OTVMMUOF
|
PAXI_HUMAN
|
Increases Expression
|
[137] |
Natural resistance-associated macrophage protein 1 (SLC11A1)
|
OTCN8N8B
|
NRAM1_HUMAN
|
Decreases Expression
|
[137] |
Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (ACADVL)
|
OT50L4XB
|
ACADV_HUMAN
|
Increases Expression
|
[137] |
Regulator of G-protein signaling 4 (RGS4)
|
OTG94HHL
|
RGS4_HUMAN
|
Decreases Expression
|
[137] |
Tuberin (TSC2)
|
OT47LWI9
|
TSC2_HUMAN
|
Increases Expression
|
[137] |
Selenoprotein P (SELENOP)
|
OT02B8IR
|
SEPP1_HUMAN
|
Increases Expression
|
[137] |
Carnitine O-palmitoyltransferase 1, liver isoform (CPT1A)
|
OTI862QH
|
CPT1A_HUMAN
|
Increases Expression
|
[137] |
Serpin H1 (SERPINH1)
|
OTKGI7BS
|
SERPH_HUMAN
|
Decreases Expression
|
[137] |
Peroxisomal multifunctional enzyme type 2 (HSD17B4)
|
OT8733D7
|
DHB4_HUMAN
|
Increases Expression
|
[137] |
Eotaxin (CCL11)
|
OT3BIFPK
|
CCL11_HUMAN
|
Decreases Expression
|
[137] |
Tyrosine-protein kinase JAK3 (JAK3)
|
OTQ8QW2L
|
JAK3_HUMAN
|
Decreases Expression
|
[137] |
Rho GDP-dissociation inhibitor 2 (ARHGDIB)
|
OT9PD6CS
|
GDIR2_HUMAN
|
Decreases Expression
|
[137] |
GTP-binding protein GEM (GEM)
|
OT6SK8ZV
|
GEM_HUMAN
|
Decreases Expression
|
[137] |
Fibroblast growth factor 8 (FGF8)
|
OTFU0IUW
|
FGF8_HUMAN
|
Decreases Expression
|
[137] |
Microfibril-associated glycoprotein 4 (MFAP4)
|
OT5W64QY
|
MFAP4_HUMAN
|
Decreases Expression
|
[137] |
Trifunctional enzyme subunit beta, mitochondrial (HADHB)
|
OT4Y1I62
|
ECHB_HUMAN
|
Increases Expression
|
[137] |
Proteinase-activated receptor 2 (F2RL1)
|
OTMRMJ8N
|
PAR2_HUMAN
|
Increases Expression
|
[137] |
ATP synthase subunit ATP5MJ, mitochondrial (ATP5MJ)
|
OT7B6C6M
|
ATP68_HUMAN
|
Decreases Expression
|
[137] |
SCAN domain-containing protein 1 (SCAND1)
|
OTRG0AGH
|
SCND1_HUMAN
|
Decreases Expression
|
[137] |
CD81 antigen (CD81)
|
OTQFXNAZ
|
CD81_HUMAN
|
Increases Expression
|
[137] |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN)
|
OTOWDUNT
|
PTEN_HUMAN
|
Increases Expression
|
[137] |
Large ribosomal subunit protein uL24 (RPL26)
|
OTFNRC27
|
RL26_HUMAN
|
Decreases Expression
|
[137] |
Fibroblast growth factor 12 (FGF12)
|
OTBM9QIO
|
FGF12_HUMAN
|
Decreases Expression
|
[137] |
Proline-rich protein 3 (PRR3)
|
OTCWSM5T
|
PRR3_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 8 (CCL8)
|
OTCTWYN8
|
CCL8_HUMAN
|
Decreases Expression
|
[137] |
Small EDRK-rich factor 2 (SERF2)
|
OTZQDYCZ
|
SERF2_HUMAN
|
Decreases Expression
|
[137] |
Cytochrome c (CYCS)
|
OTBFALJD
|
CYC_HUMAN
|
Increases Expression
|
[137] |
Transcription factor RelB (RELB)
|
OTU3QYEF
|
RELB_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-1 receptor-like 1 (IL1RL1)
|
OTJ6MW31
|
ILRL1_HUMAN
|
Decreases Expression
|
[137] |
Inositol polyphosphate 5-phosphatase OCRL (OCRL)
|
OTQ3L42N
|
OCRL_HUMAN
|
Increases Expression
|
[137] |
DNA-binding protein inhibitor ID-3 (ID3)
|
OTUULW5Z
|
ID3_HUMAN
|
Decreases Expression
|
[137] |
Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (GCNT1)
|
OTF6OC66
|
GCNT1_HUMAN
|
Increases Expression
|
[137] |
Cytochrome P450 4A11 (CYP4A11)
|
OTPU5J0S
|
CP4AB_HUMAN
|
Increases Expression
|
[137] |
Peroxisome proliferator-activated receptor delta (PPARD)
|
OTI4WTOP
|
PPARD_HUMAN
|
Decreases Expression
|
[137] |
Acetylcholine receptor subunit epsilon (CHRNE)
|
OTGGXGGB
|
ACHE_HUMAN
|
Decreases Expression
|
[137] |
Dual specificity protein phosphatase 2 (DUSP2)
|
OTH54FMR
|
DUS2_HUMAN
|
Decreases Expression
|
[137] |
Tumor necrosis factor receptor superfamily member 9 (TNFRSF9)
|
OTNOM26L
|
TNR9_HUMAN
|
Decreases Expression
|
[137] |
Peroxisome proliferator-activated receptor alpha (PPARA)
|
OTK095PP
|
PPARA_HUMAN
|
Increases Expression
|
[137] |
Regulator of G-protein signaling 1 (RGS1)
|
OTGXJYMG
|
RGS1_HUMAN
|
Decreases Expression
|
[137] |
Peroxisomal bifunctional enzyme (EHHADH)
|
OTBAAHL5
|
ECHP_HUMAN
|
Increases Expression
|
[137] |
Cytochrome P450 4F3 (CYP4F3)
|
OTYNSQAM
|
CP4F3_HUMAN
|
Increases Expression
|
[137] |
Leukocyte surface antigen CD47 (CD47)
|
OTLDZ0KZ
|
CD47_HUMAN
|
Decreases Expression
|
[137] |
Nuclear factor of activated T-cells, cytoplasmic 3 (NFATC3)
|
OTYOORME
|
NFAC3_HUMAN
|
Increases Expression
|
[137] |
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (ECH1)
|
OTA0UNHM
|
ECH1_HUMAN
|
Increases Expression
|
[137] |
TNF receptor-associated factor 3 (TRAF3)
|
OT5TQBGV
|
TRAF3_HUMAN
|
Increases Expression
|
[137] |
Natural killer cells antigen CD94 (KLRD1)
|
OTMYLOV4
|
KLRD1_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-15 receptor subunit alpha (IL15RA)
|
OTXP1QC5
|
I15RA_HUMAN
|
Decreases Expression
|
[137] |
Myotubularin (MTM1)
|
OT3B517W
|
MTM1_HUMAN
|
Increases Expression
|
[137] |
Methylglutaconyl-CoA hydratase, mitochondrial (AUH)
|
OT8VKBXX
|
AUHM_HUMAN
|
Increases Expression
|
[137] |
Pro-interleukin-16 (IL16)
|
OTZ2MO6B
|
IL16_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-18 (IL18)
|
OTBB2A8O
|
IL18_HUMAN
|
Increases Expression
|
[137] |
Next to BRCA1 gene 1 protein (NBR1)
|
OTVRL7J9
|
NBR1_HUMAN
|
Increases Expression
|
[137] |
EKC/KEOPS complex subunit LAGE3 (LAGE3)
|
OTKBQHZI
|
LAGE3_HUMAN
|
Decreases Expression
|
[137] |
Signal transducer and activator of transcription 4 (STAT4)
|
OTAK3VFR
|
STAT4_HUMAN
|
Increases Expression
|
[137] |
Caspase-8 (CASP8)
|
OTA8TVI8
|
CASP8_HUMAN
|
Increases Expression
|
[137] |
Neutrophil cytosol factor 4 (NCF4)
|
OTX007YL
|
NCF4_HUMAN
|
Decreases Expression
|
[137] |
Splicing factor 3B subunit 3 (SF3B3)
|
OTAC9LZT
|
SF3B3_HUMAN
|
Decreases Expression
|
[137] |
Protein transport protein Sec23B (SEC23B)
|
OT2NFSIQ
|
SC23B_HUMAN
|
Decreases Expression
|
[137] |
Metastasis-suppressor KiSS-1 (KISS1)
|
OT6IE3K2
|
KISS1_HUMAN
|
Decreases Expression
|
[137] |
Probable E3 ubiquitin-protein ligase HERC1 (HERC1)
|
OT73FVYZ
|
HERC1_HUMAN
|
Increases Expression
|
[137] |
Interleukin-17A (IL17A)
|
OTY72FT2
|
IL17_HUMAN
|
Decreases Expression
|
[137] |
Prostacyclin synthase (PTGIS)
|
OTT3RW6N
|
PTGIS_HUMAN
|
Decreases Expression
|
[137] |
Keratin, type II cytoskeletal 71 (KRT71)
|
OTI91X9Z
|
K2C71_HUMAN
|
Decreases Expression
|
[137] |
Pyrroline-5-carboxylate reductase 3 (PYCR3)
|
OT3SHY2S
|
P5CR3_HUMAN
|
Decreases Expression
|
[137] |
Torsin-2A (TOR2A)
|
OT1EGCDU
|
TOR2A_HUMAN
|
Decreases Expression
|
[137] |
Collectin-12 (COLEC12)
|
OTIQTK9G
|
COL12_HUMAN
|
Decreases Expression
|
[137] |
ER membrane protein complex subunit 10 (EMC10)
|
OTQ6S50X
|
EMC10_HUMAN
|
Decreases Expression
|
[137] |
Protein angel homolog 2 (ANGEL2)
|
OT2Q1KU5
|
ANGE2_HUMAN
|
Increases Expression
|
[137] |
Nucleoredoxin (NXN)
|
OT35N40G
|
NXN_HUMAN
|
Decreases Expression
|
[137] |
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (HIBCH)
|
OTU2VHWR
|
HIBCH_HUMAN
|
Increases Expression
|
[137] |
Nucleolus and neural progenitor protein (NEPRO)
|
OTE5H49L
|
NEPRO_HUMAN
|
Increases Expression
|
[137] |
Long-chain fatty acid transport protein 1 (SLC27A1)
|
OTK03OZN
|
S27A1_HUMAN
|
Decreases Expression
|
[137] |
Kelch domain-containing protein 10 (KLHDC10)
|
OTLDF1OX
|
KLD10_HUMAN
|
Increases Expression
|
[137] |
Mucin-6 (MUC6)
|
OTPVL723
|
MUC6_HUMAN
|
Decreases Expression
|
[137] |
Cytochrome P450 4V2 (CYP4V2)
|
OTQKNK0D
|
CP4V2_HUMAN
|
Increases Expression
|
[137] |
Fatty acid 2-hydroxylase (FA2H)
|
OT8HA13U
|
FA2H_HUMAN
|
Decreases Expression
|
[137] |
Phospholipid phosphatase-related protein type 4 (PLPPR4)
|
OTBOWTC5
|
PLPR4_HUMAN
|
Decreases Expression
|
[137] |
Adiponectin receptor protein 2 (ADIPOR2)
|
OT2HDTL8
|
PAQR2_HUMAN
|
Increases Expression
|
[137] |
Ras-specific guanine nucleotide-releasing factor RalGPS2 (RALGPS2)
|
OTOYS0SD
|
RGPS2_HUMAN
|
Increases Expression
|
[137] |
SURP and G-patch domain-containing protein 2 (SUGP2)
|
OTPUUJYX
|
SUGP2_HUMAN
|
Increases Expression
|
[137] |
Spindle and kinetochore-associated protein 3 (SKA3)
|
OTLHEVJD
|
SKA3_HUMAN
|
Decreases Expression
|
[137] |
NAD-dependent protein deacetylase sirtuin-2 (SIRT2)
|
OT5Q6SVK
|
SIR2_HUMAN
|
Decreases Expression
|
[137] |
Threonine synthase-like 1 (THNSL1)
|
OTQNFH3E
|
THNS1_HUMAN
|
Decreases Expression
|
[137] |
Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2)
|
OT0HFPCD
|
LIRB2_HUMAN
|
Decreases Expression
|
[137] |
Coiled-coil domain-containing protein 82 (CCDC82)
|
OT16EAZ7
|
CCD82_HUMAN
|
Increases Expression
|
[137] |
Leucine repeat adapter protein 25 (FAM89B)
|
OT11J9HL
|
LRA25_HUMAN
|
Decreases Expression
|
[137] |
Ubiquitin carboxyl-terminal hydrolase MINDY-1 (MINDY1)
|
OTVLF4G5
|
MINY1_HUMAN
|
Increases Expression
|
[137] |
Programmed cell death protein 7 (PDCD7)
|
OTK5YO7J
|
PDCD7_HUMAN
|
Increases Expression
|
[137] |
Trinucleotide repeat-containing gene 6A protein (TNRC6A)
|
OT493IOM
|
TNR6A_HUMAN
|
Increases Expression
|
[137] |
Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1)
|
OTA1STFZ
|
LIRB1_HUMAN
|
Decreases Expression
|
[137] |
N-lysine methyltransferase SETD6 (SETD6)
|
OTH5APN1
|
SETD6_HUMAN
|
Increases Expression
|
[137] |
DmX-like protein 2 (DMXL2)
|
OTB4JWN3
|
DMXL2_HUMAN
|
Increases Expression
|
[137] |
DIS3-like exonuclease 1 (DIS3L)
|
OTYWZ4EM
|
DI3L1_HUMAN
|
Increases Expression
|
[137] |
Peptidyl-prolyl cis-trans isomerase-like 4 (PPIL4)
|
OTFTLFJS
|
PPIL4_HUMAN
|
Increases Expression
|
[137] |
Spindle and kinetochore-associated protein 2 (SKA2)
|
OTVYF4XT
|
SKA2_HUMAN
|
Decreases Expression
|
[137] |
Fatty acyl-CoA reductase 1 (FAR1)
|
OTLHTYIE
|
FACR1_HUMAN
|
Decreases Expression
|
[137] |
Solute carrier organic anion transporter family member 2A1 (SLCO2A1)
|
OT3062CA
|
SO2A1_HUMAN
|
Decreases Expression
|
[137] |
Glycine N-acyltransferase-like protein 1 (GLYATL1)
|
OTS8JSRY
|
GLYL1_HUMAN
|
Increases Expression
|
[137] |
Adiponectin receptor protein 1 (ADIPOR1)
|
OT65ZFZN
|
PAQR1_HUMAN
|
Increases Expression
|
[137] |
Probable inactive tRNA-specific adenosine deaminase-like protein 3 (ADAT3)
|
OTMEU45R
|
ADAT3_HUMAN
|
Decreases Expression
|
[137] |
Multidrug and toxin extrusion protein 1 (SLC47A1)
|
OTZX0U5Q
|
S47A1_HUMAN
|
Increases Expression
|
[137] |
Kelch domain-containing protein 7B (KLHDC7B)
|
OT2H5BNX
|
KLD7B_HUMAN
|
Decreases Expression
|
[137] |
RUS family member 1 (RUSF1)
|
OTRIIY6J
|
RUSF1_HUMAN
|
Decreases Expression
|
[137] |
Hematopoietic SH2 domain-containing protein (HSH2D)
|
OTOGB2BR
|
HSH2D_HUMAN
|
Increases Expression
|
[137] |
Mas-related G-protein coupled receptor member X2 (MRGPRX2)
|
OT2XA799
|
MRGX2_HUMAN
|
Decreases Expression
|
[137] |
Cilia- and flagella-associated protein 44 (CFAP44)
|
OT1273MD
|
CFA44_HUMAN
|
Increases Expression
|
[137] |
Diacylglycerol O-acyltransferase 2 (DGAT2)
|
OTE5PDD0
|
DGAT2_HUMAN
|
Increases Expression
|
[137] |
Inositol polyphosphate-4-phosphatase type I A (INPP4A)
|
OT8FZB8T
|
INP4A_HUMAN
|
Decreases Expression
|
[137] |
Granulocyte colony-stimulating factor receptor (CSF3R)
|
OTXRAY6X
|
CSF3R_HUMAN
|
Decreases Expression
|
[137] |
Transcription factor 12 (TCF12)
|
OTZVONNU
|
HTF4_HUMAN
|
Increases Expression
|
[137] |
C-C motif chemokine 13 (CCL13)
|
OTNX0JD0
|
CCL13_HUMAN
|
Decreases Expression
|
[137] |
Zinc finger protein Gfi-1 (GFI1)
|
OT9HB9H8
|
GFI1_HUMAN
|
Decreases Expression
|
[137] |
C-C motif chemokine 19 (CCL19)
|
OTQ2UJMH
|
CCL19_HUMAN
|
Decreases Expression
|
[137] |
Endothelial PAS domain-containing protein 1 (EPAS1)
|
OTRE3O8U
|
EPAS1_HUMAN
|
Increases Expression
|
[137] |
Adenine nucleotide translocase lysine N-methyltransferase (ANTKMT)
|
OTDV54V6
|
ANKMT_HUMAN
|
Decreases Expression
|
[137] |
Protein FAM167B (FAM167B)
|
OT45SD3K
|
F167B_HUMAN
|
Decreases Expression
|
[137] |
Enoyl- reductase, mitochondrial (MECR)
|
OTJQ5XKQ
|
MECR_HUMAN
|
Increases Expression
|
[137] |
Peroxisomal trans-2-enoyl-CoA reductase (PECR)
|
OT5MS8EM
|
PECR_HUMAN
|
Increases Expression
|
[137] |
Ras-related protein Rab-6C (RAB6C)
|
OTA66R5E
|
RAB6C_HUMAN
|
Decreases Expression
|
[137] |
Semaphorin-4A (SEMA4A)
|
OT8901H3
|
SEM4A_HUMAN
|
Decreases Expression
|
[137] |
UPF0488 protein C8orf33 (C8ORF33)
|
OTFCF3V5
|
CH033_HUMAN
|
Decreases Expression
|
[137] |
Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (RSAD1)
|
OTHNSDGW
|
RSAD1_HUMAN
|
Increases Expression
|
[137] |
MLX-interacting protein (MLXIP)
|
OT30UNI7
|
MLXIP_HUMAN
|
Increases Expression
|
[137] |
Solute carrier family 38 member 10 (SLC38A10)
|
OTXPUL6S
|
S38AA_HUMAN
|
Decreases Expression
|
[137] |
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2)
|
OTPGYWKC
|
NOD2_HUMAN
|
Decreases Expression
|
[137] |
Mineralization regulator ANKH (ANKH)
|
OTCN25R5
|
ANKH_HUMAN
|
Increases Expression
|
[137] |
Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAM)
|
OTR1XD9B
|
GPAT1_HUMAN
|
Increases Expression
|
[137] |
Complement component C1q receptor (CD93)
|
OT6HZT6H
|
C1QR1_HUMAN
|
Decreases Expression
|
[137] |
Achaete-scute homolog 3 (ASCL3)
|
OT1Y3M4K
|
ASCL3_HUMAN
|
Decreases Expression
|
[137] |
Protein transport protein Sec31B (SEC31B)
|
OTHV632I
|
SC31B_HUMAN
|
Increases Expression
|
[137] |
Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2)
|
OTB1FZJU
|
ACSA_HUMAN
|
Increases Expression
|
[137] |
Sphingosine kinase 2 (SPHK2)
|
OTNFG52M
|
SPHK2_HUMAN
|
Decreases Expression
|
[137] |
Interleukin-17 receptor B (IL17RB)
|
OT0KDNSF
|
I17RB_HUMAN
|
Increases Expression
|
[137] |
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (AGPAT3)
|
OTAUR5TG
|
PLCC_HUMAN
|
Increases Expression
|
[137] |
Keratin, type II cuticular Hb2 (KRT82)
|
OT8Y9T1U
|
KRT82_HUMAN
|
Decreases Expression
|
[137] |
1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 (PNPLA3)
|
OTR4990X
|
PLPL3_HUMAN
|
Increases Expression
|
[137] |
PI-PLC X domain-containing protein 1 (PLCXD1)
|
OTU7KCQL
|
PLCX1_HUMAN
|
Increases Expression
|
[137] |
Interleukin-1 receptor-associated kinase 4 (IRAK4)
|
OT9JTJWC
|
IRAK4_HUMAN
|
Increases Expression
|
[137] |
Sphingosine kinase 1 (SPHK1)
|
OTWYPBVD
|
SPHK1_HUMAN
|
Decreases Expression
|
[137] |
Protein Mis18-alpha (MIS18A)
|
OTD80K5X
|
MS18A_HUMAN
|
Decreases Expression
|
[137] |
Protein CLN8 (CLN8)
|
OT0D4CB5
|
CLN8_HUMAN
|
Increases Expression
|
[137] |
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1)
|
OTM3H5OA
|
MALT1_HUMAN
|
Increases Expression
|
[137] |
Prenylcysteine oxidase 1 (PCYOX1)
|
OT8FBKY0
|
PCYOX_HUMAN
|
Increases Expression
|
[137] |
Alpha-methylacyl-CoA racemase (AMACR)
|
OTUU22PK
|
AMACR_HUMAN
|
Increases Expression
|
[137] |
A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAMTS7)
|
OTVKZ1DV
|
ATS7_HUMAN
|
Decreases Expression
|
[137] |
Long-chain-fatty-acid--CoA ligase 6 (ACSL6)
|
OT0TT8P8
|
ACSL6_HUMAN
|
Increases Expression
|
[137] |
Teneurin-1 (TENM1)
|
OTSKSU4V
|
TEN1_HUMAN
|
Decreases Expression
|
[137] |
Serine/threonine-protein kinase TAO2 (TAOK2)
|
OTNUMOZ1
|
TAOK2_HUMAN
|
Decreases Expression
|
[137] |
Two pore channel protein 1 (TPCN1)
|
OTT4C4DI
|
TPC1_HUMAN
|
Increases Expression
|
[137] |
Apelin (APLN)
|
OTSWJD7B
|
APEL_HUMAN
|
Decreases Expression
|
[137] |
Myotubularin-related protein 7 (MTMR7)
|
OT47NVYM
|
MTMR7_HUMAN
|
Decreases Expression
|
[137] |
Ninein-like protein (NINL)
|
OTWIK6HT
|
NINL_HUMAN
|
Increases Expression
|
[137] |
Potassium channel subfamily K member 7 (KCNK7)
|
OTFJOWT4
|
KCNK7_HUMAN
|
Decreases Expression
|
[137] |
Krueppel-like factor 2 (KLF2)
|
OTIP1UFX
|
KLF2_HUMAN
|
Decreases Expression
|
[137] |
Neuroplastin (NPTN)
|
OTAQKSAU
|
NPTN_HUMAN
|
Decreases Expression
|
[137] |
Inositol 1,4,5-triphosphate receptor associated 1 (IRAG1)
|
OTMRW5U5
|
IRAG1_HUMAN
|
Decreases Expression
|
[137] |
Mitochondrial inner membrane protease ATP23 homolog (ATP23)
|
OT303R2T
|
ATP23_HUMAN
|
Increases Expression
|
[137] |
Lymphocyte antigen 96 (LY96)
|
OTN4HXA2
|
LY96_HUMAN
|
Decreases Expression
|
[137] |
Phospholipid-transporting ATPase ABCA1 (ABCA1)
|
OT94G6BQ
|
ABCA1_HUMAN
|
Increases Expression
|
[184] |
Sterol 26-hydroxylase, mitochondrial (CYP27A1)
|
OT649C01
|
CP27A_HUMAN
|
Increases Expression
|
[184] |
CCN family member 1 (CCN1)
|
OTKJBEMD
|
CCN1_HUMAN
|
Increases Expression
|
[138] |
Phospholipid phosphatase 3 (PLPP3)
|
OTSSF7BK
|
PLPP3_HUMAN
|
Decreases Expression
|
[138] |
Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3)
|
OTPGHZB9
|
IFIT3_HUMAN
|
Decreases Expression
|
[138] |
Calmegin (CLGN)
|
OTEWVFQV
|
CLGN_HUMAN
|
Decreases Expression
|
[138] |
D-3-phosphoglycerate dehydrogenase (PHGDH)
|
OT1LMRTG
|
SERA_HUMAN
|
Decreases Expression
|
[138] |
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2)
|
OT0KMIYQ
|
RIPK2_HUMAN
|
Decreases Expression
|
[138] |
Gasdermin-E (GSDME)
|
OT1ZWY32
|
GSDME_HUMAN
|
Decreases Expression
|
[138] |
Toll-like receptor 2 (TLR2)
|
OTGO5P4R
|
TLR2_HUMAN
|
Decreases Expression
|
[138] |
Ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3)
|
OTDA431Y
|
ENTP3_HUMAN
|
Increases Expression
|
[138] |
Antiviral innate immune response receptor RIG-I (RIGI)
|
OTFIIC43
|
RIGI_HUMAN
|
Decreases Expression
|
[138] |
2'-5'-oligoadenylate synthase 1 (OAS1)
|
OT8ZLOCY
|
OAS1_HUMAN
|
Decreases Expression
|
[138] |
Superoxide dismutase , mitochondrial (SOD2)
|
OTIWXGZ9
|
SODM_HUMAN
|
Decreases Expression
|
[138] |
Ubiquitin-like protein ISG15 (ISG15)
|
OT53QQ7N
|
ISG15_HUMAN
|
Decreases Expression
|
[138] |
Fibroblast growth factor 1 (FGF1)
|
OT8I64X8
|
FGF1_HUMAN
|
Increases Expression
|
[138] |
Interleukin-6 (IL6)
|
OTUOSCCU
|
IL6_HUMAN
|
Decreases Expression
|
[138] |
Asparagine synthetase (ASNS)
|
OT8R922G
|
ASNS_HUMAN
|
Decreases Expression
|
[138] |
Hepatocyte growth factor receptor (MET)
|
OT7K55MU
|
MET_HUMAN
|
Decreases Expression
|
[138] |
Steryl-sulfatase (STS)
|
OTXTJQPC
|
STS_HUMAN
|
Increases Expression
|
[138] |
Neuromedin-B (NMB)
|
OT4NLN6H
|
NMB_HUMAN
|
Decreases Expression
|
[138] |
Stromelysin-2 (MMP10)
|
OTJDWW8Q
|
MMP10_HUMAN
|
Decreases Expression
|
[138] |
Interferon alpha-inducible protein 6 (IFI6)
|
OTWOOAM4
|
IFI6_HUMAN
|
Decreases Expression
|
[138] |
Interleukin-1 receptor antagonist protein (IL1RN)
|
OT308CBE
|
IL1RA_HUMAN
|
Decreases Expression
|
[138] |
Interferon-induced GTP-binding protein Mx1 (MX1)
|
OT6X8G5T
|
MX1_HUMAN
|
Decreases Expression
|
[138] |
Fibroblast growth factor 7 (FGF7)
|
OTGK6ANL
|
FGF7_HUMAN
|
Increases Expression
|
[138] |
Fibulin-1 (FBLN1)
|
OT5MHHOP
|
FBLN1_HUMAN
|
Increases Expression
|
[138] |
Atypical chemokine receptor 3 (ACKR3)
|
OTA6GA4F
|
ACKR3_HUMAN
|
Decreases Expression
|
[138] |
11-beta-hydroxysteroid dehydrogenase 1 (HSD11B1)
|
OTO7FJA9
|
DHI1_HUMAN
|
Decreases Expression
|
[138] |
Myristoylated alanine-rich C-kinase substrate (MARCKS)
|
OT7N056G
|
MARCS_HUMAN
|
Decreases Expression
|
[138] |
Guanylate-binding protein 1 (GBP1)
|
OTUM7RPJ
|
GBP1_HUMAN
|
Decreases Expression
|
[138] |
Prostaglandin G/H synthase 2 (PTGS2)
|
OT75U9M4
|
PGH2_HUMAN
|
Decreases Expression
|
[138] |
Macrophage metalloelastase (MMP12)
|
OT9Z7LHM
|
MMP12_HUMAN
|
Decreases Expression
|
[138] |
Interferon alpha-inducible protein 27, mitochondrial (IFI27)
|
OTI2XGIT
|
IFI27_HUMAN
|
Decreases Expression
|
[138] |
Signal transducer and activator of transcription 1-alpha/beta (STAT1)
|
OTLMBUZ6
|
STAT1_HUMAN
|
Decreases Expression
|
[138] |
Retinoic acid receptor responder protein 1 (RARRES1)
|
OTETUPP5
|
TIG1_HUMAN
|
Increases Expression
|
[138] |
Prolargin (PRELP)
|
OT9EEBUJ
|
PRELP_HUMAN
|
Increases Expression
|
[138] |
Spermine synthase (SMS)
|
OT8JYKNH
|
SPSY_HUMAN
|
Decreases Expression
|
[138] |
C-X-C chemokine receptor type 4 (CXCR4)
|
OTUFSBX2
|
CXCR4_HUMAN
|
Decreases Expression
|
[138] |
C-C motif chemokine 20 (CCL20)
|
OTUCJY4N
|
CCL20_HUMAN
|
Decreases Expression
|
[138] |
Interferon-induced 35 kDa protein (IFI35)
|
OTV9RZ53
|
IN35_HUMAN
|
Decreases Expression
|
[138] |
Tumor necrosis factor alpha-induced protein 2 (TNFAIP2)
|
OTRZH80H
|
TNAP2_HUMAN
|
Decreases Expression
|
[138] |
Bone marrow stromal antigen 2 (BST2)
|
OTU4LCJV
|
BST2_HUMAN
|
Decreases Expression
|
[138] |
EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1)
|
OTZVUOOB
|
FBLN3_HUMAN
|
Increases Expression
|
[138] |
Probable ATP-dependent RNA helicase DDX10 (DDX10)
|
OTH48438
|
DDX10_HUMAN
|
Increases Expression
|
[138] |
Neuronal membrane glycoprotein M6-b (GPM6B)
|
OT8Q1582
|
GPM6B_HUMAN
|
Increases Expression
|
[138] |
Laminin subunit beta-3 (LAMB3)
|
OTFPU6W8
|
LAMB3_HUMAN
|
Decreases Expression
|
[138] |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2)
|
OTTUU92F
|
ENPP2_HUMAN
|
Increases Expression
|
[138] |
Nidogen-2 (NID2)
|
OTHC33FF
|
NID2_HUMAN
|
Increases Expression
|
[138] |
Lymphocyte antigen 6E (LY6E)
|
OTMG16BZ
|
LY6E_HUMAN
|
Decreases Expression
|
[138] |
Interferon-induced protein 44-like (IFI44L)
|
OTXKORJP
|
IF44L_HUMAN
|
Decreases Expression
|
[138] |
E3 ubiquitin-protein ligase RNF19B (RNF19B)
|
OTYCWKBP
|
RN19B_HUMAN
|
Decreases Expression
|
[138] |
Amphoterin-induced protein 2 (AMIGO2)
|
OTPAIT1O
|
AMGO2_HUMAN
|
Decreases Expression
|
[138] |
Probable E3 ubiquitin-protein ligase HERC6 (HERC6)
|
OT7G9PQE
|
HERC6_HUMAN
|
Decreases Expression
|
[138] |
Interferon-induced protein 44 (IFI44)
|
OTOKSZVA
|
IFI44_HUMAN
|
Decreases Expression
|
[138] |
S-adenosylmethionine-dependent nucleotide dehydratase RSAD2 (RSAD2)
|
OTCA9WCM
|
RSAD2_HUMAN
|
Decreases Expression
|
[138] |
Nuclear receptor subfamily 4 group A member 3 (NR4A3)
|
OTPBE9R1
|
NR4A3_HUMAN
|
Decreases Expression
|
[138] |
Interferon-stimulated gene 20 kDa protein (ISG20)
|
OTCWRJJW
|
ISG20_HUMAN
|
Decreases Expression
|
[138] |
Latexin (LXN)
|
OTZQ2M6Y
|
LXN_HUMAN
|
Increases Expression
|
[138] |
Interferon-induced helicase C domain-containing protein 1 (IFIH1)
|
OTZA2AHA
|
IFIH1_HUMAN
|
Decreases Expression
|
[138] |
Anthrax toxin receptor 1 (ANTXR1)
|
OT5W1GPC
|
ANTR1_HUMAN
|
Increases Expression
|
[138] |
Spondin-1 (SPON1)
|
OTC06MY4
|
SPON1_HUMAN
|
Increases Expression
|
[138] |
Interleukin-23 subunit alpha (IL23A)
|
OTYO99HC
|
IL23A_HUMAN
|
Decreases Expression
|
[138] |
Matrix-remodeling-associated protein 5 (MXRA5)
|
OTXZBWCU
|
MXRA5_HUMAN
|
Increases Expression
|
[138] |
NADH dehydrogenase 1 alpha subcomplex subunit 4-like 2 (NDUFA4L2)
|
OTK0PG7R
|
NUA4L_HUMAN
|
Decreases Expression
|
[138] |
Serine/threonine-protein phosphatase 4 regulatory subunit 2 (PPP4R2)
|
OT7FCZRM
|
PP4R2_HUMAN
|
Increases Expression
|
[138] |
Large neutral amino acids transporter small subunit 2 (SLC7A8)
|
OT8XXVO8
|
LAT2_HUMAN
|
Increases Expression
|
[138] |
Cystine/glutamate transporter (SLC7A11)
|
OTKJ6PXW
|
XCT_HUMAN
|
Decreases Expression
|
[138] |
Hypoxia-inducible lipid droplet-associated protein (HILPDA)
|
OTEID3ZM
|
HLPDA_HUMAN
|
Decreases Expression
|
[138] |
Tumor necrosis factor receptor superfamily member 10A (TNFRSF10A)
|
OTBPCU2O
|
TR10A_HUMAN
|
Increases Expression
|
[140] |
Claudin-4 (CLDN4)
|
OT9C4PZ4
|
CLD4_HUMAN
|
Increases Expression
|
[140] |
Apoptotic protease-activating factor 1 (APAF1)
|
OTJWIVY0
|
APAF_HUMAN
|
Increases Expression
|
[140] |
Neuropilin-1 (NRP1)
|
OTCGULYV
|
NRP1_HUMAN
|
Increases Expression
|
[140] |
Proepiregulin (EREG)
|
OTRM4NQY
|
EREG_HUMAN
|
Increases Expression
|
[140] |
Myosin regulatory light chain 12B (MYL12B)
|
OTXMLQOT
|
ML12B_HUMAN
|
Increases Expression
|
[140] |
Toll-like receptor 3 (TLR3)
|
OT8QPYXZ
|
TLR3_HUMAN
|
Increases Expression
|
[140] |
Growth arrest and DNA damage-inducible protein GADD45 beta (GADD45B)
|
OTL9I7LO
|
GA45B_HUMAN
|
Increases Expression
|
[140] |
Semaphorin-7A (SEMA7A)
|
OT0ZJK64
|
SEM7A_HUMAN
|
Increases Expression
|
[140] |
Tumor necrosis factor receptor superfamily member 21 (TNFRSF21)
|
OT3EDGXO
|
TNR21_HUMAN
|
Increases Expression
|
[140] |
Ubiquitin-like protein ATG12 (ATG12)
|
OTJRO09Y
|
ATG12_HUMAN
|
Increases Expression
|
[140] |
Tight junction protein ZO-3 (TJP3)
|
OTC1K8HC
|
ZO3_HUMAN
|
Increases Expression
|
[140] |
Tumor necrosis factor ligand superfamily member 15 (TNFSF15)
|
OTNGA2BW
|
TNF15_HUMAN
|
Increases Expression
|
[140] |
Growth arrest and DNA damage-inducible protein GADD45 gamma (GADD45G)
|
OT8V1J4M
|
GA45G_HUMAN
|
Increases Expression
|
[140] |
Claudin-7 (CLDN7)
|
OTNE0XHQ
|
CLD7_HUMAN
|
Increases Expression
|
[140] |
Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4)
|
OTBMJUOC
|
M4K4_HUMAN
|
Increases Expression
|
[140] |
Claudin-1 (CLDN1)
|
OT27KV99
|
CLD1_HUMAN
|
Increases Expression
|
[140] |
Tissue-type plasminogen activator (PLAT)
|
OTQPDNAB
|
TPA_HUMAN
|
Increases Expression
|
[140] |
Prelamin-A/C (LMNA)
|
OT3SG7ZR
|
LMNA_HUMAN
|
Increases Expression
|
[140] |
Interstitial collagenase (MMP1)
|
OTI4I2V1
|
MMP1_HUMAN
|
Increases Expression
|
[140] |
Platelet-derived growth factor subunit A (PDGFA)
|
OTCMZ0W8
|
PDGFA_HUMAN
|
Increases Expression
|
[140] |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
OTOAUNCK
|
ERBB2_HUMAN
|
Increases Expression
|
[140] |
Integrin beta-2 (ITGB2)
|
OTEKPEPR
|
ITB2_HUMAN
|
Increases Expression
|
[140] |
Endothelin-1 (EDN1)
|
OTZCACEG
|
EDN1_HUMAN
|
Increases Expression
|
[140] |
Intercellular adhesion molecule 1 (ICAM1)
|
OTTOIX77
|
ICAM1_HUMAN
|
Increases Expression
|
[140] |
Cholecystokinin (CCK)
|
OT1GCG0L
|
CCKN_HUMAN
|
Increases Expression
|
[140] |
Gelsolin (GSN)
|
OT4KS2UU
|
GELS_HUMAN
|
Increases Expression
|
[140] |
Cyclin-dependent kinase 1 (CDK1)
|
OTW1SC2N
|
CDK1_HUMAN
|
Decreases Expression
|
[140] |
Glia-derived nexin (SERPINE2)
|
OTYF5340
|
GDN_HUMAN
|
Increases Expression
|
[140] |
Extracellular superoxide dismutase (SOD3)
|
OTIOZQAB
|
SODE_HUMAN
|
Increases Expression
|
[140] |
Matrilysin (MMP7)
|
OTVT3SEJ
|
MMP7_HUMAN
|
Increases Expression
|
[140] |
Clathrin light chain B (CLTB)
|
OTPW9VRE
|
CLCB_HUMAN
|
Increases Expression
|
[140] |
Heme oxygenase 1 (HMOX1)
|
OTC1W6UX
|
HMOX1_HUMAN
|
Increases Expression
|
[140] |
Calmodulin-1 (CALM2)
|
OTNYA92F
|
CALM1_HUMAN
|
Increases Expression
|
[140] |
Ras-related protein R-Ras (RRAS)
|
OTBBF28C
|
RRAS_HUMAN
|
Increases Expression
|
[140] |
Interferon regulatory factor 1 (IRF1)
|
OT43DI6J
|
IRF1_HUMAN
|
Increases Expression
|
[140] |
Cyclin-dependent kinase 4 (CDK4)
|
OT7EP05T
|
CDK4_HUMAN
|
Decreases Expression
|
[140] |
Proliferating cell nuclear antigen (PCNA)
|
OTHZ1RIA
|
PCNA_HUMAN
|
Increases Expression
|
[140] |
Bone morphogenetic protein 1 (BMP1)
|
OTRFFAL4
|
BMP1_HUMAN
|
Increases Expression
|
[140] |
Leukemia inhibitory factor (LIF)
|
OTO46S5S
|
LIF_HUMAN
|
Increases Expression
|
[140] |
Interferon gamma receptor 1 (IFNGR1)
|
OTCTQBWW
|
INGR1_HUMAN
|
Increases Expression
|
[140] |
Ezrin (EZR)
|
OTHBPF1Z
|
EZRI_HUMAN
|
Increases Expression
|
[140] |
Integrin beta-4 (ITGB4)
|
OT28UK84
|
ITB4_HUMAN
|
Increases Expression
|
[140] |
Beta-galactosidase (GLB1)
|
OTB0TKAG
|
BGAL_HUMAN
|
Increases Expression
|
[140] |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (ATP2A2)
|
OTPGAU0U
|
AT2A2_HUMAN
|
Increases Expression
|
[140] |
Amine oxidase A (MAOA)
|
OT8NIWMQ
|
AOFA_HUMAN
|
Increases Expression
|
[140] |
Plasma membrane calcium-transporting ATPase 4 (ATP2B4)
|
OTMWFDAC
|
AT2B4_HUMAN
|
Increases Expression
|
[140] |
G1/S-specific cyclin-D1 (CCND1)
|
OT8HPTKJ
|
CCND1_HUMAN
|
Increases Expression
|
[140] |
Interleukin-4 receptor subunit alpha (IL4R)
|
OTTXOTCW
|
IL4RA_HUMAN
|
Increases Expression
|
[140] |
Insulin-like growth factor-binding protein 6 (IGFBP6)
|
OTW878VI
|
IBP6_HUMAN
|
Increases Expression
|
[140] |
Integrin alpha-3 (ITGA3)
|
OTBCH21D
|
ITA3_HUMAN
|
Increases Expression
|
[140] |
Integrin beta-8 (ITGB8)
|
OTP4HSHG
|
ITB8_HUMAN
|
Increases Expression
|
[140] |
Amine oxidase B (MAOB)
|
OTTDFM1O
|
AOFB_HUMAN
|
Increases Expression
|
[140] |
Proteasome subunit beta type-8 (PSMB8)
|
OTW5XGMF
|
PSB8_HUMAN
|
Increases Expression
|
[140] |
Mitogen-activated protein kinase 1 (MAPK1)
|
OTH85PI5
|
MK01_HUMAN
|
Increases Expression
|
[140] |
G1/S-specific cyclin-D2 (CCND2)
|
OTDULQF9
|
CCND2_HUMAN
|
Increases Expression
|
[140] |
M-phase inducer phosphatase 3 (CDC25C)
|
OTPQI71S
|
MPIP3_HUMAN
|
Decreases Expression
|
[140] |
Leukocyte elastase inhibitor (SERPINB1)
|
OT5RDUFO
|
ILEU_HUMAN
|
Increases Expression
|
[140] |
cAMP-dependent protein kinase type I-beta regulatory subunit (PRKAR1B)
|
OT777OHS
|
KAP1_HUMAN
|
Increases Expression
|
[140] |
RAC-alpha serine/threonine-protein kinase (AKT1)
|
OT8H2YY7
|
AKT1_HUMAN
|
Increases Expression
|
[140] |
Nitric oxide synthase, inducible (NOS2)
|
OTKKIOJ1
|
NOS2_HUMAN
|
Increases Expression
|
[140] |
Metalloproteinase inhibitor 3 (TIMP3)
|
OTDGQAD1
|
TIMP3_HUMAN
|
Increases Expression
|
[140] |
Tumor necrosis factor receptor superfamily member 3 (LTBR)
|
OT2HVZGV
|
TNR3_HUMAN
|
Increases Expression
|
[140] |
Serpin B5 (SERPINB5)
|
OTSMXQRJ
|
SPB5_HUMAN
|
Increases Expression
|
[140] |
Breast cancer type 1 susceptibility protein (BRCA1)
|
OT5BN6VH
|
BRCA1_HUMAN
|
Increases Expression
|
[140] |
Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD2)
|
OTV232Y7
|
GPDM_HUMAN
|
Increases Expression
|
[140] |
Dual specificity mitogen-activated protein kinase kinase 4 (MAP2K4)
|
OTZPZX11
|
MP2K4_HUMAN
|
Increases Expression
|
[140] |
Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (PPP3CC)
|
OT0AQD93
|
PP2BC_HUMAN
|
Increases Expression
|
[140] |
Presenilin-1 (PSEN1)
|
OTKL39RT
|
PSN1_HUMAN
|
Increases Expression
|
[140] |
Matrix metalloproteinase-15 (MMP15)
|
OT1XF517
|
MMP15_HUMAN
|
Increases Expression
|
[140] |
Interleukin-1 receptor-associated kinase 1 (IRAK1)
|
OT133G8J
|
IRAK1_HUMAN
|
Increases Expression
|
[140] |
Cyclin-G1 (CCNG1)
|
OT17IA9L
|
CCNG1_HUMAN
|
Increases Expression
|
[140] |
Caspase-7 (CASP7)
|
OTAPJ040
|
CASP7_HUMAN
|
Increases Expression
|
[140] |
Transforming protein RhoA (RHOA)
|
OT6YOJ9N
|
RHOA_HUMAN
|
Increases Expression
|
[140] |
Interleukin-13 receptor subunit alpha-1 (IL13RA1)
|
OT59OYXP
|
I13R1_HUMAN
|
Increases Expression
|
[140] |
Nuclear factor NF-kappa-B p100 subunit (NFKB2)
|
OTS231V7
|
NFKB2_HUMAN
|
Increases Expression
|
[140] |
E3 ubiquitin-protein ligase Mdm2 (MDM2)
|
OTOVXARF
|
MDM2_HUMAN
|
Increases Expression
|
[140] |
2-oxoglutarate dehydrogenase complex component E1 (OGDH)
|
OTHGTQWF
|
ODO1_HUMAN
|
Increases Expression
|
[140] |
Pro-neuregulin-1, membrane-bound isoform (NRG1)
|
OTZO6F1X
|
NRG1_HUMAN
|
Increases Expression
|
[140] |
Max dimerization protein 1 (MXD1)
|
OTS5CTHX
|
MAD1_HUMAN
|
Increases Expression
|
[140] |
Peroxiredoxin-1 (PRDX1)
|
OTZ3BEC4
|
PRDX1_HUMAN
|
Increases Expression
|
[140] |
Tight junction protein ZO-1 (TJP1)
|
OTBDCUPK
|
ZO1_HUMAN
|
Increases Expression
|
[140] |
Apoptosis regulator BAX (BAX)
|
OTAW0V4V
|
BAX_HUMAN
|
Increases Expression
|
[140] |
Bcl-2-like protein 1 (BCL2L1)
|
OTRC5K9O
|
B2CL1_HUMAN
|
Increases Expression
|
[140] |
Peptidyl-prolyl cis-trans isomerase D (PPID)
|
OT2CDF7W
|
PPID_HUMAN
|
Increases Expression
|
[140] |
Mitogen-activated protein kinase 7 (MAPK7)
|
OTF7H7L7
|
MK07_HUMAN
|
Increases Expression
|
[140] |
Serine/threonine-protein kinase PAK 2 (PAK2)
|
OTLUNCIH
|
PAK2_HUMAN
|
Increases Expression
|
[140] |
Semaphorin-3B (SEMA3B)
|
OTCZCPMS
|
SEM3B_HUMAN
|
Increases Expression
|
[140] |
Baculoviral IAP repeat-containing protein 3 (BIRC3)
|
OT3E95KB
|
BIRC3_HUMAN
|
Increases Expression
|
[140] |
Sequestosome-1 (SQSTM1)
|
OTGY5D5J
|
SQSTM_HUMAN
|
Increases Expression
|
[140] |
Calcium/calmodulin-dependent protein kinase type II subunit gamma (CAMK2G)
|
OTHD9KJG
|
KCC2G_HUMAN
|
Increases Expression
|
[140] |
Calcium/calmodulin-dependent protein kinase type II subunit delta (CAMK2D)
|
OTJ5XLVU
|
KCC2D_HUMAN
|
Increases Expression
|
[140] |
Spectrin alpha chain, non-erythrocytic 1 (SPTAN1)
|
OT6VY3A3
|
SPTN1_HUMAN
|
Increases Expression
|
[140] |
Beclin-1 (BECN1)
|
OT4X293M
|
BECN1_HUMAN
|
Increases Expression
|
[140] |
Semaphorin-3A (SEMA3A)
|
OTQJSV7W
|
SEM3A_HUMAN
|
Increases Expression
|
[140] |
Inositol 1,4,5-trisphosphate receptor type 3 (ITPR3)
|
OTGQ2AOJ
|
ITPR3_HUMAN
|
Increases Expression
|
[140] |
Inositol 1,4,5-trisphosphate receptor type 1 (ITPR1)
|
OTX7MWW1
|
ITPR1_HUMAN
|
Increases Expression
|
[140] |
Glutamate receptor ionotropic, NMDA 2C (GRIN2C)
|
OTV7ZA9O
|
NMDE3_HUMAN
|
Increases Expression
|
[140] |
Toll-like receptor 1 (TLR1)
|
OTZTQIZO
|
TLR1_HUMAN
|
Increases Expression
|
[140] |
Mitogen-activated protein kinase 11 (MAPK11)
|
OT0AS010
|
MK11_HUMAN
|
Increases Expression
|
[140] |
Cystatin-M (CST6)
|
OTZVHJTF
|
CYTM_HUMAN
|
Increases Expression
|
[140] |
Bcl-2 homologous antagonist/killer (BAK1)
|
OTDP6ILW
|
BAK_HUMAN
|
Increases Expression
|
[140] |
MHC class I polypeptide-related sequence B (MICB)
|
OTS2DVDW
|
MICB_HUMAN
|
Increases Expression
|
[140] |
Quinone oxidoreductase PIG3 (TP53I3)
|
OTSCM68G
|
QORX_HUMAN
|
Increases Expression
|
[140] |
Autophagy-related protein 16-1 (ATG16L1)
|
OTEOYC5D
|
A16L1_HUMAN
|
Increases Expression
|
[140] |
Cytochrome c oxidase subunit 6B2 (COX6B2)
|
OT5KU3VV
|
CX6B2_HUMAN
|
Increases Expression
|
[140] |
Rho-related GTP-binding protein RhoU (RHOU)
|
OTERIAD4
|
RHOU_HUMAN
|
Increases Expression
|
[140] |
Ribonucleoside-diphosphate reductase subunit M2 B (RRM2B)
|
OTE8GBUR
|
RIR2B_HUMAN
|
Increases Expression
|
[140] |
Cysteine protease ATG4D (ATG4D)
|
OTSWUO4R
|
ATG4D_HUMAN
|
Increases Expression
|
[140] |
TIR domain-containing adapter molecule 1 (TICAM1)
|
OTK6Y1HK
|
TCAM1_HUMAN
|
Increases Expression
|
[140] |
DNA damage-regulated autophagy modulator protein 1 (DRAM1)
|
OTIJTXEN
|
DRAM1_HUMAN
|
Increases Expression
|
[140] |
Interleukin-22 receptor subunit alpha-1 (IL22RA1)
|
OTGVKLBR
|
I22R1_HUMAN
|
Increases Expression
|
[140] |
Protein Atg16l2 (ATG16L2)
|
OTJYU0W8
|
A16L2_HUMAN
|
Increases Expression
|
[140] |
Cysteine protease ATG4A (ATG4A)
|
OTDHXAPG
|
ATG4A_HUMAN
|
Increases Expression
|
[140] |
Histone acetyltransferase KAT2B (KAT2B)
|
OTWQITWK
|
KAT2B_HUMAN
|
Increases Expression
|
[140] |
Tumor necrosis factor receptor superfamily member 25 (TNFRSF25)
|
OTVZ7I3A
|
TNR25_HUMAN
|
Increases Expression
|
[140] |
Tumor protein p53-inducible nuclear protein 1 (TP53INP1)
|
OT2363Z9
|
T53I1_HUMAN
|
Increases Expression
|
[140] |
Claudin-23 (CLDN23)
|
OTN5RV40
|
CLD23_HUMAN
|
Increases Expression
|
[140] |
p53 apoptosis effector related to PMP-22 (PERP)
|
OTP0YL53
|
PERP_HUMAN
|
Increases Expression
|
[140] |
Rho-related GTP-binding protein RhoV (RHOV)
|
OTW4N3QN
|
RHOV_HUMAN
|
Increases Expression
|
[140] |
Mitogen-activated protein kinase kinase kinase 14 (MAP3K14)
|
OTT3DOOL
|
M3K14_HUMAN
|
Increases Expression
|
[140] |
Myeloid differentiation primary response protein MyD88 (MYD88)
|
OTB4D6FL
|
MYD88_HUMAN
|
Increases Expression
|
[140] |
Microtubule-associated proteins 1A/1B light chain 3B (MAP1LC3B)
|
OTUYHB84
|
MLP3B_HUMAN
|
Increases Expression
|
[140] |
Transient receptor potential cation channel subfamily V member 6 (TRPV6)
|
OTZ0LGNO
|
TRPV6_HUMAN
|
Increases Expression
|
[140] |
p53-induced death domain-containing protein 1 (PIDD1)
|
OTWFM930
|
PIDD1_HUMAN
|
Increases Expression
|
[140] |
Rho-related GTP-binding protein RhoF (RHOF)
|
OTPA3F8Q
|
RHOF_HUMAN
|
Increases Expression
|
[140] |
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A)
|
OT5V52LN
|
TNR12_HUMAN
|
Increases Expression
|
[140] |
Fructose-2,6-bisphosphatase TIGAR (TIGAR)
|
OTR7NMRJ
|
TIGAR_HUMAN
|
Increases Expression
|
[140] |
Serine/threonine-protein kinase PAK 6 (PAK6)
|
OTAHPZTT
|
PAK6_HUMAN
|
Increases Expression
|
[140] |
TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (TAB2)
|
OTPZK76F
|
TAB2_HUMAN
|
Increases Expression
|
[140] |
Cingulin (CGN)
|
OTBCQ8AQ
|
CING_HUMAN
|
Increases Expression
|
[140] |
Zinc finger protein PLAGL1 (PLAGL1)
|
OTZAO900
|
PLAL1_HUMAN
|
Increases Expression
|
[140] |
Cytosolic phospholipase A2 gamma (PLA2G4C)
|
OTIK5GT5
|
PA24C_HUMAN
|
Increases Expression
|
[140] |
Cofilin-2 (CFL2)
|
OTE2W0DH
|
COF2_HUMAN
|
Increases Expression
|
[140] |
Complex I intermediate-associated protein 30, mitochondrial (NDUFAF1)
|
OTYK9JU6
|
CIA30_HUMAN
|
Increases Expression
|
[140] |
Talin-2 (TLN2)
|
OT10QQBC
|
TLN2_HUMAN
|
Increases Expression
|
[140] |
Cysteine protease ATG4B (ATG4B)
|
OTQ4RNRM
|
ATG4B_HUMAN
|
Increases Expression
|
[140] |
NF-kappa-B essential modulator (IKBKG)
|
OTNWJWSD
|
NEMO_HUMAN
|
Increases Expression
|
[140] |
S-adenosylmethionine synthase isoform type-2 (MAT2A)
|
OTFJMIQR
|
METK2_HUMAN
|
Decreases Expression
|
[185] |
Serine/threonine-protein kinase Chk1 (CHEK1)
|
OTTTI622
|
CHK1_HUMAN
|
Increases Expression
|
[186] |
Retinoblastoma-associated protein (RB1)
|
OTQJUJMZ
|
RB_HUMAN
|
Increases Phosphorylation
|
[186] |
M-phase inducer phosphatase 1 (CDC25A)
|
OTSLKKCO
|
MPIP1_HUMAN
|
Increases Degradation
|
[186] |
Bifunctional purine biosynthesis protein ATIC (ATIC)
|
OT8XE052
|
PUR9_HUMAN
|
Decreases Expression
|
[174] |
Uncharacterized protein C20orf204 (C20ORF204)
|
OT0GVQPP
|
CT204_HUMAN
|
Decreases Expression
|
[141] |
Uncharacterized protein CXorf51A (CXORF51A)
|
OTDN5YLP
|
CX05A_HUMAN
|
Increases Expression
|
[141] |
Transmembrane protein 120B (TMEM120B)
|
OTA5XMI9
|
T120B_HUMAN
|
Decreases Expression
|
[141] |
Probable ATP-dependent DNA helicase HFM1 (HFM1)
|
OTHV3EFE
|
HFM1_HUMAN
|
Decreases Expression
|
[141] |
Homeobox protein HMX2 (HMX2)
|
OTBRXY6D
|
HMX2_HUMAN
|
Increases Expression
|
[141] |
Protein FAM181B (FAM181B)
|
OTGZHJ7K
|
F181B_HUMAN
|
Decreases Expression
|
[141] |
RNA binding protein fox-1 homolog 3 (RBFOX3)
|
OTL0F3D6
|
RFOX3_HUMAN
|
Decreases Expression
|
[141] |
Protein ANKUB1 (ANKUB1)
|
OT8QXDL8
|
ANKUB_HUMAN
|
Increases Expression
|
[141] |
Olfactory receptor 5H1 (OR5H1)
|
OT9YQR5A
|
OR5H1_HUMAN
|
Increases Expression
|
[141] |
Uncharacterized protein C15orf62, mitochondrial (C15ORF62)
|
OT2VU9TN
|
CO062_HUMAN
|
Increases Expression
|
[141] |
Espin (ESPN)
|
OT7Z6LX2
|
ESPN_HUMAN
|
Increases Expression
|
[141] |
Sperm axonemal maintenance protein CFAP97D1 (CFAP97D1)
|
OTCPE947
|
CF97D_HUMAN
|
Increases Expression
|
[141] |
Putative adrenomedullin-5-like protein (ADM5)
|
OTFOA92Z
|
ADM5_HUMAN
|
Decreases Expression
|
[141] |
Fibronectin type III domain-containing protein 10 (FNDC10)
|
OT06NW7W
|
FND10_HUMAN
|
Decreases Expression
|
[141] |
26S proteasome non-ATPase regulatory subunit 9 (PSMD9)
|
OT6Y5CC3
|
PSMD9_HUMAN
|
Decreases Expression
|
[141] |
Signal-regulatory protein beta-1 (SIRPB1)
|
OTGHALWJ
|
SIRB1_HUMAN
|
Increases Expression
|
[141] |
Basic helix-loop-helix ARNT-like protein 1 (BMAL1)
|
OTMI12L2
|
BMAL1_HUMAN
|
Decreases Expression
|
[141] |
Sulfotransferase 1C2 (SULT1C2)
|
OT07MMZS
|
ST1C2_HUMAN
|
Increases Expression
|
[141] |
C-C chemokine receptor-like 2 (CCRL2)
|
OT5PX0RX
|
CCRL2_HUMAN
|
Decreases Expression
|
[141] |
Synaptotagmin-5 (SYT5)
|
OT718PRY
|
SYT5_HUMAN
|
Decreases Expression
|
[141] |
Voltage-dependent P/Q-type calcium channel subunit alpha-1A (CACNA1A)
|
OTY08SIX
|
CAC1A_HUMAN
|
Increases Expression
|
[141] |
Transcription factor SOX-1 (SOX1)
|
OTVI1RAR
|
SOX1_HUMAN
|
Decreases Expression
|
[141] |
C-X-C chemokine receptor type 6 (CXCR6)
|
OTK9R50G
|
CXCR6_HUMAN
|
Decreases Expression
|
[141] |
Ribonuclease T2 (RNASET2)
|
OTWY64L7
|
RNT2_HUMAN
|
Decreases Expression
|
[141] |
Ficolin-1 (FCN1)
|
OTK6ZHXH
|
FCN1_HUMAN
|
Decreases Expression
|
[141] |
Transcription factor E2F3 (E2F3)
|
OT5VQMWY
|
E2F3_HUMAN
|
Decreases Expression
|
[141] |
Cocaine esterase (CES2)
|
OTC647SQ
|
EST2_HUMAN
|
Decreases Expression
|
[141] |
Suppressor of cytokine signaling 3 (SOCS3)
|
OTY183WJ
|
SOCS3_HUMAN
|
Decreases Expression
|
[141] |
Tumor necrosis factor receptor superfamily member 10B (TNFRSF10B)
|
OTA1CPBV
|
TR10B_HUMAN
|
Decreases Expression
|
[141] |
Gamma-aminobutyric acid receptor subunit delta (GABRD)
|
OTO38I2R
|
GBRD_HUMAN
|
Decreases Expression
|
[141] |
Protein lin-7 homolog A (LIN7A)
|
OTFL3PUX
|
LIN7A_HUMAN
|
Decreases Expression
|
[141] |
Guanine nucleotide exchange factor DBS (MCF2L)
|
OTEURA8N
|
MCF2L_HUMAN
|
Increases Expression
|
[141] |
DNA-directed RNA polymerases I and III subunit RPAC1 (POLR1C)
|
OT7DVQB0
|
RPAC1_HUMAN
|
Decreases Expression
|
[141] |
Nephrocystin-1 (NPHP1)
|
OTZHCFFQ
|
NPHP1_HUMAN
|
Increases Expression
|
[141] |
Cytoplasmic dynein 1 light intermediate chain 2 (DYNC1LI2)
|
OTR7WJES
|
DC1L2_HUMAN
|
Increases Expression
|
[141] |
U4/U6 small nuclear ribonucleoprotein Prp3 (PRPF3)
|
OTUA4OLZ
|
PRPF3_HUMAN
|
Decreases Expression
|
[141] |
Peptidyl-prolyl cis-trans isomerase H (PPIH)
|
OTB3HCLB
|
PPIH_HUMAN
|
Decreases Expression
|
[141] |
Potassium voltage-gated channel subfamily KQT member 2 (KCNQ2)
|
OT3CXQJT
|
KCNQ2_HUMAN
|
Decreases Expression
|
[141] |
Mothers against decapentaplegic homolog 6 (SMAD6)
|
OTUZZWUD
|
SMAD6_HUMAN
|
Decreases Expression
|
[141] |
Neuronal migration protein doublecortin (DCX)
|
OTISR7K3
|
DCX_HUMAN
|
Increases Expression
|
[141] |
A-kinase anchor protein 7 isoforms alpha and beta (AKAP7)
|
OT0L3PZ6
|
AKA7A_HUMAN
|
Increases Expression
|
[141] |
Peptidase inhibitor 15 (PI15)
|
OTPJL6ML
|
PI15_HUMAN
|
Increases Expression
|
[141] |
Cytohesin-3 (CYTH3)
|
OTBXAT3Z
|
CYH3_HUMAN
|
Increases Expression
|
[141] |
5'-AMP-activated protein kinase subunit beta-2 (PRKAB2)
|
OTLVN68B
|
AAKB2_HUMAN
|
Increases Expression
|
[141] |
Kalirin (KALRN)
|
OT8WRCBH
|
KALRN_HUMAN
|
Increases Expression
|
[141] |
Protocadherin-7 (PCDH7)
|
OTP091X8
|
PCDH7_HUMAN
|
Increases Expression
|
[141] |
Adenylate cyclase type 3 (ADCY3)
|
OTGOQM6B
|
ADCY3_HUMAN
|
Decreases Expression
|
[141] |
Katanin-interacting protein (KATNIP)
|
OTLLA1BX
|
KATIP_HUMAN
|
Decreases Expression
|
[141] |
Centrosomal protein of 104 kDa (CEP104)
|
OTOLRJLH
|
CE104_HUMAN
|
Increases Expression
|
[141] |
Germinal-center associated nuclear protein (MCM3AP)
|
OT895FEC
|
GANP_HUMAN
|
Increases Expression
|
[141] |
Phospholipid-transporting ATPase IK (ATP8B3)
|
OTZOGEJO
|
AT8B3_HUMAN
|
Decreases Expression
|
[141] |
Ecotropic viral integration site 5 protein homolog (EVI5)
|
OTOPAP55
|
EVI5_HUMAN
|
Increases Expression
|
[141] |
Beta-1,4-galactosyltransferase 3 (B4GALT3)
|
OTHX77K8
|
B4GT3_HUMAN
|
Decreases Expression
|
[141] |
Catenin delta-1 (CTNND1)
|
OTUMPSHR
|
CTND1_HUMAN
|
Decreases Expression
|
[141] |
Dual specificity protein phosphatase CDC14B (CDC14B)
|
OTAESVOZ
|
CC14B_HUMAN
|
Increases Expression
|
[141] |
PRAME family member 11 (PRAMEF11)
|
OT15BWSL
|
PRA11_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase TRIM13 (TRIM13)
|
OTQIUACB
|
TRI13_HUMAN
|
Increases Expression
|
[141] |
Short stature homeobox protein 2 (SHOX2)
|
OTLCZZJW
|
SHOX2_HUMAN
|
Increases Expression
|
[141] |
mRNA-capping enzyme (RNGTT)
|
OT59E0KX
|
MCE1_HUMAN
|
Increases Expression
|
[141] |
Calcium-transporting ATPase type 2C member 2 (ATP2C2)
|
OTGIHTYQ
|
AT2C2_HUMAN
|
Decreases Expression
|
[141] |
Transcription initiation protein SPT3 homolog (SUPT3H)
|
OT7B6FRO
|
SUPT3_HUMAN
|
Decreases Expression
|
[141] |
DNA-directed RNA polymerase III subunit RPC9 (CRCP)
|
OT4K9BT7
|
RPC9_HUMAN
|
Decreases Expression
|
[141] |
Decapping and exoribonuclease protein (DXO)
|
OTFDTNW4
|
DXO_HUMAN
|
Decreases Expression
|
[141] |
Pre-mRNA-processing factor 6 (PRPF6)
|
OT3U0ABN
|
PRP6_HUMAN
|
Increases Expression
|
[141] |
Protein furry homolog-like (FRYL)
|
OTBN3XHN
|
FRYL_HUMAN
|
Increases Expression
|
[141] |
Glutaminase kidney isoform, mitochondrial (GLS)
|
OTGOZG2M
|
GLSK_HUMAN
|
Decreases Expression
|
[141] |
Lysine-specific demethylase 4B (KDM4B)
|
OT5P1UPY
|
KDM4B_HUMAN
|
Increases Expression
|
[141] |
Olfactory receptor 2F2 (OR2F2)
|
OTPYQL7R
|
OR2F2_HUMAN
|
Increases Expression
|
[141] |
Olfactory receptor 2A4 (OR2A4)
|
OT70V8VC
|
OR2A4_HUMAN
|
Increases Expression
|
[141] |
Sphingosine 1-phosphate receptor 2 (S1PR2)
|
OTRTJF29
|
S1PR2_HUMAN
|
Increases Expression
|
[141] |
Olfactory receptor 6A2 (OR6A2)
|
OTWKCMOD
|
OR6A2_HUMAN
|
Increases Expression
|
[141] |
Myelin protein zero-like protein 1 (MPZL1)
|
OTJSUUHR
|
MPZL1_HUMAN
|
Increases Expression
|
[141] |
Transforming acidic coiled-coil-containing protein 2 (TACC2)
|
OTW4M7HI
|
TACC2_HUMAN
|
Increases Expression
|
[141] |
Mitogen-activated protein kinase kinase kinase 6 (MAP3K6)
|
OTOE0Z1R
|
M3K6_HUMAN
|
Decreases Expression
|
[141] |
Sodium-dependent phosphate transport protein 2B (SLC34A2)
|
OTLFMBB0
|
NPT2B_HUMAN
|
Decreases Expression
|
[141] |
Claudin-9 (CLDN9)
|
OTCKI2IZ
|
CLD9_HUMAN
|
Decreases Expression
|
[141] |
Neuronal pentraxin receptor (NPTXR)
|
OTQJEOIH
|
NPTXR_HUMAN
|
Increases Expression
|
[141] |
Glucagon-like peptide 2 receptor (GLP2R)
|
OTVKNDVL
|
GLP2R_HUMAN
|
Increases Expression
|
[141] |
Diphosphoinositol polyphosphate phosphohydrolase 1 (NUDT3)
|
OTXITZUB
|
NUDT3_HUMAN
|
Increases Expression
|
[141] |
G1/S-specific cyclin-E2 (CCNE2)
|
OTBBUKQQ
|
CCNE2_HUMAN
|
Decreases Expression
|
[141] |
Coagulation factor XIII A chain (F13A1)
|
OTO8O184
|
F13A_HUMAN
|
Decreases Expression
|
[141] |
Haptoglobin-related protein (HPR)
|
OTXSC9UB
|
HPTR_HUMAN
|
Decreases Expression
|
[141] |
Urokinase-type plasminogen activator (PLAU)
|
OTX0QGKK
|
UROK_HUMAN
|
Decreases Expression
|
[141] |
Protransforming growth factor alpha (TGFA)
|
OTPD1LL9
|
TGFA_HUMAN
|
Decreases Expression
|
[141] |
Interleukin-2 receptor subunit alpha (IL2RA)
|
OT0MWCHG
|
IL2RA_HUMAN
|
Decreases Expression
|
[141] |
Alpha-2-HS-glycoprotein (AHSG)
|
OTUG0LEA
|
FETUA_HUMAN
|
Increases Expression
|
[141] |
Ferritin heavy chain (FTH1)
|
OT6IFS0O
|
FRIH_HUMAN
|
Decreases Expression
|
[141] |
Arginase-1 (ARG1)
|
OTHZITAM
|
ARGI1_HUMAN
|
Increases Expression
|
[141] |
T-cell surface glycoprotein CD1a (CD1A)
|
OTKSSG6N
|
CD1A_HUMAN
|
Decreases Expression
|
[141] |
Prothymosin alpha (PTMA)
|
OT2W4T1M
|
PTMA_HUMAN
|
Decreases Expression
|
[141] |
Thrombomodulin (THBD)
|
OT8VHLKY
|
TRBM_HUMAN
|
Decreases Expression
|
[141] |
Asialoglycoprotein receptor 2 (ASGR2)
|
OTFSGOVY
|
ASGR2_HUMAN
|
Decreases Expression
|
[141] |
Beta-2 adrenergic receptor (ADRB2)
|
OTSDOX4Q
|
ADRB2_HUMAN
|
Increases Expression
|
[141] |
Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC)
|
OT47AK4C
|
HNRPC_HUMAN
|
Decreases Expression
|
[141] |
Tumor necrosis factor receptor superfamily member 16 (NGFR)
|
OTPKSM49
|
TNR16_HUMAN
|
Decreases Expression
|
[141] |
Signal recognition particle receptor subunit alpha (SRPRA)
|
OT5NMYTY
|
SRPRA_HUMAN
|
Decreases Expression
|
[141] |
Glutathione S-transferase A1 (GSTA1)
|
OTA7K5XA
|
GSTA1_HUMAN
|
Increases Expression
|
[141] |
Beta-1 adrenergic receptor (ADRB1)
|
OTQBWN4U
|
ADRB1_HUMAN
|
Decreases Expression
|
[141] |
Fibrocystin (PKHD1)
|
OTAH8SMF
|
PKHD1_HUMAN
|
Decreases Expression
|
[141] |
Growth-regulated alpha protein (CXCL1)
|
OT3WCTZV
|
GROA_HUMAN
|
Decreases Expression
|
[141] |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
OTLSZR00
|
TACD2_HUMAN
|
Decreases Expression
|
[141] |
Protein ELFN1 (ELFN1)
|
OTM7M52U
|
ELFN1_HUMAN
|
Decreases Expression
|
[141] |
Myocardial zonula adherens protein (MYZAP)
|
OTAZCNBT
|
MYZAP_HUMAN
|
Decreases Expression
|
[141] |
A-kinase anchor protein inhibitor 1 (AKAIN1)
|
OTXO2ZVV
|
AKAI1_HUMAN
|
Increases Expression
|
[141] |
Paraneoplastic antigen-like protein 6A (PNMA6A)
|
OTW96SNS
|
PNM6A_HUMAN
|
Increases Expression
|
[141] |
Endothelin-converting enzyme 2 (ECE2)
|
OTZLNQVL
|
ECE2_HUMAN
|
Increases Expression
|
[141] |
Ras-related protein Rap-2a (RAP2A)
|
OT0JB5S4
|
RAP2A_HUMAN
|
Increases Expression
|
[141] |
Transcriptional activator Myb (MYB)
|
OTJH64IV
|
MYB_HUMAN
|
Increases Expression
|
[141] |
60 kDa heat shock protein, mitochondrial (HSPD1)
|
OTTO1Y11
|
CH60_HUMAN
|
Decreases Expression
|
[141] |
Microtubule-associated protein 2 (MAP2)
|
OT6UYT3X
|
MTAP2_HUMAN
|
Increases Expression
|
[141] |
Solute carrier family 2, facilitated glucose transporter member 2 (SLC2A2)
|
OTBL2W7R
|
GTR2_HUMAN
|
Increases Expression
|
[141] |
Solute carrier family 2, facilitated glucose transporter member 3 (SLC2A3)
|
OT2HZK5M
|
GTR3_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein kinase pim-1 (PIM1)
|
OTWEKXTU
|
PIM1_HUMAN
|
Decreases Expression
|
[141] |
DNA topoisomerase 1 (TOP1)
|
OT51O0CF
|
TOP1_HUMAN
|
Decreases Expression
|
[141] |
Cytochrome P450 2C9 (CYP2C9)
|
OTGLBN29
|
CP2C9_HUMAN
|
Decreases Expression
|
[141] |
Parathyroid hormone-related protein (PTHLH)
|
OTI1JF13
|
PTHR_HUMAN
|
Increases Expression
|
[141] |
Protein L-Myc (MYCL)
|
OT1MFQ5U
|
MYCL_HUMAN
|
Decreases Expression
|
[141] |
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (COX4I1)
|
OTU0FC24
|
COX41_HUMAN
|
Decreases Expression
|
[141] |
Interferon-induced transmembrane protein 1 (IFITM1)
|
OTECO1G8
|
IFM1_HUMAN
|
Decreases Expression
|
[141] |
HLA class II histocompatibility antigen, DR beta 4 chain (HLA-DRB4)
|
OTNXIHQU
|
DRB4_HUMAN
|
Decreases Expression
|
[141] |
Beta-enolase (ENO3)
|
OT3HYKYI
|
ENOB_HUMAN
|
Increases Expression
|
[141] |
Nidogen-1 (NID1)
|
OTKLBLS6
|
NID1_HUMAN
|
Increases Expression
|
[141] |
Homeobox protein Hox-B3 (HOXB3)
|
OT9UC5PE
|
HXB3_HUMAN
|
Increases Expression
|
[141] |
Small nuclear ribonucleoprotein-associated proteins B and B' (SNRPB)
|
OT3UJ4ZU
|
RSMB_HUMAN
|
Decreases Expression
|
[141] |
Cyclic AMP-dependent transcription factor ATF-2 (ATF2)
|
OTNIZPEA
|
ATF2_HUMAN
|
Increases Expression
|
[141] |
Amphiregulin (AREG)
|
OTJFOR67
|
AREG_HUMAN
|
Decreases Expression
|
[141] |
Histone H1.3 (H1-3)
|
OTT7VPRB
|
H13_HUMAN
|
Increases Expression
|
[141] |
Natriuretic peptides B (NPPB)
|
OTSN2IPY
|
ANFB_HUMAN
|
Increases Expression
|
[141] |
Homeobox protein Hox-B8 (HOXB8)
|
OTKHOD17
|
HXB8_HUMAN
|
Decreases Expression
|
[141] |
Homeobox protein Hox-B9 (HOXB9)
|
OTMVHQOU
|
HXB9_HUMAN
|
Increases Expression
|
[141] |
CCAAT/enhancer-binding protein beta (CEBPB)
|
OTM9MQIA
|
CEBPB_HUMAN
|
Decreases Expression
|
[141] |
Complement receptor type 1 (CR1)
|
OTODWRW4
|
CR1_HUMAN
|
Decreases Expression
|
[141] |
Large ribosomal subunit protein eL33 (RPL35A)
|
OTDDJUWF
|
RL35A_HUMAN
|
Increases Expression
|
[141] |
Early growth response protein 1 (EGR1)
|
OTCP6XGZ
|
EGR1_HUMAN
|
Decreases Expression
|
[141] |
Nucleolin (NCL)
|
OTBXPKMP
|
NUCL_HUMAN
|
Decreases Expression
|
[141] |
Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A)
|
OT2D9DOV
|
TNR1A_HUMAN
|
Decreases Expression
|
[141] |
C-X-C motif chemokine 2 (CXCL2)
|
OTEJCYMY
|
CXCL2_HUMAN
|
Decreases Expression
|
[141] |
C-X-C motif chemokine 3 (CXCL3)
|
OTSL94KH
|
CXCL3_HUMAN
|
Decreases Expression
|
[141] |
Tryptase beta-2 (TPSB2)
|
OTN769MT
|
TRYB2_HUMAN
|
Increases Expression
|
[141] |
Interferon-induced GTP-binding protein Mx2 (MX2)
|
OT05NF37
|
MX2_HUMAN
|
Decreases Expression
|
[141] |
B-cell lymphoma 3 protein (BCL3)
|
OT1M5B95
|
BCL3_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein kinase MAK (MAK)
|
OTEU2G41
|
MAK_HUMAN
|
Decreases Expression
|
[141] |
Phosphatidylcholine translocator ABCB4 (ABCB4)
|
OTE6PY83
|
MDR3_HUMAN
|
Increases Expression
|
[141] |
Synaptotagmin-1 (SYT1)
|
OTVTPOI6
|
SYT1_HUMAN
|
Increases Expression
|
[141] |
Trifunctional purine biosynthetic protein adenosine-3 (GART)
|
OT01JWJB
|
PUR2_HUMAN
|
Decreases Expression
|
[141] |
Tenascin-X (TNXB)
|
OTVBWAV5
|
TENX_HUMAN
|
Increases Expression
|
[141] |
Acetylcholinesterase (ACHE)
|
OT2H8HG6
|
ACES_HUMAN
|
Increases Expression
|
[141] |
Cytochrome P450 7A1 (CYP7A1)
|
OT8Z5KLD
|
CP7A1_HUMAN
|
Decreases Expression
|
[141] |
Insulin-like growth factor-binding protein 4 (IGFBP4)
|
OT2HZRBD
|
IBP4_HUMAN
|
Decreases Expression
|
[141] |
DNA-directed RNA polymerase II subunit RPB1 (POLR2A)
|
OTHJQ1DZ
|
RPB1_HUMAN
|
Increases Expression
|
[141] |
Signal transducer CD24 (CD24)
|
OT7CODJ4
|
CD24_HUMAN
|
Increases Expression
|
[141] |
Polypyrimidine tract-binding protein 1 (PTBP1)
|
OT2OBJUK
|
PTBP1_HUMAN
|
Decreases Expression
|
[141] |
Aryl hydrocarbon receptor nuclear translocator (ARNT)
|
OTMSIEZY
|
ARNT_HUMAN
|
Decreases Expression
|
[141] |
Grancalcin (GCA)
|
OTAJ7ZHG
|
GRAN_HUMAN
|
Decreases Expression
|
[141] |
Retinoblastoma-like protein 1 (RBL1)
|
OTDEBFYC
|
RBL1_HUMAN
|
Increases Expression
|
[141] |
Nitric oxide synthase 3 (NOS3)
|
OTLDT7NR
|
NOS3_HUMAN
|
Decreases Expression
|
[141] |
Lens fiber major intrinsic protein (MIP)
|
OTEBLU3E
|
MIP_HUMAN
|
Increases Expression
|
[141] |
Homeobox protein Hox-A11 (HOXA11)
|
OT42C4HF
|
HXA11_HUMAN
|
Decreases Expression
|
[141] |
Gamma-aminobutyric acid receptor subunit alpha-5 (GABRA5)
|
OTBIKWQT
|
GBRA5_HUMAN
|
Decreases Expression
|
[141] |
Homeobox protein OTX1 (OTX1)
|
OTRGSGH9
|
OTX1_HUMAN
|
Decreases Expression
|
[141] |
G protein-coupled receptor kinase 4 (GRK4)
|
OTUU8V2S
|
GRK4_HUMAN
|
Increases Expression
|
[141] |
Desmoglein-3 (DSG3)
|
OTGO4GEY
|
DSG3_HUMAN
|
Increases Expression
|
[141] |
Catenin alpha-1 (CTNNA1)
|
OTFC725Z
|
CTNA1_HUMAN
|
Decreases Expression
|
[141] |
Merlin (NF2)
|
OT6E5ACG
|
MERL_HUMAN
|
Decreases Expression
|
[141] |
Mu-type opioid receptor (OPRM1)
|
OT16AAT8
|
OPRM_HUMAN
|
Increases Expression
|
[141] |
Alpha-adducin (ADD1)
|
OTTF68DC
|
ADDA_HUMAN
|
Increases Expression
|
[141] |
RNA-binding protein FUS (FUS)
|
OTPPNGQO
|
FUS_HUMAN
|
Decreases Expression
|
[141] |
Choline kinase alpha (CHKA)
|
OT7FVO3Z
|
CHKA_HUMAN
|
Decreases Expression
|
[141] |
Vitamin K-dependent gamma-carboxylase (GGCX)
|
OTE0FNAP
|
VKGC_HUMAN
|
Decreases Expression
|
[141] |
DNA-binding protein SMUBP-2 (IGHMBP2)
|
OTAZFPF5
|
SMBP2_HUMAN
|
Decreases Expression
|
[141] |
Large ribosomal subunit protein uL3 (RPL3)
|
OTX6VXLB
|
RL3_HUMAN
|
Decreases Expression
|
[141] |
Chymotrypsin-like protease CTRL-1 (CTRL)
|
OTB6NA5O
|
CTRL_HUMAN
|
Decreases Expression
|
[141] |
Pre-B-cell leukemia transcription factor 2 (PBX2)
|
OTEBYCAW
|
PBX2_HUMAN
|
Decreases Expression
|
[141] |
Signal transducer and activator of transcription 3 (STAT3)
|
OTAAGKYZ
|
STAT3_HUMAN
|
Decreases Expression
|
[141] |
Chloride anion exchanger (SLC26A3)
|
OTBNK2U2
|
S26A3_HUMAN
|
Decreases Expression
|
[141] |
Extracellular calcium-sensing receptor (CASR)
|
OT2PEJDO
|
CASR_HUMAN
|
Decreases Expression
|
[141] |
Mitogen-activated protein kinase kinase kinase 8 (MAP3K8)
|
OTOZTA1F
|
M3K8_HUMAN
|
Decreases Expression
|
[141] |
C-C chemokine receptor type 2 (CCR2)
|
OTQ7T10J
|
CCR2_HUMAN
|
Decreases Expression
|
[141] |
Signal transducer and activator of transcription 6 (STAT6)
|
OTCKMP49
|
STAT6_HUMAN
|
Decreases Expression
|
[141] |
Caspase-2 (CASP2)
|
OTUDYSPP
|
CASP2_HUMAN
|
Increases Expression
|
[141] |
Neuronal vesicle trafficking-associated protein 1 (NSG1)
|
OTRIMA50
|
NSG1_HUMAN
|
Increases Expression
|
[141] |
Glucagon-like peptide 1 receptor (GLP1R)
|
OTMB1WEY
|
GLP1R_HUMAN
|
Decreases Expression
|
[141] |
ETS translocation variant 4 (ETV4)
|
OT8C98UZ
|
ETV4_HUMAN
|
Increases Expression
|
[141] |
Melanoma-associated antigen 12 (MAGEA12)
|
OT8ULELL
|
MAGAC_HUMAN
|
Increases Expression
|
[141] |
Ran-specific GTPase-activating protein (RANBP1)
|
OTQE226K
|
RANG_HUMAN
|
Decreases Expression
|
[141] |
Killer cell immunoglobulin-like receptor 2DS2 (KIR2DS2)
|
OTX31RLZ
|
KI2S2_HUMAN
|
Decreases Expression
|
[141] |
G-protein coupled receptor 4 (GPR4)
|
OTIBF32I
|
GPR4_HUMAN
|
Decreases Expression
|
[141] |
Dual specificity mitogen-activated protein kinase kinase 3 (MAP2K3)
|
OTI2OREX
|
MP2K3_HUMAN
|
Decreases Expression
|
[141] |
Olfactory marker protein (OMP)
|
OT7JH0DY
|
OMP_HUMAN
|
Decreases Expression
|
[141] |
Interferon alpha/beta receptor 2 (IFNAR2)
|
OTBIRNIJ
|
INAR2_HUMAN
|
Decreases Expression
|
[141] |
Serpin B4 (SERPINB4)
|
OT88LHZ8
|
SPB4_HUMAN
|
Increases Expression
|
[141] |
Neuropeptide Y receptor type 2 (NPY2R)
|
OTEWQJ6B
|
NPY2R_HUMAN
|
Decreases Expression
|
[141] |
Melatonin receptor type 1B (MTNR1B)
|
OT6VFHX9
|
MTR1B_HUMAN
|
Increases Expression
|
[141] |
Beta-arrestin-1 (ARRB1)
|
OT2NJS37
|
ARRB1_HUMAN
|
Decreases Expression
|
[141] |
Transmembrane ascorbate-dependent reductase CYB561 (CYB561)
|
OT61GMNV
|
CY561_HUMAN
|
Increases Expression
|
[141] |
Cysteine--tRNA ligase, cytoplasmic (CARS1)
|
OTOUZF6O
|
SYCC_HUMAN
|
Decreases Expression
|
[141] |
Proteasome subunit beta type-2 (PSMB2)
|
OTX0UG5W
|
PSB2_HUMAN
|
Decreases Expression
|
[141] |
Regulator of G-protein signaling 7 (RGS7)
|
OTDQA90X
|
RGS7_HUMAN
|
Increases Expression
|
[141] |
Serpin B9 (SERPINB9)
|
OTJ811IF
|
SPB9_HUMAN
|
Decreases Expression
|
[141] |
Matrix metalloproteinase-16 (MMP16)
|
OTSFQ2BJ
|
MMP16_HUMAN
|
Increases Expression
|
[141] |
Arylsulfatase D (ARSD)
|
OTAHW9M8
|
ARSD_HUMAN
|
Decreases Expression
|
[141] |
Ataxin-1 (ATXN1)
|
OTQF0HNR
|
ATX1_HUMAN
|
Increases Expression
|
[141] |
RNA polymerase II elongation factor ELL (ELL)
|
OTCBN5LF
|
ELL_HUMAN
|
Decreases Expression
|
[141] |
Caspase-9 (CASP9)
|
OTD4RFFG
|
CASP9_HUMAN
|
Decreases Expression
|
[141] |
FAD-linked sulfhydryl oxidase ALR (GFER)
|
OTVK43OK
|
ALR_HUMAN
|
Decreases Expression
|
[141] |
Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (OXCT1)
|
OT536PE7
|
SCOT1_HUMAN
|
Decreases Expression
|
[141] |
Period circadian protein homolog 3 (PER3)
|
OTVKYVJA
|
PER3_HUMAN
|
Increases Expression
|
[141] |
Sestrin-3 (SESN3)
|
OTJRY1Y5
|
SESN3_HUMAN
|
Increases Expression
|
[141] |
Taste receptor type 2 member 50 (TAS2R50)
|
OTPRMVZW
|
T2R50_HUMAN
|
Decreases Expression
|
[141] |
FXYD domain-containing ion transport regulator 4 (FXYD4)
|
OT06IH3H
|
FXYD4_HUMAN
|
Increases Expression
|
[141] |
Eukaryotic initiation factor 4A-I (EIF4A1)
|
OTMTBX6N
|
IF4A1_HUMAN
|
Decreases Expression
|
[141] |
Ras-related protein Rap-2b (RAP2B)
|
OTD2NDQP
|
RAP2B_HUMAN
|
Decreases Expression
|
[141] |
LIM domain transcription factor LMO4 (LMO4)
|
OT5NDCT9
|
LMO4_HUMAN
|
Increases Expression
|
[141] |
Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PPP2CB)
|
OT24GMCM
|
PP2AB_HUMAN
|
Decreases Expression
|
[141] |
Small ribosomal subunit protein eS6 (RPS6)
|
OTT4D1LN
|
RS6_HUMAN
|
Decreases Expression
|
[141] |
Histone H4 (H4C1)
|
OTB71W46
|
H4_HUMAN
|
Decreases Expression
|
[141] |
Peptidyl-prolyl cis-trans isomerase A (PPIA)
|
OTHJMWQQ
|
PPIA_HUMAN
|
Decreases Expression
|
[141] |
Peptidyl-prolyl cis-trans isomerase FKBP1A (FKBP1A)
|
OT6285L4
|
FKB1A_HUMAN
|
Decreases Expression
|
[141] |
Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA)
|
OT2CEYTT
|
SHPS1_HUMAN
|
Increases Expression
|
[141] |
Disintegrin and metalloproteinase domain-containing protein 8 (ADAM8)
|
OT24S8YN
|
ADAM8_HUMAN
|
Decreases Expression
|
[141] |
SRSF protein kinase 2 (SRPK2)
|
OTFFKMU1
|
SRPK2_HUMAN
|
Increases Expression
|
[141] |
UDP-galactose translocator (SLC35A2)
|
OTQOTOWZ
|
S35A2_HUMAN
|
Decreases Expression
|
[141] |
mRNA export factor RAE1 (RAE1)
|
OT54OKC3
|
RAE1L_HUMAN
|
Increases Expression
|
[141] |
Enhancer of rudimentary homolog (ERH)
|
OTJDWX99
|
ERH_HUMAN
|
Decreases Expression
|
[141] |
Histone H3.3 (H3-3B)
|
OT9XHQ3C
|
H33_HUMAN
|
Decreases Expression
|
[141] |
Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG2)
|
OT6HTSJT
|
PGBM_HUMAN
|
Increases Expression
|
[141] |
Low-density lipoprotein receptor-related protein 2 (LRP2)
|
OTZ6W681
|
LRP2_HUMAN
|
Increases Expression
|
[141] |
Phosphatidylinositol transfer protein alpha isoform (PITPNA)
|
OTTWC00K
|
PIPNA_HUMAN
|
Decreases Expression
|
[141] |
Cyclin-dependent kinase 6 (CDK6)
|
OTR95N0X
|
CDK6_HUMAN
|
Increases Expression
|
[141] |
Forkhead box protein K2 (FOXK2)
|
OTFXDZ3R
|
FOXK2_HUMAN
|
Increases Expression
|
[141] |
High affinity immunoglobulin epsilon receptor subunit beta (MS4A2)
|
OTMCAS2D
|
FCERB_HUMAN
|
Increases Expression
|
[141] |
Interferon-induced transmembrane protein 3 (IFITM3)
|
OT2QP8D3
|
IFM3_HUMAN
|
Decreases Expression
|
[141] |
Interferon-induced transmembrane protein 2 (IFITM2)
|
OTAT6TI6
|
IFM2_HUMAN
|
Decreases Expression
|
[141] |
POU domain, class 4, transcription factor 1 (POU4F1)
|
OTMHYGWQ
|
PO4F1_HUMAN
|
Decreases Expression
|
[141] |
Collagen alpha-3(IV) chain (COL4A3)
|
OT6SB8X5
|
CO4A3_HUMAN
|
Increases Expression
|
[141] |
Amyloid-beta A4 precursor protein-binding family A member 1 (APBA1)
|
OTUH9JPD
|
APBA1_HUMAN
|
Increases Expression
|
[141] |
Peptidyl-prolyl cis-trans isomerase FKBP4 (FKBP4)
|
OTPV1D60
|
FKBP4_HUMAN
|
Decreases Expression
|
[141] |
Mucin-2 (MUC2)
|
OT3X4QVX
|
MUC2_HUMAN
|
Decreases Expression
|
[141] |
cAMP-responsive element modulator (CREM)
|
OTJIJ5AL
|
CREM_HUMAN
|
Decreases Expression
|
[141] |
Tyrosine-protein phosphatase non-receptor type 12 (PTPN12)
|
OT5WA666
|
PTN12_HUMAN
|
Increases Expression
|
[141] |
Early growth response protein 4 (EGR4)
|
OT4R3ECK
|
EGR4_HUMAN
|
Decreases Expression
|
[141] |
Aldehyde oxidase (AOX1)
|
OT2FZP6H
|
AOXA_HUMAN
|
Decreases Expression
|
[141] |
Sulfotransferase 2A1 (SULT2A1)
|
OT0ISKQ4
|
ST2A1_HUMAN
|
Decreases Expression
|
[141] |
Rho GTPase-activating protein 1 (ARHGAP1)
|
OT0H2ZBZ
|
RHG01_HUMAN
|
Increases Expression
|
[141] |
3',5'-cyclic-AMP phosphodiesterase 4C (PDE4C)
|
OTI8VMHZ
|
PDE4C_HUMAN
|
Increases Expression
|
[141] |
Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (MGAT5)
|
OTU4DD4G
|
MGT5A_HUMAN
|
Increases Expression
|
[141] |
Uncharacterized protein C17orf67 (C17ORF67)
|
OTCL5EE8
|
CQ067_HUMAN
|
Decreases Expression
|
[141] |
Thyrotroph embryonic factor (TEF)
|
OTY3LAD9
|
TEF_HUMAN
|
Increases Expression
|
[141] |
CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (ST3GAL1)
|
OTFCO8QX
|
SIA4A_HUMAN
|
Decreases Expression
|
[141] |
Calcium-activated potassium channel subunit alpha-1 (KCNMA1)
|
OTNYXOZO
|
KCMA1_HUMAN
|
Increases Expression
|
[141] |
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1)
|
OT2LP7LJ
|
SNF5_HUMAN
|
Increases Expression
|
[141] |
Glutamate receptor ionotropic, NMDA 2A (GRIN2A)
|
OTTP0KN8
|
NMDE1_HUMAN
|
Increases Expression
|
[141] |
Receptor-type tyrosine-protein phosphatase eta (PTPRJ)
|
OT10OKOF
|
PTPRJ_HUMAN
|
Increases Expression
|
[141] |
Forkhead box protein C1 (FOXC1)
|
OTOWZGYO
|
FOXC1_HUMAN
|
Decreases Expression
|
[141] |
Glutamate receptor ionotropic, kainate 3 (GRIK3)
|
OTX6K345
|
GRIK3_HUMAN
|
Decreases Expression
|
[141] |
Rho GTPase-activating protein 5 (ARHGAP5)
|
OTOQELUN
|
RHG05_HUMAN
|
Increases Expression
|
[141] |
PR domain zinc finger protein 2 (PRDM2)
|
OT8L7CGX
|
PRDM2_HUMAN
|
Decreases Expression
|
[141] |
Lymphocyte cytosolic protein 2 (LCP2)
|
OT57KE22
|
LCP2_HUMAN
|
Decreases Expression
|
[141] |
S-methyl-5'-thioadenosine phosphorylase (MTAP)
|
OTOWN2K9
|
MTAP_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase CBL-B (CBLB)
|
OTPLRER9
|
CBLB_HUMAN
|
Decreases Expression
|
[141] |
DNA excision repair protein ERCC-8 (ERCC8)
|
OT0T4WKI
|
ERCC8_HUMAN
|
Increases Expression
|
[141] |
Signaling lymphocytic activation molecule (SLAMF1)
|
OTBTT3ZQ
|
SLAF1_HUMAN
|
Decreases Expression
|
[141] |
Limbic system-associated membrane protein (LSAMP)
|
OTYXVQX2
|
LSAMP_HUMAN
|
Decreases Expression
|
[141] |
GRB2-associated-binding protein 1 (GAB1)
|
OTQKE6V4
|
GAB1_HUMAN
|
Increases Expression
|
[141] |
Histone deacetylase 1 (HDAC1)
|
OTQDNOXZ
|
HDAC1_HUMAN
|
Decreases Expression
|
[141] |
Interferon regulatory factor 5 (IRF5)
|
OT8SIIAP
|
IRF5_HUMAN
|
Increases Expression
|
[141] |
Nucleic acid dioxygenase ALKBH1 (ALKBH1)
|
OTADGU5D
|
ALKB1_HUMAN
|
Affects Expression
|
[141] |
Sodium/potassium-transporting ATPase subunit alpha-4 (ATP1A4)
|
OT9PLMBH
|
AT1A4_HUMAN
|
Increases Expression
|
[141] |
Integrin alpha-9 (ITGA9)
|
OTHN1IKA
|
ITA9_HUMAN
|
Decreases Expression
|
[141] |
Plakophilin-1 (PKP1)
|
OT9HSQ8F
|
PKP1_HUMAN
|
Decreases Expression
|
[141] |
Myelin-associated oligodendrocyte basic protein (MOBP)
|
OTHJT5CX
|
MOBP_HUMAN
|
Decreases Expression
|
[141] |
Voltage-dependent L-type calcium channel subunit alpha-1C (CACNA1C)
|
OT6KFNMS
|
CAC1C_HUMAN
|
Decreases Expression
|
[141] |
Dihydropyrimidinase-related protein 3 (DPYSL3)
|
OTINJV20
|
DPYL3_HUMAN
|
Increases Expression
|
[141] |
Elongin-A (ELOA)
|
OTOQTF5K
|
ELOA1_HUMAN
|
Increases Expression
|
[141] |
Peptidyl-prolyl cis-trans isomerase FKBP8 (FKBP8)
|
OT8RPSOC
|
FKBP8_HUMAN
|
Decreases Expression
|
[141] |
ATP-dependent RNA helicase DHX8 (DHX8)
|
OT97S0IH
|
DHX8_HUMAN
|
Decreases Expression
|
[141] |
Nuclear receptor coactivator 6 (NCOA6)
|
OTOMIGTV
|
NCOA6_HUMAN
|
Decreases Expression
|
[141] |
Raftlin (RFTN1)
|
OT8875JE
|
RFTN1_HUMAN
|
Increases Expression
|
[141] |
Chromobox protein homolog 2 (CBX2)
|
OTOQ5WS4
|
CBX2_HUMAN
|
Increases Expression
|
[141] |
Nuclear factor 1 X-type (NFIX)
|
OT1DPZAE
|
NFIX_HUMAN
|
Increases Expression
|
[141] |
Importin subunit beta-1 (KPNB1)
|
OTBT2HFL
|
IMB1_HUMAN
|
Increases Expression
|
[141] |
GTPase-activating protein and VPS9 domain-containing protein 1 (GAPVD1)
|
OT5K42IK
|
GAPD1_HUMAN
|
Increases Expression
|
[141] |
MAD2L1-binding protein (MAD2L1BP)
|
OT2O2IUJ
|
MD2BP_HUMAN
|
Decreases Expression
|
[141] |
Rab GTPase-binding effector protein 1 (RABEP1)
|
OTQROTGT
|
RABE1_HUMAN
|
Increases Expression
|
[141] |
SH2 domain-containing adapter protein B (SHB)
|
OTF2HSC0
|
SHB_HUMAN
|
Decreases Expression
|
[141] |
Ficolin-2 (FCN2)
|
OTTHJBKZ
|
FCN2_HUMAN
|
Increases Expression
|
[141] |
Transcription elongation factor A protein 2 (TCEA2)
|
OT1OS9TY
|
TCEA2_HUMAN
|
Increases Expression
|
[141] |
Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF2)
|
OTRHB9SR
|
NHRF2_HUMAN
|
Decreases Expression
|
[141] |
Olfactory receptor 1C1 (OR1C1)
|
OT9WTEX5
|
OR1C1_HUMAN
|
Decreases Expression
|
[141] |
Tumor necrosis factor receptor type 1-associated DEATH domain protein (TRADD)
|
OTBOSJHO
|
TRADD_HUMAN
|
Increases Expression
|
[141] |
Tryptase alpha/beta-1 (TPSAB1)
|
OTJYI4WV
|
TRYB1_HUMAN
|
Increases Expression
|
[141] |
Leukotriene B4 receptor 1 (LTB4R)
|
OT3SRH4H
|
LT4R1_HUMAN
|
Decreases Expression
|
[141] |
CCAAT/enhancer-binding protein epsilon (CEBPE)
|
OTKZA25M
|
CEBPE_HUMAN
|
Decreases Expression
|
[141] |
Ras-related protein Rab-30 (RAB30)
|
OTW49G8B
|
RAB30_HUMAN
|
Increases Expression
|
[141] |
Acid-sensing ion channel 2 (ASIC2)
|
OTIVFS3H
|
ASIC2_HUMAN
|
Increases Expression
|
[141] |
Myelin-oligodendrocyte glycoprotein (MOG)
|
OTYNB7Y5
|
MOG_HUMAN
|
Decreases Expression
|
[141] |
Tyrosine-protein phosphatase non-receptor type 21 (PTPN21)
|
OTQBZWSE
|
PTN21_HUMAN
|
Increases Expression
|
[141] |
Dual oxidase maturation factor 2 (DUOXA2)
|
OT7AZBZJ
|
DOXA2_HUMAN
|
Decreases Expression
|
[141] |
Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2)
|
OTJ6JTGT
|
HNRL2_HUMAN
|
Increases Expression
|
[141] |
R-spondin-4 (RSPO4)
|
OTFX5N3G
|
RSPO4_HUMAN
|
Decreases Expression
|
[141] |
ATP-binding cassette sub-family B member 5 (ABCB5)
|
OT8AKP1J
|
ABCB5_HUMAN
|
Increases Expression
|
[141] |
Neuroblastoma breakpoint family member 1 (NBPF1)
|
OTAZ55UQ
|
NBPF1_HUMAN
|
Increases Expression
|
[141] |
TBC1 domain family member 25 (TBC1D25)
|
OT11OABF
|
TBC25_HUMAN
|
Decreases Expression
|
[141] |
Transmembrane protein 176B (TMEM176B)
|
OTEGF2BV
|
T176B_HUMAN
|
Decreases Expression
|
[141] |
C2 domain-containing protein 3 (C2CD3)
|
OTC52E7V
|
C2CD3_HUMAN
|
Increases Expression
|
[141] |
tRNA-queuosine alpha-mannosyltransferase (GTDC1)
|
OT8OBXKK
|
QTMAN_HUMAN
|
Increases Expression
|
[141] |
Coiled-coil domain-containing protein 152 (CCDC152)
|
OTJQTQXC
|
CC152_HUMAN
|
Increases Expression
|
[141] |
Coiled-coil domain-containing protein 40 (CCDC40)
|
OTFHEUUN
|
CCD40_HUMAN
|
Decreases Expression
|
[141] |
Minichromosome maintenance domain-containing protein 2 (MCMDC2)
|
OTTG0EQU
|
MCMD2_HUMAN
|
Decreases Expression
|
[141] |
Synaptotagmin-like protein 3 (SYTL3)
|
OT6TPBA9
|
SYTL3_HUMAN
|
Increases Expression
|
[141] |
Protein lin-52 homolog (LIN52)
|
OT14OQ1C
|
LIN52_HUMAN
|
Increases Expression
|
[141] |
Seizure protein 6 homolog (SEZ6)
|
OTCD8K5D
|
SEZ6_HUMAN
|
Decreases Expression
|
[141] |
Transmembrane 4 L6 family member 20 (TM4SF20)
|
OTNXU9QW
|
T4S20_HUMAN
|
Decreases Expression
|
[141] |
HCLS1-binding protein 3 (HS1BP3)
|
OT5NSZJ1
|
H1BP3_HUMAN
|
Decreases Expression
|
[141] |
Germinal center-associated signaling and motility-like protein (GCSAML)
|
OTYWDOA6
|
GSAML_HUMAN
|
Increases Expression
|
[141] |
Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1 (SOHLH1)
|
OT3RBLSK
|
SOLH1_HUMAN
|
Decreases Expression
|
[141] |
Intracellular hyaluronan-binding protein 4 (HABP4)
|
OTU223PA
|
HABP4_HUMAN
|
Increases Expression
|
[141] |
Coiled-coil domain-containing protein 158 (CCDC158)
|
OTT3RXZN
|
CD158_HUMAN
|
Decreases Expression
|
[141] |
RNA-binding protein 26 (RBM26)
|
OTG4C53Y
|
RBM26_HUMAN
|
Decreases Expression
|
[141] |
Roquin-1 (RC3H1)
|
OTCU6CYA
|
RC3H1_HUMAN
|
Decreases Expression
|
[141] |
Radial spoke head protein 4 homolog A (RSPH4A)
|
OTNDPGEE
|
RSH4A_HUMAN
|
Decreases Expression
|
[141] |
Four and a half LIM domains protein 5 (FHL5)
|
OT6C00Z1
|
FHL5_HUMAN
|
Decreases Expression
|
[141] |
Protein PRR14L (PRR14L)
|
OT290EDE
|
PR14L_HUMAN
|
Increases Expression
|
[141] |
Centrosome-associated protein 350 (CEP350)
|
OT5Q3AEA
|
CE350_HUMAN
|
Increases Expression
|
[141] |
Divergent protein kinase domain 1B (DIPK1B)
|
OTSPU5O5
|
DIK1B_HUMAN
|
Increases Expression
|
[141] |
OTU domain-containing protein 1 (OTUD1)
|
OTE6O5XB
|
OTUD1_HUMAN
|
Decreases Expression
|
[141] |
DDB1- and CUL4-associated factor 12-like protein 2 (DCAF12L2)
|
OTLEF5TY
|
DC122_HUMAN
|
Increases Expression
|
[141] |
Interleukin-23 receptor (IL23R)
|
OTT6L7U8
|
IL23R_HUMAN
|
Decreases Expression
|
[141] |
Muscular LMNA-interacting protein (MLIP)
|
OTMT7AII
|
MLIP_HUMAN
|
Increases Expression
|
[141] |
Ankyrin repeat domain-containing protein 34A (ANKRD34A)
|
OTI00ROL
|
AN34A_HUMAN
|
Decreases Expression
|
[141] |
Multiple C2 and transmembrane domain-containing protein 2 (MCTP2)
|
OTFMZ8I2
|
MCTP2_HUMAN
|
Decreases Expression
|
[141] |
General transcription factor II-I repeat domain-containing protein 2B (GTF2IRD2B)
|
OTO0L3A2
|
GTD2B_HUMAN
|
Increases Expression
|
[141] |
Tyrosine-protein kinase STYK1 (STYK1)
|
OT61CSU7
|
STYK1_HUMAN
|
Decreases Expression
|
[141] |
Kelch-like protein 10 (KLHL10)
|
OTB41MP9
|
KLH10_HUMAN
|
Increases Expression
|
[141] |
Proline-rich protein 5-like (PRR5L)
|
OTQ1Z0OU
|
PRR5L_HUMAN
|
Decreases Expression
|
[141] |
RPA-related protein RADX (RADX)
|
OTKV8BMJ
|
RADX_HUMAN
|
Increases Expression
|
[141] |
Glutamate-rich protein 5 (ERICH5)
|
OTQEY1SQ
|
ERIC5_HUMAN
|
Increases Expression
|
[141] |
Ankyrin repeat domain-containing protein 16 (ANKRD16)
|
OTZD4JUO
|
ANR16_HUMAN
|
Decreases Expression
|
[141] |
MTOR-associated protein MEAK7 (MEAK7)
|
OT9A8JSO
|
MEAK7_HUMAN
|
Decreases Expression
|
[141] |
E3 ubiquitin-protein ligase RFWD3 (RFWD3)
|
OTDUULBQ
|
RFWD3_HUMAN
|
Decreases Expression
|
[141] |
F-box only protein 38 (FBXO38)
|
OTSZ3768
|
FBX38_HUMAN
|
Decreases Expression
|
[141] |
Consortin (CNST)
|
OTOUCB98
|
CNST_HUMAN
|
Increases Expression
|
[141] |
Docking protein 6 (DOK6)
|
OTX55OIF
|
DOK6_HUMAN
|
Increases Expression
|
[141] |
Type-1 angiotensin II receptor-associated protein (AGTRAP)
|
OT02N7LD
|
ATRAP_HUMAN
|
Decreases Expression
|
[141] |
Coiled-coil domain-containing protein 171 (CCDC171)
|
OT9NL2D9
|
CC171_HUMAN
|
Increases Expression
|
[141] |
Monofunctional C1-tetrahydrofolate synthase, mitochondrial (MTHFD1L)
|
OTV01EFP
|
C1TM_HUMAN
|
Increases Expression
|
[141] |
Transmembrane protein 107 (TMEM107)
|
OT9RMLBJ
|
TM107_HUMAN
|
Decreases Expression
|
[141] |
C-type lectin domain family 4 member G (CLEC4G)
|
OTUGTR0H
|
CLC4G_HUMAN
|
Decreases Expression
|
[141] |
Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (TPTE2)
|
OTR3K733
|
TPTE2_HUMAN
|
Increases Expression
|
[141] |
Sulfhydryl oxidase 2 (QSOX2)
|
OTMLKYFP
|
QSOX2_HUMAN
|
Decreases Expression
|
[141] |
Patched domain-containing protein 4 (PTCHD4)
|
OTGJ8NRP
|
PTHD4_HUMAN
|
Increases Expression
|
[141] |
Cyclic AMP-responsive element-binding protein 3-like protein 2 (CREB3L2)
|
OT09MHV0
|
CR3L2_HUMAN
|
Increases Expression
|
[141] |
Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (PREX2)
|
OTYT1J6J
|
PREX2_HUMAN
|
Decreases Expression
|
[141] |
Protein FRA10AC1 (FRA10AC1)
|
OT730MMV
|
F10C1_HUMAN
|
Increases Expression
|
[141] |
Mediator of RNA polymerase II transcription subunit 13-like (MED13L)
|
OTSP1W0F
|
MD13L_HUMAN
|
Increases Expression
|
[141] |
Immunoglobulin-like domain-containing receptor 2 (ILDR2)
|
OTNNK3VC
|
ILDR2_HUMAN
|
Increases Expression
|
[141] |
GRB2-associated and regulator of MAPK protein 2 (GAREM2)
|
OTQNQAC7
|
GARE2_HUMAN
|
Increases Expression
|
[141] |
Carbohydrate sulfotransferase 15 (CHST15)
|
OTNTM2SP
|
CHSTF_HUMAN
|
Decreases Expression
|
[141] |
STE20-related kinase adapter protein alpha (STRADA)
|
OTG1Z6TY
|
STRAA_HUMAN
|
Decreases Expression
|
[141] |
#NAME?
|
OTD229X7
|
MICA3_HUMAN
|
Increases Expression
|
[141] |
Aprataxin (APTX)
|
OTPAS5G8
|
APTX_HUMAN
|
Decreases Expression
|
[141] |
Endoplasmic reticulum metallopeptidase 1 (ERMP1)
|
OT9CIEO2
|
ERMP1_HUMAN
|
Decreases Expression
|
[141] |
Nucleoporin p54 (NUP54)
|
OTHOIRMG
|
NUP54_HUMAN
|
Decreases Expression
|
[141] |
Keratin, type I cytoskeletal 25 (KRT25)
|
OT4JMRN6
|
K1C25_HUMAN
|
Increases Expression
|
[141] |
Transmembrane channel-like protein 6 (TMC6)
|
OTKH50J4
|
TMC6_HUMAN
|
Decreases Expression
|
[141] |
Cytoplasmic polyadenylation element-binding protein 2 (CPEB2)
|
OTKES4YR
|
CPEB2_HUMAN
|
Decreases Expression
|
[141] |
FERM domain-containing protein 5 (FRMD5)
|
OTC73XJK
|
FRMD5_HUMAN
|
Increases Expression
|
[141] |
Beta-defensin 132 (DEFB132)
|
OT5SRTW1
|
DB132_HUMAN
|
Increases Expression
|
[141] |
Cytokine-dependent hematopoietic cell linker (CLNK)
|
OTOWK51S
|
CLNK_HUMAN
|
Decreases Expression
|
[141] |
Protein polybromo-1 (PBRM1)
|
OT39WUR9
|
PB1_HUMAN
|
Increases Expression
|
[141] |
CUB and zona pellucida-like domain-containing protein 1 (CUZD1)
|
OTDQJVZ8
|
CUZD1_HUMAN
|
Increases Expression
|
[141] |
Organic solute transporter subunit alpha (SLC51A)
|
OTDJRZ0P
|
OSTA_HUMAN
|
Increases Expression
|
[141] |
Zinc finger protein castor homolog 1 (CASZ1)
|
OTWJ2OR8
|
CASZ1_HUMAN
|
Increases Expression
|
[141] |
Liprin-beta-1 (PPFIBP1)
|
OTRA2S7B
|
LIPB1_HUMAN
|
Increases Expression
|
[141] |
Fibrocystin-L (PKHD1L1)
|
OTREFCAA
|
PKHL1_HUMAN
|
Increases Expression
|
[141] |
Protein NLRC5 (NLRC5)
|
OTY8X6MC
|
NLRC5_HUMAN
|
Decreases Expression
|
[141] |
Vasculin (GPBP1)
|
OTUXR2GD
|
GPBP1_HUMAN
|
Increases Expression
|
[141] |
Ral GTPase-activating protein subunit beta (RALGAPB)
|
OTY8CGA3
|
RLGPB_HUMAN
|
Increases Expression
|
[141] |
Diacylglycerol kinase eta (DGKH)
|
OTYNPJ4B
|
DGKH_HUMAN
|
Decreases Expression
|
[141] |
Probable guanine nucleotide exchange factor MCF2L2 (MCF2L2)
|
OTOGFMIH
|
MF2L2_HUMAN
|
Decreases Expression
|
[141] |
Ras-related protein Rab-43 (RAB43)
|
OTVCSILI
|
RAB43_HUMAN
|
Decreases Expression
|
[141] |
NudC domain-containing protein 3 (NUDCD3)
|
OT2WYBNC
|
NUDC3_HUMAN
|
Decreases Expression
|
[141] |
Somatomedin-B and thrombospondin type-1 domain-containing protein (SBSPON)
|
OTBHAW5K
|
SBSPO_HUMAN
|
Increases Expression
|
[141] |
Kinase suppressor of Ras 1 (KSR1)
|
OT9GUVLI
|
KSR1_HUMAN
|
Decreases Expression
|
[141] |
Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 (NKAIN4)
|
OT91HOEP
|
NKAI4_HUMAN
|
Decreases Expression
|
[141] |
Sphingosine-1-phosphate transporter SPNS2 (SPNS2)
|
OTPODAPU
|
SPNS2_HUMAN
|
Decreases Expression
|
[141] |
FAD-dependent oxidoreductase domain-containing protein 2 (FOXRED2)
|
OTSJOZ3O
|
FXRD2_HUMAN
|
Decreases Expression
|
[141] |
PHD finger protein 6 (PHF6)
|
OT8DXI40
|
PHF6_HUMAN
|
Increases Expression
|
[141] |
Calcium homeostasis endoplasmic reticulum protein (CHERP)
|
OTJL4OB3
|
CHERP_HUMAN
|
Decreases Expression
|
[141] |
GTP-binding protein REM 2 (REM2)
|
OT0RTOI8
|
REM2_HUMAN
|
Decreases Expression
|
[141] |
Cilia- and flagella-associated protein 46 (CFAP46)
|
OTRZZHB9
|
CFA46_HUMAN
|
Increases Expression
|
[141] |
Rhotekin-2 (RTKN2)
|
OTV2AXQM
|
RTKN2_HUMAN
|
Increases Expression
|
[141] |
Heparan-sulfate 6-O-sulfotransferase 3 (HS6ST3)
|
OTTW9PDL
|
H6ST3_HUMAN
|
Decreases Expression
|
[141] |
Leucine-rich repeat LGI family member 3 (LGI3)
|
OT0CZ85H
|
LGI3_HUMAN
|
Increases Expression
|
[141] |
Protein SYS1 homolog (SYS1)
|
OTTVS1LN
|
SYS1_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase pellino homolog 3 (PELI3)
|
OTCBUSKJ
|
PELI3_HUMAN
|
Increases Expression
|
[141] |
Protein FAM43A (FAM43A)
|
OT5RPQRE
|
FA43A_HUMAN
|
Increases Expression
|
[141] |
Leucine-rich repeat-containing protein 25 (LRRC25)
|
OTCKAZA5
|
LRC25_HUMAN
|
Decreases Expression
|
[141] |
Chemokine-like protein TAFA-2 (TAFA2)
|
OTU6WP6J
|
TAFA2_HUMAN
|
Decreases Expression
|
[141] |
Follistatin-related protein 5 (FSTL5)
|
OT18C29S
|
FSTL5_HUMAN
|
Increases Expression
|
[141] |
Kinesin-like protein KIF2B (KIF2B)
|
OTLPAX4N
|
KIF2B_HUMAN
|
Increases Expression
|
[141] |
T-complex protein 11-like protein 2 (TCP11L2)
|
OTTIZO7B
|
T11L2_HUMAN
|
Increases Expression
|
[141] |
Prolyl 3-hydroxylase OGFOD1 (OGFOD1)
|
OTTUQ5O3
|
OGFD1_HUMAN
|
Increases Expression
|
[141] |
Ceramide synthase 5 (CERS5)
|
OT5A2DNI
|
CERS5_HUMAN
|
Increases Expression
|
[141] |
Leukocyte immunoglobulin-like receptor subfamily A member 3 (LILRA3)
|
OTBNQCOS
|
LIRA3_HUMAN
|
Decreases Expression
|
[141] |
IQ domain-containing protein F1 (IQCF1)
|
OTXFEQ37
|
IQCF1_HUMAN
|
Decreases Expression
|
[141] |
Stress-associated endoplasmic reticulum protein 2 (SERP2)
|
OT5GA6JZ
|
SERP2_HUMAN
|
Increases Expression
|
[141] |
Leucine-rich repeat-containing protein 17 (LRRC17)
|
OT3NZSX3
|
LRC17_HUMAN
|
Increases Expression
|
[141] |
ER membrane protein complex subunit 1 (EMC1)
|
OTYAH4LX
|
EMC1_HUMAN
|
Decreases Expression
|
[141] |
Androglobin (ADGB)
|
OT1TM9DT
|
ADGB_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (ANKRD44)
|
OTUI0WOO
|
ANR44_HUMAN
|
Decreases Expression
|
[141] |
Coiled-coil domain-containing protein 71L (CCDC71L)
|
OT7ECVUW
|
CC71L_HUMAN
|
Decreases Expression
|
[141] |
Tetratricopeptide repeat protein 29 (TTC29)
|
OT37KCUL
|
TTC29_HUMAN
|
Increases Expression
|
[141] |
Fanconi anemia group B protein (FANCB)
|
OTMZTXB5
|
FANCB_HUMAN
|
Increases Expression
|
[141] |
Hemicentin-2 (HMCN2)
|
OTJK9CGG
|
HMCN2_HUMAN
|
Increases Expression
|
[141] |
Phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3)
|
OTLUM9L7
|
PK3C3_HUMAN
|
Increases Expression
|
[141] |
Microcephalin (MCPH1)
|
OTYT3TT5
|
MCPH1_HUMAN
|
Increases Expression
|
[141] |
Methylcytosine dioxygenase TET1 (TET1)
|
OTZDHT1D
|
TET1_HUMAN
|
Increases Expression
|
[141] |
Telomere repeats-binding bouquet formation protein 2 (TERB2)
|
OTUJDOF8
|
TERB2_HUMAN
|
Increases Expression
|
[141] |
Checkpoint protein HUS1B (HUS1B)
|
OT3VFQWS
|
HUS1B_HUMAN
|
Decreases Expression
|
[141] |
Stomatin-like protein 3 (STOML3)
|
OTLQGALK
|
STML3_HUMAN
|
Increases Expression
|
[141] |
Protein odd-skipped-related 1 (OSR1)
|
OTB19LEQ
|
OSR1_HUMAN
|
Increases Expression
|
[141] |
Ras and Rab interactor 3 (RIN3)
|
OT5Z6F8O
|
RIN3_HUMAN
|
Decreases Expression
|
[141] |
Piwi-like protein 2 (PIWIL2)
|
OT1PXQIF
|
PIWL2_HUMAN
|
Decreases Expression
|
[141] |
Glutamate receptor ionotropic, NMDA 3A (GRIN3A)
|
OTQS9GYY
|
NMD3A_HUMAN
|
Increases Expression
|
[141] |
Mirror-image polydactyly gene 1 protein (MIPOL1)
|
OTLPN3D0
|
MIPO1_HUMAN
|
Increases Expression
|
[141] |
Chromodomain-helicase-DNA-binding protein 6 (CHD6)
|
OTEHW1U2
|
CHD6_HUMAN
|
Increases Expression
|
[141] |
Protocadherin Fat 3 (FAT3)
|
OT3C6H8W
|
FAT3_HUMAN
|
Decreases Expression
|
[141] |
GPI ethanolamine phosphate transferase 3 (PIGO)
|
OTGDOBO1
|
PIGO_HUMAN
|
Decreases Expression
|
[141] |
Guanine nucleotide exchange protein SMCR8 (SMCR8)
|
OT52BQH4
|
SMCR8_HUMAN
|
Decreases Expression
|
[141] |
Partitioning defective 3 homolog B (PARD3B)
|
OTGZ43YI
|
PAR3L_HUMAN
|
Increases Expression
|
[141] |
SH3 domain and tetratricopeptide repeat-containing protein 2 (SH3TC2)
|
OTJ6XY2A
|
S3TC2_HUMAN
|
Increases Expression
|
[141] |
F-box only protein 41 (FBXO41)
|
OT5MC4TZ
|
FBX41_HUMAN
|
Increases Expression
|
[141] |
Protein prune homolog 2 (PRUNE2)
|
OTGW2974
|
PRUN2_HUMAN
|
Increases Expression
|
[141] |
Protein POF1B (POF1B)
|
OTFWNK8G
|
POF1B_HUMAN
|
Decreases Expression
|
[141] |
GTPase IMAP family member 1 (GIMAP1)
|
OT7AJ1TT
|
GIMA1_HUMAN
|
Decreases Expression
|
[141] |
Palladin (PALLD)
|
OTZ2MUJZ
|
PALLD_HUMAN
|
Increases Expression
|
[141] |
RUN and FYVE domain-containing protein 2 (RUFY2)
|
OTT9C6SM
|
RUFY2_HUMAN
|
Increases Expression
|
[141] |
Stonin-2 (STON2)
|
OT01JHHE
|
STON2_HUMAN
|
Increases Expression
|
[141] |
Connector enhancer of kinase suppressor of ras 2 (CNKSR2)
|
OTAGERJ2
|
CNKR2_HUMAN
|
Increases Expression
|
[141] |
Voltage-dependent calcium channel gamma-8 subunit (CACNG8)
|
OTP6227G
|
CCG8_HUMAN
|
Increases Expression
|
[141] |
Cationic amino acid transporter 3 (SLC7A3)
|
OTKEFAHV
|
CTR3_HUMAN
|
Decreases Expression
|
[141] |
Transmembrane O-methyltransferase (LRTOMT)
|
OTMLESUJ
|
TOMT_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase rififylin (RFFL)
|
OT85MGDH
|
RFFL_HUMAN
|
Increases Expression
|
[141] |
Alpha-2,8-sialyltransferase 8B (ST8SIA2)
|
OTRBBBD8
|
SIA8B_HUMAN
|
Increases Expression
|
[141] |
Sorting nexin-19 (SNX19)
|
OTGNS3HG
|
SNX19_HUMAN
|
Increases Expression
|
[141] |
Transmembrane protein 131 (TMEM131)
|
OT72FBLT
|
TM131_HUMAN
|
Decreases Expression
|
[141] |
Stalled ribosome sensor GCN1 (GCN1)
|
OTBFVD7Z
|
GCN1_HUMAN
|
Decreases Expression
|
[141] |
Centromere protein I (CENPI)
|
OTWRIMZ3
|
CENPI_HUMAN
|
Decreases Expression
|
[141] |
Caspase-10 (CASP10)
|
OTE6J88E
|
CASPA_HUMAN
|
Decreases Expression
|
[141] |
Phosphatidate cytidylyltransferase 1 (CDS1)
|
OT2F591M
|
CDS1_HUMAN
|
Increases Expression
|
[141] |
Endonuclease 8-like 2 (NEIL2)
|
OTV6JEON
|
NEIL2_HUMAN
|
Decreases Expression
|
[141] |
Polyamine deacetylase HDAC10 (HDAC10)
|
OTHCKKUQ
|
HDA10_HUMAN
|
Decreases Expression
|
[141] |
Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ERGIC1)
|
OT351FKB
|
ERGI1_HUMAN
|
Increases Expression
|
[141] |
Autophagy-related protein 2 homolog B (ATG2B)
|
OT7FGFJ1
|
ATG2B_HUMAN
|
Decreases Expression
|
[141] |
Pyrroline-5-carboxylate reductase 2 (PYCR2)
|
OTS2HLGD
|
P5CR2_HUMAN
|
Decreases Expression
|
[141] |
FAS-associated factor 2 (FAF2)
|
OTE8CE2E
|
FAF2_HUMAN
|
Increases Expression
|
[141] |
RalBP1-associated Eps domain-containing protein 1 (REPS1)
|
OTX4ERRK
|
REPS1_HUMAN
|
Increases Expression
|
[141] |
U8 snoRNA-decapping enzyme (NUDT16)
|
OTWSL9JQ
|
NUD16_HUMAN
|
Decreases Expression
|
[141] |
THAP domain-containing protein 11 (THAP11)
|
OTEMWLZ0
|
THA11_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase CHFR (CHFR)
|
OTRAD2TT
|
CHFR_HUMAN
|
Decreases Expression
|
[141] |
Small integral membrane protein 12 (SMIM12)
|
OTMOQSL4
|
SIM12_HUMAN
|
Decreases Expression
|
[141] |
UDP-N-acetylglucosamine transferase subunit ALG14 homolog (ALG14)
|
OTBM7K28
|
ALG14_HUMAN
|
Increases Expression
|
[141] |
OTU domain-containing protein 5 (OTUD5)
|
OTMCR6JM
|
OTUD5_HUMAN
|
Decreases Expression
|
[141] |
Solute carrier family 25 member 44 (SLC25A44)
|
OTHHPC3C
|
S2544_HUMAN
|
Decreases Expression
|
[141] |
Dedicator of cytokinesis protein 6 (DOCK6)
|
OTPNUVLT
|
DOCK6_HUMAN
|
Increases Expression
|
[141] |
Kin of IRRE-like protein 1 (KIRREL1)
|
OTOA7ON7
|
KIRR1_HUMAN
|
Increases Expression
|
[141] |
Spatacsin (SPG11)
|
OTZ7LJX4
|
SPTCS_HUMAN
|
Affects Expression
|
[141] |
Protein SPMIP9 (SPMIP9)
|
OT66UEFP
|
SMIP9_HUMAN
|
Decreases Expression
|
[141] |
Coiled-coil domain-containing protein 7 (CCDC7)
|
OTNCL9JR
|
CCDC7_HUMAN
|
Increases Expression
|
[141] |
Protein-L-isoaspartate O-methyltransferase domain-containing protein 1 (PCMTD1)
|
OT5TS6P7
|
PCMD1_HUMAN
|
Increases Expression
|
[141] |
Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST2)
|
OT8A3H9Y
|
H6ST2_HUMAN
|
Increases Expression
|
[141] |
Transmembrane protein 74 (TMEM74)
|
OT3IZBM0
|
TMM74_HUMAN
|
Increases Expression
|
[141] |
2-oxoglutarate receptor 1 (OXGR1)
|
OT2D4V93
|
OXGR1_HUMAN
|
Increases Expression
|
[141] |
N-acetylneuraminate 9-O-acetyltransferase (CASD1)
|
OT1YB54Z
|
CASD1_HUMAN
|
Decreases Expression
|
[141] |
AP-1 complex subunit sigma-3 (AP1S3)
|
OTPCMV24
|
AP1S3_HUMAN
|
Increases Expression
|
[141] |
BTB/POZ domain-containing protein 9 (BTBD9)
|
OTWQ6GA3
|
BTBD9_HUMAN
|
Decreases Expression
|
[141] |
Rho GTPase-activating protein 7 (DLC1)
|
OTP8LMCR
|
RHG07_HUMAN
|
Increases Expression
|
[141] |
Sorting nexin-18 (SNX18)
|
OT68KT3X
|
SNX18_HUMAN
|
Increases Expression
|
[141] |
Tribbles homolog 1 (TRIB1)
|
OTPEO17G
|
TRIB1_HUMAN
|
Decreases Expression
|
[141] |
Ras-related protein Rab-40C (RAB40C)
|
OTM2V2R0
|
RB40C_HUMAN
|
Increases Expression
|
[141] |
Protein ABHD1 (ABHD1)
|
OTY56U02
|
ABHD1_HUMAN
|
Decreases Expression
|
[141] |
CDK5 regulatory subunit-associated protein 2 (CDK5RAP2)
|
OTRKEVTY
|
CK5P2_HUMAN
|
Increases Expression
|
[141] |
Insulinoma-associated protein 2 (INSM2)
|
OTNMQUZV
|
INSM2_HUMAN
|
Increases Expression
|
[141] |
Glutamate decarboxylase 1 (GAD1)
|
OT52Z39J
|
DCE1_HUMAN
|
Decreases Expression
|
[141] |
M-phase phosphoprotein 6 (MPHOSPH6)
|
OT6E2S48
|
MPH6_HUMAN
|
Decreases Expression
|
[141] |
Max-binding protein MNT (MNT)
|
OTPC4ANL
|
MNT_HUMAN
|
Decreases Expression
|
[141] |
Mitochondrial import inner membrane translocase subunit Tim17-A (TIMM17A)
|
OTVFRL8G
|
TI17A_HUMAN
|
Decreases Expression
|
[141] |
Heterogeneous nuclear ribonucleoprotein A/B (HNRNPAB)
|
OTUKPFOK
|
ROAA_HUMAN
|
Decreases Expression
|
[141] |
Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LITAF)
|
OTT5JX1F
|
LITAF_HUMAN
|
Decreases Expression
|
[141] |
Noelin (OLFM1)
|
OTOYPEWW
|
NOE1_HUMAN
|
Decreases Expression
|
[141] |
Spindlin-2A (SPIN2A)
|
OT93VTU4
|
SPI2A_HUMAN
|
Increases Expression
|
[141] |
Histone H2B type 1-M (H2BC14)
|
OTSDZZZY
|
H2B1M_HUMAN
|
Decreases Expression
|
[141] |
Cyclic AMP-dependent transcription factor ATF-6 beta (ATF6B)
|
OTT2ZGSR
|
ATF6B_HUMAN
|
Increases Expression
|
[141] |
Tyrosine-protein phosphatase non-receptor type 18 (PTPN18)
|
OT0S09B3
|
PTN18_HUMAN
|
Decreases Expression
|
[141] |
F-box-like/WD repeat-containing protein TBL1Y (TBL1Y)
|
OTA0F7TM
|
TBL1Y_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein phosphatase CPPED1 (CPPED1)
|
OT88U8X5
|
CPPED_HUMAN
|
Decreases Expression
|
[141] |
Suppressor of IKBKE 1 (SIKE1)
|
OT5O11J0
|
SIKE1_HUMAN
|
Increases Expression
|
[141] |
Mitochondrial nucleoid-associated protein 1 (MTNAP1)
|
OT8FB2F8
|
CQ080_HUMAN
|
Increases Expression
|
[141] |
Trichoplein keratin filament-binding protein (TCHP)
|
OTVDMHSY
|
TCHP_HUMAN
|
Decreases Expression
|
[141] |
Immediate early response gene 2 protein (IER2)
|
OT5OY8BO
|
IER2_HUMAN
|
Decreases Expression
|
[141] |
Protein misato homolog 1 (MSTO1)
|
OT37XCNP
|
MSTO1_HUMAN
|
Decreases Expression
|
[141] |
PHD finger protein 23 (PHF23)
|
OTVF5VZC
|
PHF23_HUMAN
|
Decreases Expression
|
[141] |
Specifically androgen-regulated gene protein (C1ORF116)
|
OTPYEXDM
|
SARG_HUMAN
|
Increases Expression
|
[141] |
DET1- and DDB1-associated protein 1 (DDA1)
|
OTAZIAIH
|
DDA1_HUMAN
|
Increases Expression
|
[141] |
GTP-binding protein 2 (GTPBP2)
|
OTOJ1KUA
|
GTPB2_HUMAN
|
Increases Expression
|
[141] |
Protein LSM14 homolog B (LSM14B)
|
OTW646HP
|
LS14B_HUMAN
|
Increases Expression
|
[141] |
Transient receptor potential cation channel subfamily M member 6 (TRPM6)
|
OTW7SPUV
|
TRPM6_HUMAN
|
Decreases Expression
|
[141] |
Protein amnionless (AMN)
|
OTS1TJXG
|
AMNLS_HUMAN
|
Decreases Expression
|
[141] |
Complement factor H-related protein 5 (CFHR5)
|
OT7BMOYE
|
FHR5_HUMAN
|
Decreases Expression
|
[141] |
Testis-expressed protein 12 (TEX12)
|
OTXHQWTA
|
TEX12_HUMAN
|
Decreases Expression
|
[141] |
Calcium-binding protein 8 (CALN1)
|
OTN2XE4T
|
CABP8_HUMAN
|
Increases Expression
|
[141] |
Cell adhesion molecule 1 (CADM1)
|
OTRWG9QS
|
CADM1_HUMAN
|
Increases Expression
|
[141] |
Polymerase delta-interacting protein 3 (POLDIP3)
|
OTTB5SV7
|
PDIP3_HUMAN
|
Increases Expression
|
[141] |
Large ribosomal subunit protein uL4m (MRPL4)
|
OT8AE74Y
|
RM04_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein kinase 33 (STK33)
|
OT98KLEL
|
STK33_HUMAN
|
Increases Expression
|
[141] |
FERM domain-containing protein 8 (FRMD8)
|
OTTH5DUJ
|
FRMD8_HUMAN
|
Decreases Expression
|
[141] |
F-box-like/WD repeat-containing protein TBL1XR1 (TBL1XR1)
|
OTM3B3OA
|
TBL1R_HUMAN
|
Decreases Expression
|
[141] |
Group XIIA secretory phospholipase A2 (PLA2G12A)
|
OTHHCQ17
|
PG12A_HUMAN
|
Increases Expression
|
[141] |
Testicular spindle-associated protein SHCBP1L (SHCBP1L)
|
OTYGG089
|
SHP1L_HUMAN
|
Decreases Expression
|
[141] |
GREB1-like protein (GREB1L)
|
OTZTY5KQ
|
GRB1L_HUMAN
|
Increases Expression
|
[141] |
E3 ubiquitin-protein ligase makorin-2 (MKRN2)
|
OTDD1V3O
|
MKRN2_HUMAN
|
Increases Expression
|
[141] |
Large subunit GTPase 1 homolog (LSG1)
|
OTDAXJ9L
|
LSG1_HUMAN
|
Decreases Expression
|
[141] |
NUAK family SNF1-like kinase 2 (NUAK2)
|
OTUEZLO8
|
NUAK2_HUMAN
|
Decreases Expression
|
[141] |
Oxysterol-binding protein-related protein 5 (OSBPL5)
|
OTI1UJXT
|
OSBL5_HUMAN
|
Decreases Expression
|
[141] |
Nucleoporin-62 C-terminal-like protein (NUP62CL)
|
OTEN1HET
|
N62CL_HUMAN
|
Increases Expression
|
[141] |
Oxysterol-binding protein-related protein 2 (OSBPL2)
|
OTCK671N
|
OSBL2_HUMAN
|
Decreases Expression
|
[141] |
Ciliary microtubule inner protein 1 (CIMIP1)
|
OTKOYVKF
|
CMIP1_HUMAN
|
Increases Expression
|
[141] |
Mediator of RNA polymerase II transcription subunit 28 (MED28)
|
OTEDM1L5
|
MED28_HUMAN
|
Decreases Expression
|
[141] |
EH domain-containing protein 4 (EHD4)
|
OT7G5JTT
|
EHD4_HUMAN
|
Decreases Expression
|
[141] |
Translation initiation factor IF-3, mitochondrial (MTIF3)
|
OTPQ7FPQ
|
IF3M_HUMAN
|
Increases Expression
|
[141] |
Kallikrein-15 (KLK15)
|
OT7BVG17
|
KLK15_HUMAN
|
Decreases Expression
|
[141] |
Chordin (CHRD)
|
OTNM60Y1
|
CHRD_HUMAN
|
Decreases Expression
|
[141] |
Sorting nexin-25 (SNX25)
|
OT8JY8M1
|
SNX25_HUMAN
|
Increases Expression
|
[141] |
BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (KCTD10)
|
OT5HFZXU
|
BACD3_HUMAN
|
Decreases Expression
|
[141] |
Histamine H4 receptor (HRH4)
|
OTBJO49O
|
HRH4_HUMAN
|
Decreases Expression
|
[141] |
Leucine-rich repeat neuronal protein 3 (LRRN3)
|
OT7X0AA7
|
LRRN3_HUMAN
|
Increases Expression
|
[141] |
Cystatin-9-like (CST9L)
|
OT7GBIWW
|
CST9L_HUMAN
|
Increases Expression
|
[141] |
Cilia- and flagella-associated protein 68 (CFAP68)
|
OTG4EK2P
|
CFA68_HUMAN
|
Decreases Expression
|
[141] |
tRNA (NSUN3)
|
OTLBKU22
|
NSUN3_HUMAN
|
Decreases Expression
|
[141] |
DENN domain-containing protein 2D (DENND2D)
|
OTXEFJWM
|
DEN2D_HUMAN
|
Decreases Expression
|
[141] |
HAUS augmin-like complex subunit 4 (HAUS4)
|
OTFIO49N
|
HAUS4_HUMAN
|
Decreases Expression
|
[141] |
PDZ domain-containing protein MAGIX (MAGIX)
|
OT8EU651
|
MAGIX_HUMAN
|
Increases Expression
|
[141] |
Tudor domain-containing protein 3 (TDRD3)
|
OTG83E2C
|
TDRD3_HUMAN
|
Increases Expression
|
[141] |
Nuclear exosome regulator NRDE2 (NRDE2)
|
OTJ1V33O
|
NRDE2_HUMAN
|
Increases Expression
|
[141] |
Proton-activated chloride channel (PACC1)
|
OTKBS8CC
|
PACC1_HUMAN
|
Increases Expression
|
[141] |
Jupiter microtubule associated homolog 2 (JPT2)
|
OTJGPA4T
|
JUPI2_HUMAN
|
Increases Expression
|
[141] |
Akirin-1 (AKIRIN1)
|
OTINWTT9
|
AKIR1_HUMAN
|
Decreases Expression
|
[141] |
DNA-directed RNA polymerase I subunit RPA2 (POLR1B)
|
OTKREU8M
|
RPA2_HUMAN
|
Decreases Expression
|
[141] |
Pleckstrin homology domain-containing family A member 5 (PLEKHA5)
|
OT2MNW8T
|
PKHA5_HUMAN
|
Increases Expression
|
[141] |
Claspin (CLSPN)
|
OTZZXNDK
|
CLSPN_HUMAN
|
Increases Expression
|
[141] |
Dual specificity protein kinase CLK4 (CLK4)
|
OTD38YJI
|
CLK4_HUMAN
|
Increases Expression
|
[141] |
Sp110 nuclear body protein (SP110)
|
OTFW6WH7
|
SP110_HUMAN
|
Decreases Expression
|
[141] |
POZ-, AT hook-, and zinc finger-containing protein 1 (PATZ1)
|
OT0X9WGR
|
PATZ1_HUMAN
|
Decreases Expression
|
[141] |
Interleukin-21 receptor (IL21R)
|
OTDIOB63
|
IL21R_HUMAN
|
Decreases Expression
|
[141] |
UPF0606 protein KIAA1549 (KIAA1549)
|
OTA5B18F
|
K1549_HUMAN
|
Increases Expression
|
[141] |
CD209 antigen (CD209)
|
OTCAX8NI
|
CD209_HUMAN
|
Decreases Expression
|
[141] |
3',5'-cyclic-AMP phosphodiesterase 7B (PDE7B)
|
OTK3SHT2
|
PDE7B_HUMAN
|
Increases Expression
|
[141] |
Potassium channel subfamily K member 9 (KCNK9)
|
OT8P734M
|
KCNK9_HUMAN
|
Decreases Expression
|
[141] |
Frizzled-3 (FZD3)
|
OTIWDN78
|
FZD3_HUMAN
|
Increases Expression
|
[141] |
Odorant-binding protein 2b (OBP2B)
|
OTVKMIM4
|
OBP2B_HUMAN
|
Increases Expression
|
[141] |
Proline-rich nuclear receptor coactivator 2 (PNRC2)
|
OTE7W7Y5
|
PNRC2_HUMAN
|
Increases Expression
|
[141] |
Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (B3GAT2)
|
OTNSM9XP
|
B3GA2_HUMAN
|
Decreases Expression
|
[141] |
Anoctamin-2 (ANO2)
|
OT650E98
|
ANO2_HUMAN
|
Decreases Expression
|
[141] |
Mitochondrial dynamics protein MIEF1 (MIEF1)
|
OTFSP3FS
|
MID51_HUMAN
|
Decreases Expression
|
[141] |
Scavenger receptor cysteine-rich type 1 protein M160 (CD163L1)
|
OTZHN1XQ
|
C163B_HUMAN
|
Decreases Expression
|
[141] |
Matrix metalloproteinase-26 (MMP26)
|
OT9O89KU
|
MMP26_HUMAN
|
Decreases Expression
|
[141] |
Teashirt homolog 2 (TSHZ2)
|
OTZWBXXY
|
TSH2_HUMAN
|
Increases Expression
|
[141] |
Bromodomain adjacent to zinc finger domain protein 1A (BAZ1A)
|
OTWHOVZS
|
BAZ1A_HUMAN
|
Decreases Expression
|
[141] |
CDC42 small effector protein 1 (CDC42SE1)
|
OTV3MRFE
|
C42S1_HUMAN
|
Decreases Expression
|
[141] |
Cysteinyl leukotriene receptor 2 (CYSLTR2)
|
OTRNEOZ0
|
CLTR2_HUMAN
|
Decreases Expression
|
[141] |
LanC-like protein 2 (LANCL2)
|
OT7KWGMR
|
LANC2_HUMAN
|
Decreases Expression
|
[141] |
Cytokine-inducible SH2-containing protein (CISH)
|
OT8T5NYL
|
CISH_HUMAN
|
Decreases Expression
|
[141] |
GPI mannosyltransferase 2 (PIGV)
|
OTI6LT46
|
PIGV_HUMAN
|
Increases Expression
|
[141] |
Probable ATP-dependent RNA helicase DDX28 (DDX28)
|
OTIIHNYN
|
DDX28_HUMAN
|
Decreases Expression
|
[141] |
SPATS2-like protein (SPATS2L)
|
OTFO07H8
|
SPS2L_HUMAN
|
Increases Expression
|
[141] |
DNA-directed RNA polymerase III subunit RPC5 (POLR3E)
|
OT69PWBM
|
RPC5_HUMAN
|
Decreases Expression
|
[141] |
Arginine and glutamate-rich protein 1 (ARGLU1)
|
OTRVRZ4Z
|
ARGL1_HUMAN
|
Increases Expression
|
[141] |
Protein FAM118A (FAM118A)
|
OT6EM97E
|
F118A_HUMAN
|
Decreases Expression
|
[141] |
Ankyrin repeat and SOCS box protein 6 (ASB6)
|
OTFAJPSF
|
ASB6_HUMAN
|
Decreases Expression
|
[141] |
Ras-related protein Rab-20 (RAB20)
|
OTP9OOVS
|
RAB20_HUMAN
|
Decreases Expression
|
[141] |
Pre-mRNA-splicing factor CWC25 homolog (CWC25)
|
OT96LFJH
|
CWC25_HUMAN
|
Decreases Expression
|
[141] |
Stabilin-1 (STAB1)
|
OTW2HMCE
|
STAB1_HUMAN
|
Decreases Expression
|
[141] |
Gamma-2-syntrophin (SNTG2)
|
OTD8HJCD
|
SNTG2_HUMAN
|
Decreases Expression
|
[141] |
Cyclin-dependent kinase 12 (CDK12)
|
OTZUDGNU
|
CDK12_HUMAN
|
Decreases Expression
|
[141] |
Placenta-specific gene 8 protein (PLAC8)
|
OT3SYRUJ
|
PLAC8_HUMAN
|
Decreases Expression
|
[141] |
Opioid growth factor receptor (OGFR)
|
OTROS6RJ
|
OGFR_HUMAN
|
Decreases Expression
|
[141] |
Disintegrin and metalloproteinase domain-containing protein 22 (ADAM22)
|
OT452ZDC
|
ADA22_HUMAN
|
Increases Expression
|
[141] |
SLAIN motif-containing protein 2 (SLAIN2)
|
OTSM5QIO
|
SLAI2_HUMAN
|
Increases Expression
|
[141] |
RNA-binding protein 27 (RBM27)
|
OTBVP6VJ
|
RBM27_HUMAN
|
Increases Expression
|
[141] |
Arginine-glutamic acid dipeptide repeats protein (RERE)
|
OT3G4GBZ
|
RERE_HUMAN
|
Increases Expression
|
[141] |
Cardiotrophin-like cytokine factor 1 (CLCF1)
|
OTHQUDDI
|
CLCF1_HUMAN
|
Decreases Expression
|
[141] |
Cornulin (CRNN)
|
OTAORBR4
|
CRNN_HUMAN
|
Increases Expression
|
[141] |
Phosphatidylserine decarboxylase proenzyme, mitochondrial (PISD)
|
OTP9COQT
|
PISD_HUMAN
|
Decreases Expression
|
[141] |
ATP-binding cassette sub-family F member 2 (ABCF2)
|
OTXIBZ3N
|
ABCF2_HUMAN
|
Decreases Expression
|
[141] |
5'-AMP-activated protein kinase subunit gamma-2 (PRKAG2)
|
OTHTAM54
|
AAKG2_HUMAN
|
Decreases Expression
|
[141] |
Poly polymerase 2 (PARP2)
|
OTYL81ZI
|
PARP2_HUMAN
|
Increases Expression
|
[141] |
LIM domain-containing protein 1 (LIMD1)
|
OTN1CG6R
|
LIMD1_HUMAN
|
Decreases Expression
|
[141] |
Armadillo repeat-containing X-linked protein 3 (ARMCX3)
|
OTMG7RWW
|
ARMX3_HUMAN
|
Increases Expression
|
[141] |
Max-like protein X (MLX)
|
OTZ74KFI
|
MLX_HUMAN
|
Decreases Expression
|
[141] |
NPC1-like intracellular cholesterol transporter 1 (NPC1L1)
|
OT6GWW1P
|
NPCL1_HUMAN
|
Increases Expression
|
[141] |
Adhesion G protein-coupled receptor E2 (ADGRE2)
|
OTUYJVYG
|
AGRE2_HUMAN
|
Decreases Expression
|
[141] |
Dimethylglycine dehydrogenase, mitochondrial (DMGDH)
|
OTPJEWQ8
|
M2GD_HUMAN
|
Increases Expression
|
[141] |
Importin-11 (IPO11)
|
OTG19WN0
|
IPO11_HUMAN
|
Decreases Expression
|
[141] |
Methyl-CpG-binding domain protein 1 (MBD1)
|
OTD19VO6
|
MBD1_HUMAN
|
Increases Expression
|
[141] |
Adherens junction-associated protein 1 (AJAP1)
|
OTAAW121
|
AJAP1_HUMAN
|
Decreases Expression
|
[141] |
Zinc finger protein Helios (IKZF2)
|
OTZIMARJ
|
IKZF2_HUMAN
|
Increases Expression
|
[141] |
Nuclear pore complex protein Nup50 (NUP50)
|
OTOZ98K3
|
NUP50_HUMAN
|
Decreases Expression
|
[141] |
Transcription factor-like 5 protein (TCFL5)
|
OTJL4348
|
TCFL5_HUMAN
|
Decreases Expression
|
[141] |
Malignant T-cell-amplified sequence 1 (MCTS1)
|
OT7SAOJP
|
MCTS1_HUMAN
|
Increases Expression
|
[141] |
Signal-transducing adaptor protein 1 (STAP1)
|
OTUTZH0W
|
STAP1_HUMAN
|
Increases Expression
|
[141] |
Hippocalcin-like protein 4 (HPCAL4)
|
OT793RNP
|
HPCL4_HUMAN
|
Decreases Expression
|
[141] |
Ornithine decarboxylase antizyme 3 (OAZ3)
|
OT8Q5PVB
|
OAZ3_HUMAN
|
Increases Expression
|
[141] |
Protocadherin gamma-C3 (PCDHGC3)
|
OTDXTUMI
|
PCDGK_HUMAN
|
Increases Expression
|
[141] |
Rab effector Noc2 (RPH3AL)
|
OT9VFJEL
|
RPH3L_HUMAN
|
Increases Expression
|
[141] |
Trinucleotide repeat-containing gene 6B protein (TNRC6B)
|
OTGVT0SH
|
TNR6B_HUMAN
|
Increases Expression
|
[141] |
Protein Smaug homolog 1 (SAMD4A)
|
OT4MKCC8
|
SMAG1_HUMAN
|
Increases Expression
|
[141] |
Protein phosphatase 1 regulatory subunit 3C (PPP1R3C)
|
OTEU05TX
|
PPR3C_HUMAN
|
Increases Expression
|
[141] |
Solute carrier family 22 member 13 (SLC22A13)
|
OTM96T5U
|
S22AD_HUMAN
|
Increases Expression
|
[141] |
Nucleotide-binding oligomerization domain-containing protein 1 (NOD1)
|
OTUN9GUS
|
NOD1_HUMAN
|
Decreases Expression
|
[141] |
Inversin (INVS)
|
OT8KPESR
|
INVS_HUMAN
|
Increases Expression
|
[141] |
F-box/WD repeat-containing protein 1A (BTRC)
|
OT2EZDGR
|
FBW1A_HUMAN
|
Increases Expression
|
[141] |
Sodium/hydrogen exchanger 8 (SLC9A8)
|
OTR56QTT
|
SL9A8_HUMAN
|
Decreases Expression
|
[141] |
Protein strawberry notch homolog 2 (SBNO2)
|
OT1C6J3K
|
SBNO2_HUMAN
|
Decreases Expression
|
[141] |
Serine/threonine-protein kinase SIK3 (SIK3)
|
OTH0V1L5
|
SIK3_HUMAN
|
Decreases Expression
|
[141] |
Hypoxia-inducible factor 3-alpha (HIF3A)
|
OTPWAAMC
|
HIF3A_HUMAN
|
Decreases Expression
|
[141] |
Long-chain fatty acid transport protein 6 (SLC27A6)
|
OT2AJU6L
|
S27A6_HUMAN
|
Increases Expression
|
[141] |
G-protein coupled receptor 55 (GPR55)
|
OTUSATXO
|
GPR55_HUMAN
|
Decreases Expression
|
[141] |
RNA-binding motif protein, X-linked 2 (RBMX2)
|
OTGGU7N1
|
RBMX2_HUMAN
|
Decreases Expression
|
[141] |
Nucleolar complex protein 2 homolog (NOC2L)
|
OTNT7R33
|
NOC2L_HUMAN
|
Decreases Expression
|
[141] |
DDB1- and CUL4-associated factor 1 (DCAF1)
|
OT3ZDVOE
|
DCAF1_HUMAN
|
Decreases Expression
|
[141] |
Meiosis regulator and mRNA stability factor 1 (MARF1)
|
OTYRJ4V2
|
MARF1_HUMAN
|
Increases Expression
|
[141] |
Lysyl oxidase homolog 2 (LOXL2)
|
OTRT46B5
|
LOXL2_HUMAN
|
Increases Expression
|
[141] |
Cyanocobalamin reductase / alkylcobalamin dealkylase (MMACHC)
|
OTX0TT3W
|
MMAC_HUMAN
|
Increases Expression
|
[141] |
Protocadherin gamma-A9 (PCDHGA9)
|
OTKJE2H2
|
PCDG9_HUMAN
|
Increases Expression
|
[141] |
Protocadherin gamma-A3 (PCDHGA3)
|
OTTOGYJA
|
PCDG3_HUMAN
|
Decreases Expression
|
[141] |
Doublesex- and mab-3-related transcription factor 1 (DMRT1)
|
OT5PU9U1
|
DMRT1_HUMAN
|
Decreases Expression
|
[141] |
RNA-binding protein 8A (RBM8A)
|
OT5SR6G0
|
RBM8A_HUMAN
|
Decreases Expression
|
[141] |
Solute carrier family 12 member 7 (SLC12A7)
|
OT29GM25
|
S12A7_HUMAN
|
Decreases Expression
|
[141] |
Gap junction alpha-3 protein (GJA3)
|
OTXV6ETF
|
CXA3_HUMAN
|
Increases Expression
|
[141] |
Peroxisomal membrane protein 4 (PXMP4)
|
OTNDYSHU
|
PXMP4_HUMAN
|
Increases Expression
|
[141] |
Serine/threonine/tyrosine-interacting-like protein 1 (STYXL1)
|
OTSPVITK
|
STYL1_HUMAN
|
Decreases Expression
|
[141] |
DNA (DNMT3A)
|
OTEJP0GH
|
DNM3A_HUMAN
|
Increases Expression
|
[141] |
Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2)
|
OT4ZSEEE
|
IF2B2_HUMAN
|
Increases Expression
|
[141] |
Transcription factor E2F8 (E2F8)
|
OTQKZGFP
|
E2F8_HUMAN
|
Decreases Expression
|
[142] |
Class E basic helix-loop-helix protein 40 (BHLHE40)
|
OTITX14U
|
BHE40_HUMAN
|
Increases Expression
|
[142] |
Citron Rho-interacting kinase (CIT)
|
OTOZDKPG
|
CTRO_HUMAN
|
Decreases Expression
|
[142] |
Kinetochore protein NDC80 homolog (NDC80)
|
OTS7D306
|
NDC80_HUMAN
|
Decreases Expression
|
[142] |
Aurora kinase A (AURKA)
|
OTMX0HYT
|
AURKA_HUMAN
|
Decreases Expression
|
[142] |
Protein Mis18-beta (OIP5)
|
OTI5C2DE
|
MS18B_HUMAN
|
Decreases Expression
|
[142] |
Mitotic checkpoint serine/threonine-protein kinase BUB1 (BUB1)
|
OT80DZMT
|
BUB1_HUMAN
|
Decreases Expression
|
[142] |
Dual specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3)
|
OTX1C2GS
|
DYRK3_HUMAN
|
Increases Expression
|
[142] |
Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (BUB1B)
|
OT8KME51
|
BUB1B_HUMAN
|
Decreases Expression
|
[142] |
Hyaluronan mediated motility receptor (HMMR)
|
OT4M0JTZ
|
HMMR_HUMAN
|
Decreases Expression
|
[142] |
Protein phosphatase 1 regulatory subunit 15A (PPP1R15A)
|
OTYG179K
|
PR15A_HUMAN
|
Increases Expression
|
[142] |
G2/mitotic-specific cyclin-B2 (CCNB2)
|
OTIEXTDK
|
CCNB2_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIF20A (KIF20A)
|
OTXOQHE0
|
KI20A_HUMAN
|
Decreases Expression
|
[142] |
Chromosome-associated kinesin KIF4A (KIF4A)
|
OT3UWL7D
|
KIF4A_HUMAN
|
Decreases Expression
|
[142] |
Integrin beta-like protein 1 (ITGBL1)
|
OTJDHE17
|
ITGBL_HUMAN
|
Decreases Expression
|
[142] |
Aldehyde dehydrogenase 1A1 (ALDH1A1)
|
OTCUWZKB
|
AL1A1_HUMAN
|
Decreases Expression
|
[142] |
DNA topoisomerase 2-alpha (TOP2A)
|
OT6LPS08
|
TOP2A_HUMAN
|
Decreases Expression
|
[142] |
G2/mitotic-specific cyclin-B1 (CCNB1)
|
OT19S7E5
|
CCNB1_HUMAN
|
Decreases Expression
|
[142] |
Histone H1.5 (H1-5)
|
OTAN7RD9
|
H15_HUMAN
|
Decreases Expression
|
[142] |
Cyclin-A2 (CCNA2)
|
OTPHHYZJ
|
CCNA2_HUMAN
|
Decreases Expression
|
[142] |
Lamin-B1 (LMNB1)
|
OT100T3P
|
LMNB1_HUMAN
|
Decreases Expression
|
[142] |
Interleukin-11 (IL11)
|
OTXHN86R
|
IL11_HUMAN
|
Increases Expression
|
[142] |
Diamine acetyltransferase 1 (SAT1)
|
OT52AU22
|
SAT1_HUMAN
|
Increases Expression
|
[142] |
Arylacetamide deacetylase (AADAC)
|
OT8VACT2
|
AAAD_HUMAN
|
Increases Expression
|
[142] |
GTP cyclohydrolase 1 (GCH1)
|
OTOZ6NSL
|
GCH1_HUMAN
|
Increases Expression
|
[142] |
Ribonucleoside-diphosphate reductase subunit M2 (RRM2)
|
OTOB6J6R
|
RIR2_HUMAN
|
Decreases Expression
|
[142] |
Histone H2B type 1-B (H2BC3)
|
OT1BLFJO
|
H2B1B_HUMAN
|
Decreases Expression
|
[142] |
DNA damage-inducible transcript 3 protein (DDIT3)
|
OTI8YKKE
|
DDIT3_HUMAN
|
Increases Expression
|
[142] |
Proliferation marker protein Ki-67 (MKI67)
|
OTA8N1QI
|
KI67_HUMAN
|
Decreases Expression
|
[142] |
Centromere protein F (CENPF)
|
OT7AG0SW
|
CENPF_HUMAN
|
Decreases Expression
|
[142] |
DNA primase small subunit (PRIM1)
|
OTWWP8Y6
|
PRI1_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIF11 (KIF11)
|
OTHRGLCQ
|
KIF11_HUMAN
|
Decreases Expression
|
[142] |
Serine/threonine-protein kinase PLK1 (PLK1)
|
OTRZX45T
|
PLK1_HUMAN
|
Decreases Expression
|
[142] |
DNA polymerase epsilon subunit 2 (POLE2)
|
OTAC9V6L
|
DPOE2_HUMAN
|
Decreases Expression
|
[142] |
Sestrin-2 (SESN2)
|
OT889IXY
|
SESN2_HUMAN
|
Increases Expression
|
[142] |
Rho-related GTP-binding protein RhoE (RND3)
|
OTXMXPIH
|
RND3_HUMAN
|
Increases Expression
|
[142] |
Histone H3.1 (H3C1)
|
OTGBGOZW
|
H31_HUMAN
|
Decreases Expression
|
[142] |
Arginase-2, mitochondrial (ARG2)
|
OTCPI0E8
|
ARGI2_HUMAN
|
Increases Expression
|
[142] |
G-protein-signaling modulator 2 (GPSM2)
|
OT6RPMRM
|
GPSM2_HUMAN
|
Decreases Expression
|
[142] |
55 kDa erythrocyte membrane protein (MPP1)
|
OTA2ENZQ
|
EM55_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIF23 (KIF23)
|
OTY850JC
|
KIF23_HUMAN
|
Decreases Expression
|
[142] |
Forkhead box protein M1 (FOXM1)
|
OT5887KR
|
FOXM1_HUMAN
|
Decreases Expression
|
[142] |
Magnesium transporter NIPA4 (NIPAL4)
|
OT43JC9A
|
NIPA4_HUMAN
|
Increases Expression
|
[142] |
Cell division cycle protein 20 homolog (CDC20)
|
OTCOEZRV
|
CDC20_HUMAN
|
Decreases Expression
|
[142] |
TNF receptor-associated factor 1 (TRAF1)
|
OTTLM5RU
|
TRAF1_HUMAN
|
Increases Expression
|
[142] |
S-phase kinase-associated protein 2 (SKP2)
|
OTD5B41X
|
SKP2_HUMAN
|
Decreases Expression
|
[142] |
DNA replication licensing factor MCM6 (MCM6)
|
OTKLIAWT
|
MCM6_HUMAN
|
Decreases Expression
|
[142] |
Maternal embryonic leucine zipper kinase (MELK)
|
OTEY2UQA
|
MELK_HUMAN
|
Decreases Expression
|
[142] |
Condensin complex subunit 2 (NCAPH)
|
OTXOS97C
|
CND2_HUMAN
|
Decreases Expression
|
[142] |
PCNA-associated factor (PCLAF)
|
OTMVIOUU
|
PAF15_HUMAN
|
Decreases Expression
|
[142] |
Disks large-associated protein 5 (DLGAP5)
|
OTWCN39U
|
DLGP5_HUMAN
|
Decreases Expression
|
[142] |
Nuclear factor interleukin-3-regulated protein (NFIL3)
|
OTQH9HM3
|
NFIL3_HUMAN
|
Increases Expression
|
[142] |
Cyclin-dependent kinase inhibitor 3 (CDKN3)
|
OTBE3H07
|
CDKN3_HUMAN
|
Decreases Expression
|
[142] |
DNA excision repair protein ERCC-6-like (ERCC6L)
|
OTE9V7D9
|
ERC6L_HUMAN
|
Decreases Expression
|
[142] |
Borealin (CDCA8)
|
OT17D55D
|
BOREA_HUMAN
|
Decreases Expression
|
[142] |
Shugoshin 2 (SGO2)
|
OTNGJDS8
|
SGO2_HUMAN
|
Decreases Expression
|
[142] |
Fidgetin (FIGN)
|
OTJF6EZR
|
FIGN_HUMAN
|
Decreases Expression
|
[142] |
RRP12-like protein (RRP12)
|
OTQQAEH4
|
RRP12_HUMAN
|
Increases Expression
|
[142] |
Alkaline ceramidase 2 (ACER2)
|
OTS3DDE5
|
ACER2_HUMAN
|
Increases Expression
|
[142] |
DEP domain-containing protein 1A (DEPDC1)
|
OT0JWE1B
|
DEP1A_HUMAN
|
Decreases Expression
|
[142] |
Rho GTPase-activating protein 11A (ARHGAP11A)
|
OTVQCFVP
|
RHGBA_HUMAN
|
Decreases Expression
|
[142] |
Transmembrane protein 71 (TMEM71)
|
OTA7W26O
|
TMM71_HUMAN
|
Decreases Expression
|
[142] |
Serine protease FAM111B (FAM111B)
|
OT9IQ9NV
|
F111B_HUMAN
|
Decreases Expression
|
[142] |
Collagen and calcium-binding EGF domain-containing protein 1 (CCBE1)
|
OTO4UIDB
|
CCBE1_HUMAN
|
Decreases Expression
|
[142] |
Lysine-specific demethylase 7A (KDM7A)
|
OT1VGYCX
|
KDM7A_HUMAN
|
Increases Expression
|
[142] |
Alkylglycerol monooxygenase (AGMO)
|
OTGMAHAT
|
ALKMO_HUMAN
|
Decreases Expression
|
[142] |
Condensin-2 complex subunit G2 (NCAPG2)
|
OTZYENKO
|
CNDG2_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIF18B (KIF18B)
|
OTOBUDOE
|
KI18B_HUMAN
|
Decreases Expression
|
[142] |
Abnormal spindle-like microcephaly-associated protein (ASPM)
|
OTKXQMNA
|
ASPM_HUMAN
|
Decreases Expression
|
[142] |
Kinetochore protein Spc24 (SPC24)
|
OT1HVYV4
|
SPC24_HUMAN
|
Decreases Expression
|
[142] |
Meiosis-specific nuclear structural protein 1 (MNS1)
|
OT67F3JQ
|
MNS1_HUMAN
|
Decreases Expression
|
[142] |
SHC SH2 domain-binding protein 1 (SHCBP1)
|
OT3A21CM
|
SHCBP_HUMAN
|
Decreases Expression
|
[142] |
Kelch repeat and BTB domain-containing protein 8 (KBTBD8)
|
OTO8X1UF
|
KBTB8_HUMAN
|
Increases Expression
|
[142] |
Kinetochore scaffold 1 (KNL1)
|
OT4Q3LHV
|
KNL1_HUMAN
|
Decreases Expression
|
[142] |
Endonuclease 8-like 3 (NEIL3)
|
OTBCI2NS
|
NEIL3_HUMAN
|
Decreases Expression
|
[142] |
Enkurin (ENKUR)
|
OTXXBBQT
|
ENKUR_HUMAN
|
Increases Expression
|
[142] |
Transcription initiation factor TFIID subunit 4B (TAF4B)
|
OTCICY31
|
TAF4B_HUMAN
|
Increases Expression
|
[142] |
Histone H2B type 1-H (H2BC9)
|
OTQ9XX72
|
H2B1H_HUMAN
|
Decreases Expression
|
[142] |
Proline-rich protein 11 (PRR11)
|
OT2JJ08Z
|
PRR11_HUMAN
|
Decreases Expression
|
[142] |
Lymphokine-activated killer T-cell-originated protein kinase (PBK)
|
OT5Z27TW
|
TOPK_HUMAN
|
Decreases Expression
|
[142] |
Guanine nucleotide exchange factor C9orf72 (C9ORF72)
|
OT0WH38E
|
CI072_HUMAN
|
Increases Expression
|
[142] |
Sperm-associated antigen 5 (SPAG5)
|
OTCLJ56M
|
SPAG5_HUMAN
|
Decreases Expression
|
[142] |
Centromere protein K (CENPK)
|
OTKPUF8K
|
CENPK_HUMAN
|
Decreases Expression
|
[142] |
Transmembrane protein 106C (TMEM106C)
|
OTDOD9OQ
|
T106C_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIFC1 (KIFC1)
|
OTNQDS00
|
KIFC1_HUMAN
|
Decreases Expression
|
[142] |
Fanconi anemia group J protein (BRIP1)
|
OT38QBD4
|
FANCJ_HUMAN
|
Decreases Expression
|
[142] |
Nucleolar and spindle-associated protein 1 (NUSAP1)
|
OT85HIJ5
|
NUSAP_HUMAN
|
Decreases Expression
|
[142] |
Fanconi anemia group D2 protein (FANCD2)
|
OTVEB5LF
|
FACD2_HUMAN
|
Decreases Expression
|
[142] |
Kinetochore protein Nuf2 (NUF2)
|
OTOOQL35
|
NUF2_HUMAN
|
Decreases Expression
|
[142] |
Ankyrin repeat family A protein 2 (ANKRA2)
|
OTLSLV5A
|
ANRA2_HUMAN
|
Increases Expression
|
[142] |
Kinetochore protein Spc25 (SPC25)
|
OTCAS0OH
|
SPC25_HUMAN
|
Decreases Expression
|
[142] |
Anillin (ANLN)
|
OTXJY54C
|
ANLN_HUMAN
|
Decreases Expression
|
[142] |
Ectonucleoside triphosphate diphosphohydrolase 7 (ENTPD7)
|
OT3QER33
|
ENTP7_HUMAN
|
Increases Expression
|
[142] |
Phospholipid scramblase 4 (PLSCR4)
|
OT2AMYLY
|
PLS4_HUMAN
|
Decreases Expression
|
[142] |
Kinesin-like protein KIF15 (KIF15)
|
OTJRJEXL
|
KIF15_HUMAN
|
Decreases Expression
|
[142] |
Histone chaperone ASF1B (ASF1B)
|
OTKXX12I
|
ASF1B_HUMAN
|
Decreases Expression
|
[142] |
GTPase IMAP family member 2 (GIMAP2)
|
OTHH2EFT
|
GIMA2_HUMAN
|
Decreases Expression
|
[142] |
Kelch-like protein 21 (KLHL21)
|
OT28Y2LQ
|
KLH21_HUMAN
|
Increases Expression
|
[142] |
DNA replication complex GINS protein PSF2 (GINS2)
|
OT974IYI
|
PSF2_HUMAN
|
Decreases Expression
|
[142] |
E3 ubiquitin-protein ligase RNF114 (RNF114)
|
OTF06FRP
|
RN114_HUMAN
|
Increases Expression
|
[142] |
POTE ankyrin domain family member F (POTEF)
|
OTV3WXYE
|
POTEF_HUMAN
|
Decreases Expression
|
[143] |
NADH dehydrogenase 1 alpha subcomplex subunit 10, mitochondrial (NDUFA10)
|
OTBURQ3A
|
NDUAA_HUMAN
|
Increases Expression
|
[143] |
Fructose-bisphosphate aldolase A (ALDOA)
|
OTWRFTIB
|
ALDOA_HUMAN
|
Decreases Expression
|
[143] |
Keratin, type I cytoskeletal 18 (KRT18)
|
OTVLQFIP
|
K1C18_HUMAN
|
Increases Expression
|
[143] |
Keratin, type II cytoskeletal 8 (KRT8)
|
OTTM4X11
|
K2C8_HUMAN
|
Decreases Expression
|
[143] |
Alpha-enolase (ENO1)
|
OTB1KWJS
|
ENOA_HUMAN
|
Increases Expression
|
[143] |
Nucleophosmin (NPM1)
|
OTTBYYT0
|
NPM_HUMAN
|
Increases Expression
|
[143] |
Phosphoglycerate mutase 1 (PGAM1)
|
OTZ5DB06
|
PGAM1_HUMAN
|
Decreases Expression
|
[143] |
Proteasome subunit alpha type-2 (PSMA2)
|
OTJRT2ZL
|
PSA2_HUMAN
|
Decreases Expression
|
[143] |
Endoplasmic reticulum resident protein 29 (ERP29)
|
OTNKANMH
|
ERP29_HUMAN
|
Decreases Expression
|
[143] |
Triosephosphate isomerase (TPI1)
|
OT14KP4B
|
TPIS_HUMAN
|
Decreases Expression
|
[143] |
Poly(rC)-binding protein 1 (PCBP1)
|
OTHN0TD7
|
PCBP1_HUMAN
|
Decreases Expression
|
[143] |
Fascin (FSCN1)
|
OTTGIHTM
|
FSCN1_HUMAN
|
Decreases Expression
|
[143] |
Lambda-crystallin homolog (CRYL1)
|
OT0SJSJM
|
CRYL1_HUMAN
|
Increases Expression
|
[143] |
NF-kappa-B inhibitor epsilon (NFKBIE)
|
OTLAYEL9
|
IKBE_HUMAN
|
Decreases Expression
|
[187] |
Tumor necrosis factor receptor superfamily member 11B (TNFRSF11B)
|
OTQ4W7MT
|
TR11B_HUMAN
|
Increases Secretion
|
[188] |
Importin subunit alpha-4 (KPNA3)
|
OTLI3TM2
|
IMA4_HUMAN
|
Decreases Expression
|
[189] |
Tumor necrosis factor ligand superfamily member 11 (TNFSF11)
|
OTJEPKEQ
|
TNF11_HUMAN
|
Decreases Expression
|
[188] |
Tumor necrosis factor receptor superfamily member 10C (TNFRSF10C)
|
OTVHOL9B
|
TR10C_HUMAN
|
Increases Expression
|
[187] |
Angiopoietin-2 (ANGPT2)
|
OTEQK65P
|
ANGP2_HUMAN
|
Increases Expression
|
[145] |
Protein SLC31A2 (SLC31A2)
|
OTQC136Q
|
COPT2_HUMAN
|
Increases Expression
|
[190] |
CASP8 and FADD-like apoptosis regulator (CFLAR)
|
OTX14BAS
|
CFLAR_HUMAN
|
Increases Expression
|
[187] |
Mitogen-activated protein kinase kinase kinase 7 (MAP3K7)
|
OTUXEASC
|
M3K7_HUMAN
|
Decreases Expression
|
[189] |
Tumor necrosis factor ligand superfamily member 14 (TNFSF14)
|
OT5QRF09
|
TNF14_HUMAN
|
Increases Expression
|
[191] |
Protein regulator of cytokinesis 1 (PRC1)
|
OTHD0XS0
|
PRC1_HUMAN
|
Decreases Expression
|
[144] |
Integral membrane protein 2A (ITM2A)
|
OT590V63
|
ITM2A_HUMAN
|
Increases Expression
|
[148] |
KH domain-containing, RNA-binding, signal transduction-associated protein 3 (KHDRBS3)
|
OTUG02U7
|
KHDR3_HUMAN
|
Increases Expression
|
[148] |
Dual specificity protein phosphatase 14 (DUSP14)
|
OTGODFCR
|
DUS14_HUMAN
|
Increases Expression
|
[190] |
CCN family member 4 (CCN4)
|
OT69BER9
|
CCN4_HUMAN
|
Decreases Expression
|
[146] |
Superoxide dismutase (SOD1)
|
OT39TA1L
|
SODC_HUMAN
|
Increases Expression
|
[192] |
Cystatin-A (CSTA)
|
OT1K68KE
|
CYTA_HUMAN
|
Increases Expression
|
[148] |
Protein c-Fos (FOS)
|
OTJBUVWS
|
FOS_HUMAN
|
Increases Expression
|
[193] |
Vasopressin-neurophysin 2-copeptin (AVP)
|
OTAVZ76K
|
NEU2_HUMAN
|
Increases Secretion
|
[194] |
Tumor necrosis factor (TNF)
|
OT4IE164
|
TNFA_HUMAN
|
Increases Expression
|
[192] |
Interleukin-1 beta (IL1B)
|
OT0DWXXB
|
IL1B_HUMAN
|
Increases Expression
|
[148] |
T-cell surface glycoprotein CD4 (CD4)
|
OT7Z5LNF
|
CD4_HUMAN
|
Decreases Expression
|
[195] |
T-cell surface glycoprotein CD8 alpha chain (CD8A)
|
OTDWQJXK
|
CD8A_HUMAN
|
Decreases Expression
|
[195] |
Collagen alpha-1(I) chain (COL1A1)
|
OTI31178
|
CO1A1_HUMAN
|
Decreases Expression
|
[148] |
Albumin (ALB)
|
OTVMM513
|
ALBU_HUMAN
|
Decreases Secretion
|
[196] |
Heat shock protein beta-1 (HSPB1)
|
OTHFZ8ED
|
HSPB1_HUMAN
|
Increases Expression
|
[190] |
Plasminogen activator inhibitor 1 (SERPINE1)
|
OTT0MPQ3
|
PAI1_HUMAN
|
Increases Expression
|
[197] |
Transcription factor Jun (JUN)
|
OTCYBO6X
|
JUN_HUMAN
|
Increases Phosphorylation
|
[198] |
Integrin beta-1 (ITGB1)
|
OT6G1IAR
|
ITB1_HUMAN
|
Decreases Expression
|
[189] |
Glutathione peroxidase 1 (GPX1)
|
OTE2O72Q
|
GPX1_HUMAN
|
Increases Expression
|
[199] |
Complement decay-accelerating factor (CD55)
|
OTZ3HWTO
|
DAF_HUMAN
|
Increases Expression
|
[147] |
Stromelysin-1 (MMP3)
|
OTGBI74Z
|
MMP3_HUMAN
|
Decreases Expression
|
[195] |
Dihydropteridine reductase (QDPR)
|
OTSKOIUX
|
DHPR_HUMAN
|
Decreases Activity
|
[200] |
Poly polymerase 1 (PARP1)
|
OT310QSG
|
PARP1_HUMAN
|
Increases Cleavage
|
[201] |
Intestinal-type alkaline phosphatase (ALPI)
|
OTTQ468O
|
PPBI_HUMAN
|
Increases Activity
|
[202] |
Adenosine receptor A3 (ADORA3)
|
OTHO1BLK
|
AA3R_HUMAN
|
Increases Expression
|
[203] |
Interleukin-8 (CXCL8)
|
OTS7T5VH
|
IL8_HUMAN
|
Decreases Expression
|
[195] |
Apoptosis regulator Bcl-2 (BCL2)
|
OT9DVHC0
|
BCL2_HUMAN
|
Decreases Expression
|
[204] |
Ornithine decarboxylase (ODC1)
|
OTNDAGRR
|
DCOR_HUMAN
|
Increases Expression
|
[202] |
Bone morphogenetic protein 2 (BMP2)
|
OT23T37S
|
BMP2_HUMAN
|
Increases Expression
|
[191] |
Tissue factor (F3)
|
OT3MSU3B
|
TF_HUMAN
|
Increases Expression
|
[205] |
Matrix metalloproteinase-9 (MMP9)
|
OTB2QDAV
|
MMP9_HUMAN
|
Increases Expression
|
[187] |
Aminopeptidase N (ANPEP)
|
OTP3WYFD
|
AMPN_HUMAN
|
Increases Expression
|
[206] |
Histone H2AX (H2AX)
|
OT18UX57
|
H2AX_HUMAN
|
Increases Phosphorylation
|
[207] |
Cyclic AMP-responsive element-binding protein 1 (CREB1)
|
OT1MDLA1
|
CREB1_HUMAN
|
Decreases Expression
|
[189] |
E-selectin (SELE)
|
OT33RZWY
|
LYAM2_HUMAN
|
Decreases Expression
|
[195] |
Platelet glycoprotein 4 (CD36)
|
OT5CZWKY
|
CD36_HUMAN
|
Increases Expression
|
[208] |
Interleukin-7 receptor subunit alpha (IL7R)
|
OTBMFLQQ
|
IL7RA_HUMAN
|
Decreases Expression
|
[189] |
Desmin (DES)
|
OTI09KBW
|
DESM_HUMAN
|
Increases Expression
|
[209] |
Insulin-like growth factor-binding protein 3 (IGFBP3)
|
OTIX63TX
|
IBP3_HUMAN
|
Increases Expression
|
[148] |
Cyclic AMP-dependent transcription factor ATF-3 (ATF3)
|
OTC1UOHP
|
ATF3_HUMAN
|
Increases Expression
|
[150] |
Nuclear factor NF-kappa-B p105 subunit (NFKB1)
|
OTNRRD8I
|
NFKB1_HUMAN
|
Decreases Expression
|
[192] |
Tumor necrosis factor alpha-induced protein 3 (TNFAIP3)
|
OTVLI4DD
|
TNAP3_HUMAN
|
Decreases Expression
|
[187] |
Interleukin-10 (IL10)
|
OTIRFRXC
|
IL10_HUMAN
|
Increases Expression
|
[190] |
Integrin alpha-6 (ITGA6)
|
OT3FA39C
|
ITA6_HUMAN
|
Increases Expression
|
[148] |
Growth arrest and DNA damage-inducible protein GADD45 alpha (GADD45A)
|
OTDRV63V
|
GA45A_HUMAN
|
Increases Expression
|
[210] |
Cyclin-dependent kinase 2 (CDK2)
|
OTB5DYYZ
|
CDK2_HUMAN
|
Increases Expression
|
[187] |
Tumor necrosis factor receptor superfamily member 6 (FAS)
|
OTP9XG86
|
TNR6_HUMAN
|
Decreases Expression
|
[204] |
Dual specificity protein phosphatase 1 (DUSP1)
|
OTN6BR75
|
DUS1_HUMAN
|
Increases Expression
|
[190] |
Adenosine receptor A2a (ADORA2A)
|
OTVRBZ0I
|
AA2AR_HUMAN
|
Increases Expression
|
[211] |
Adenosine receptor A2b (ADORA2B)
|
OTCDYBBP
|
AA2BR_HUMAN
|
Increases Expression
|
[211] |
Interleukin-12 subunit alpha (IL12A)
|
OTDQT8GI
|
IL12A_HUMAN
|
Decreases Expression
|
[212] |
14-3-3 protein sigma (SFN)
|
OTLJCZ1U
|
1433S_HUMAN
|
Increases Expression
|
[148] |
Macrosialin (CD68)
|
OTOYEY3J
|
CD68_HUMAN
|
Decreases Expression
|
[213] |
Interleukin-13 (IL13)
|
OTI4YS3Y
|
IL13_HUMAN
|
Decreases Secretion
|
[196] |
Basigin (BSG)
|
OTD0CVEC
|
BASI_HUMAN
|
Decreases Expression
|
[189] |
TGF-beta receptor type-2 (TGFBR2)
|
OT3P7GZP
|
TGFR2_HUMAN
|
Decreases Expression
|
[189] |
Cyclin-dependent kinase inhibitor 1 (CDKN1A)
|
OTQWHCZE
|
CDN1A_HUMAN
|
Increases Expression
|
[207] |
Caspase-3 (CASP3)
|
OTIJRBE7
|
CASP3_HUMAN
|
Increases Expression
|
[214] |
Nuclear receptor subfamily 4 group A member 2 (NR4A2)
|
OT3F9IR2
|
NR4A2_HUMAN
|
Decreases Expression
|
[213] |
Mitogen-activated protein kinase 9 (MAPK9)
|
OTCEVJ9E
|
MK09_HUMAN
|
Increases Expression
|
[215] |
Cyclin-dependent kinase inhibitor 1B (CDKN1B)
|
OTNY5LLZ
|
CDN1B_HUMAN
|
Increases Expression
|
[215] |
MAP kinase-activated protein kinase 2 (MAPKAPK2)
|
OT460SBO
|
MAPK2_HUMAN
|
Increases Expression
|
[190] |
Tumor necrosis factor ligand superfamily member 10 (TNFSF10)
|
OT4PXBTA
|
TNF10_HUMAN
|
Increases Expression
|
[187] |
Caveolin-2 (CAV2)
|
OT1FGRQX
|
CAV2_HUMAN
|
Increases Expression
|
[148] |
Dual specificity mitogen-activated protein kinase kinase 6 (MAP2K6)
|
OTK13JKC
|
MP2K6_HUMAN
|
Decreases Expression
|
[190] |
Collagen alpha-4(IV) chain (COL4A4)
|
OT9G0MCT
|
CO4A4_HUMAN
|
Increases Expression
|
[209] |
Phospholipid transfer protein (PLTP)
|
OTVJJO5Z
|
PLTP_HUMAN
|
Increases Expression
|
[148] |
Caspase-6 (CASP6)
|
OTXLD3EC
|
CASP6_HUMAN
|
Decreases Expression
|
[210] |
Cadherin-4 (CDH4)
|
OT8LH3HN
|
CADH4_HUMAN
|
Decreases Expression
|
[148] |
Interleukin-2 (IL2)
|
OTGI4NSA
|
IL2_HUMAN
|
Decreases Secretion
|
[216] |
Actin-related protein 2 (ACTR2)
|
OT3C8U5T
|
ARP2_HUMAN
|
Decreases Expression
|
[189] |
Actin, aortic smooth muscle (ACTA2)
|
OTEDLG8E
|
ACTA_HUMAN
|
Increases Expression
|
[196] |
Ras-related C3 botulinum toxin substrate 1 (RAC1)
|
OTKRO61U
|
RAC1_HUMAN
|
Increases Expression
|
[190] |
Protein jagged-1 (JAG1)
|
OT3LGT6K
|
JAG1_HUMAN
|
Increases Expression
|
[148] |
Protein S100-A12 (S100A12)
|
OTF9IIXW
|
S10AC_HUMAN
|
Increases Expression
|
[187] |
CD83 antigen (CD83)
|
OT1V4WQF
|
CD83_HUMAN
|
Decreases Expression
|
[187] |
Transgelin (TAGLN)
|
OTAEZ0KP
|
TAGL_HUMAN
|
Decreases Expression
|
[146] |
Induced myeloid leukemia cell differentiation protein Mcl-1 (MCL1)
|
OT2YYI1A
|
MCL1_HUMAN
|
Increases Expression
|
[187] |
Bcl-2-interacting killer (BIK)
|
OTTH1T3D
|
BIK_HUMAN
|
Increases Expression
|
[210] |
RING-type E3 ubiquitin-protein ligase PPIL2 (PPIL2)
|
OTL9Y4IO
|
PPIL2_HUMAN
|
Decreases Expression
|
[189] |
Phorbol-12-myristate-13-acetate-induced protein 1 (PMAIP1)
|
OTXEE550
|
APR_HUMAN
|
Increases Expression
|
[207] |
Frizzled-2 (FZD2)
|
OT952ML1
|
FZD2_HUMAN
|
Decreases Expression
|
[148] |
Structural maintenance of chromosomes protein 1A (SMC1A)
|
OT9ZMRK9
|
SMC1A_HUMAN
|
Decreases Expression
|
[189] |
Angiopoietin-1 (ANGPT1)
|
OTVZ1NG3
|
ANGP1_HUMAN
|
Decreases Expression
|
[145] |
Histone-lysine N-methyltransferase EZH2 (EZH2)
|
OTIEHTKW
|
EZH2_HUMAN
|
Decreases Expression
|
[207] |
Mitogen-activated protein kinase 14 (MAPK14)
|
OT5TCO3O
|
MK14_HUMAN
|
Decreases Expression
|
[190] |
Occludin (OCLN)
|
OTSUTVWL
|
OCLN_HUMAN
|
Decreases Expression
|
[192] |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 (B3GNT9)
|
OTO385AU
|
B3GN9_HUMAN
|
Increases Expression
|
[148] |
Jouberin (AHI1)
|
OT8K2YWY
|
AHI1_HUMAN
|
Increases Expression
|
[217] |
Retinoic acid-induced protein 3 (GPRC5A)
|
OTPOCWR7
|
RAI3_HUMAN
|
Increases Expression
|
[148] |
Aquaporin-3 (AQP3)
|
OT2J7JPD
|
AQP3_HUMAN
|
Decreases Expression
|
[187] |
Protein Jumonji (JARID2)
|
OT14UM8H
|
JARD2_HUMAN
|
Decreases Expression
|
[150] |
Bcl-2-binding component 3, isoforms 3/4 (BBC3)
|
OTUAXDAY
|
BBC3B_HUMAN
|
Increases Expression
|
[207] |
Perilipin-2 (PLIN2)
|
OTRXJ9UN
|
PLIN2_HUMAN
|
Increases Expression
|
[148] |
Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5)
|
OTH91ETM
|
SIA7E_HUMAN
|
Decreases Expression
|
[148] |
Protein FAM117A (FAM117A)
|
OT2FBGGV
|
F117A_HUMAN
|
Decreases Expression
|
[150] |
Proline-serine-threonine phosphatase-interacting protein 2 (PSTPIP2)
|
OTG6F93V
|
PPIP2_HUMAN
|
Increases Expression
|
[148] |
Bcl-2-like protein 12 (BCL2L12)
|
OTS6IFZY
|
B2L12_HUMAN
|
Decreases Expression
|
[218] |
Mid1-interacting protein 1 (MID1IP1)
|
OTFCORJM
|
M1IP1_HUMAN
|
Increases Expression
|
[148] |
AP-5 complex subunit sigma-1 (AP5S1)
|
OTGS53SC
|
AP5S1_HUMAN
|
Increases Expression
|
[150] |
DNA damage-inducible transcript 4 protein (DDIT4)
|
OTHY8SY4
|
DDIT4_HUMAN
|
Increases Expression
|
[148] |
Heat shock protein beta-8 (HSPB8)
|
OT0I83YS
|
HSPB8_HUMAN
|
Increases Expression
|
[148] |
Endothelial protein C receptor (PROCR)
|
OTRHED17
|
EPCR_HUMAN
|
Increases Expression
|
[148] |
Forkhead box protein J3 (FOXJ3)
|
OTXAUJ47
|
FOXJ3_HUMAN
|
Decreases Expression
|
[189] |
RWD domain-containing protein 3 (RWDD3)
|
OTE76DY5
|
RWDD3_HUMAN
|
Increases Expression
|
[150] |
Dual specificity protein phosphatase 10 (DUSP10)
|
OTNG467B
|
DUS10_HUMAN
|
Increases Expression
|
[190] |
Elongation factor 1-alpha 1 (EEF1A1)
|
OT00THXS
|
EF1A1_HUMAN
|
Decreases Response To Substance
|
[219] |
Glycoprotein hormones alpha chain (CGA)
|
OT00U3Y3
|
GLHA_HUMAN
|
Affects Response To Substance
|
[151] |
Cyclic AMP-dependent transcription factor ATF-5 (ATF5)
|
OT03QCLM
|
ATF5_HUMAN
|
Affects Response To Substance
|
[151] |
Mediator of RNA polymerase II transcription subunit 15 (MED15)
|
OT0D0JVD
|
MED15_HUMAN
|
Affects Response To Substance
|
[151] |
Phospholipid phosphatase 1 (PLPP1)
|
OT0IIMI5
|
PLPP1_HUMAN
|
Affects Response To Substance
|
[151] |
Guanine nucleotide-binding protein subunit alpha-11 (GNA11)
|
OT0K99TO
|
GNA11_HUMAN
|
Affects Response To Substance
|
[151] |
Succinate--CoA ligase subunit beta, mitochondrial (SUCLG2)
|
OT0KHLY2
|
SUCB2_HUMAN
|
Affects Response To Substance
|
[151] |
Insulin-like growth factor-binding protein 7 (IGFBP7)
|
OT1D416P
|
IBP7_HUMAN
|
Affects Response To Substance
|
[151] |
Alpha-centractin (ACTR1A)
|
OT1QAU16
|
ACTZ_HUMAN
|
Affects Response To Substance
|
[151] |
Endoplasmic reticulum membrane sensor NFE2L1 (NFE2L1)
|
OT1QHOS2
|
NF2L1_HUMAN
|
Affects Response To Substance
|
[151] |
DNA-directed RNA polymerase I subunit RPA12 (POLR1H)
|
OT30S3SB
|
RPA12_HUMAN
|
Decreases Response To Substance
|
[220] |
Epidermal growth factor-like protein 6 (EGFL6)
|
OT331X59
|
EGFL6_HUMAN
|
Decreases Response To Substance
|
[152] |
Protein FAM171A1 (FAM171A1)
|
OT33BHEP
|
F1711_HUMAN
|
Affects Response To Substance
|
[151] |
Cip1-interacting zinc finger protein (CIZ1)
|
OT3UKHPI
|
CIZ1_HUMAN
|
Affects Response To Substance
|
[151] |
Transcobalamin-2 (TCN2)
|
OT41D0L3
|
TCO2_HUMAN
|
Affects Metabolism
|
[221] |
Elafin (PI3)
|
OT47MTC3
|
ELAF_HUMAN
|
Affects Response To Substance
|
[151] |
CCR4-NOT transcription complex subunit 3 (CNOT3)
|
OT4D5Z9L
|
CNOT3_HUMAN
|
Affects Response To Substance
|
[151] |
ATP-dependent RNA helicase DHX15 (DHX15)
|
OT4F98TK
|
DHX15_HUMAN
|
Affects Response To Substance
|
[151] |
Fibroblast growth factor receptor 1 (FGFR1)
|
OT4GLCXW
|
FGFR1_HUMAN
|
Affects Response To Substance
|
[151] |
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 (BNIP3)
|
OT4SO7J4
|
BNIP3_HUMAN
|
Affects Response To Substance
|
[151] |
PRELI domain containing protein 3B (PRELID3B)
|
OT4TRT4K
|
PLD3B_HUMAN
|
Affects Response To Substance
|
[151] |
Exocyst complex component 7 (EXOC7)
|
OT4YA137
|
EXOC7_HUMAN
|
Affects Response To Substance
|
[151] |
Large proline-rich protein BAG6 (BAG6)
|
OT4Z0S2U
|
BAG6_HUMAN
|
Affects Response To Substance
|
[151] |
Transducin-like enhancer protein 1 (TLE1)
|
OT50MRZ1
|
TLE1_HUMAN
|
Affects Response To Substance
|
[151] |
Protein phosphatase 3 catalytic subunit alpha (PPP3CA)
|
OT58PUEN
|
PP2BA_HUMAN
|
Affects Response To Substance
|
[151] |
Transcription termination factor 2 (TTF2)
|
OT5LJOWM
|
TTF2_HUMAN
|
Affects Response To Substance
|
[151] |
Protein kinase C alpha type (PRKCA)
|
OT5UWNRD
|
KPCA_HUMAN
|
Decreases Response To Substance
|
[175] |
Collagen alpha-2(V) chain (COL5A2)
|
OT5VOSQE
|
CO5A2_HUMAN
|
Decreases Response To Substance
|
[152] |
Nuclear pore complex protein Nup88 (NUP88)
|
OT647WOR
|
NUP88_HUMAN
|
Affects Response To Substance
|
[151] |
Mitochondrial enolase superfamily member 1 (ENOSF1)
|
OT65D3ZK
|
ENOF1_HUMAN
|
Affects Response To Substance
|
[151] |
C-C motif chemokine 4 (CCL4)
|
OT6B8P25
|
CCL4_HUMAN
|
Decreases Response To Substance
|
[222] |
Melanoma-associated antigen D1 (MAGED1)
|
OT6EOLFC
|
MAGD1_HUMAN
|
Affects Response To Substance
|
[151] |
Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PPRC1)
|
OT6GB3WR
|
PPRC1_HUMAN
|
Affects Response To Substance
|
[151] |
Follistatin-related protein 1 (FSTL1)
|
OT6KEZUD
|
FSTL1_HUMAN
|
Affects Response To Substance
|
[151] |
Glutathione peroxidase 3 (GPX3)
|
OT6PK94R
|
GPX3_HUMAN
|
Affects Response To Substance
|
[151] |
Dual specificity protein phosphatase 4 (DUSP4)
|
OT6WAO12
|
DUS4_HUMAN
|
Affects Response To Substance
|
[151] |
Semenogelin-1 (SEMG1)
|
OT6Z4BPQ
|
SEMG1_HUMAN
|
Affects Response To Substance
|
[151] |
GTPase KRas (KRAS)
|
OT78QCN8
|
RASK_HUMAN
|
Increases Response To Substance
|
[223] |
Polyunsaturated fatty acid 5-lipoxygenase (ALOX5)
|
OT7FOIK2
|
LOX5_HUMAN
|
Affects Response To Substance
|
[151] |
Glutamate receptor ionotropic, NMDA 3B (GRIN3B)
|
OT7T1OJP
|
NMD3B_HUMAN
|
Affects Response To Substance
|
[151] |
Interferon-inducible protein AIM2 (AIM2)
|
OT86QUI8
|
AIM2_HUMAN
|
Affects Response To Substance
|
[151] |
Tyrosine-protein kinase Lck (LCK)
|
OT883FG9
|
LCK_HUMAN
|
Affects Response To Substance
|
[151] |
Peroxisomal membrane protein 11A (PEX11A)
|
OT8MJ9CJ
|
PX11A_HUMAN
|
Affects Response To Substance
|
[151] |
Mediator of RNA polymerase II transcription subunit 16 (MED16)
|
OT8SCI48
|
MED16_HUMAN
|
Affects Response To Substance
|
[151] |
Annexin A11 (ANXA11)
|
OT8SRY1C
|
ANX11_HUMAN
|
Affects Response To Substance
|
[151] |
ER lumen protein-retaining receptor 1 (KDELR1)
|
OT8YBS5G
|
ERD21_HUMAN
|
Affects Response To Substance
|
[151] |
Prostate tumor-overexpressed gene 1 protein (PTOV1)
|
OT94WT5X
|
PTOV1_HUMAN
|
Affects Response To Substance
|
[151] |
Cyclic AMP-responsive element-binding protein 3 (CREB3)
|
OT9617UO
|
CREB3_HUMAN
|
Affects Response To Substance
|
[151] |
Runt-related transcription factor 2 (RUNX2)
|
OT97RQQM
|
RUNX2_HUMAN
|
Decreases Response To Substance
|
[191] |
Fibromodulin (FMOD)
|
OT9EJ5H8
|
FMOD_HUMAN
|
Affects Response To Substance
|
[151] |
Epsilon-sarcoglycan (SGCE)
|
OT9F17JB
|
SGCE_HUMAN
|
Affects Response To Substance
|
[151] |
Tyrosine-protein kinase Fer (FER)
|
OT9JR7AE
|
FER_HUMAN
|
Affects Response To Substance
|
[151] |
Receptor-type tyrosine-protein phosphatase gamma (PTPRG)
|
OT9N2WOF
|
PTPRG_HUMAN
|
Affects Response To Substance
|
[151] |
Extended synaptotagmin-1 (ESYT1)
|
OTA8NSJF
|
ESYT1_HUMAN
|
Affects Response To Substance
|
[151] |
HLA class I histocompatibility antigen, A alpha chain (HLA-A)
|
OTAH14LU
|
HLAA_HUMAN
|
Affects Response To Substance
|
[151] |
Cleavage and polyadenylation specificity factor subunit 1 (CPSF1)
|
OTAU1KOM
|
CPSF1_HUMAN
|
Affects Response To Substance
|
[151] |
PDZ and LIM domain protein 7 (PDLIM7)
|
OTAZVODU
|
PDLI7_HUMAN
|
Affects Response To Substance
|
[151] |
Coagulation factor XII (F12)
|
OTBFD2FU
|
FA12_HUMAN
|
Affects Response To Substance
|
[151] |
Protein DGCR6 (DGCR6)
|
OTBOXM33
|
DGCR6_HUMAN
|
Affects Response To Substance
|
[151] |
Histone H1.10 (H1-10)
|
OTBWDA4E
|
H1X_HUMAN
|
Affects Response To Substance
|
[151] |
Potassium channel subfamily K member 1 (KCNK1)
|
OTBXPTKX
|
KCNK1_HUMAN
|
Affects Response To Substance
|
[151] |
CCN family member 2 (CCN2)
|
OTC39NSU
|
CCN2_HUMAN
|
Decreases Response To Substance
|
[224] |
Serine protease HTRA2, mitochondrial (HTRA2)
|
OTC7616F
|
HTRA2_HUMAN
|
Affects Response To Substance
|
[222] |
Cystathionine gamma-lyase (CTH)
|
OTC90LA0
|
CGL_HUMAN
|
Affects Response To Substance
|
[151] |
Creatine kinase U-type, mitochondrial (CKMT1A)
|
OTCINHH5
|
KCRU_HUMAN
|
Affects Response To Substance
|
[151] |
KRR1 small subunit processome component homolog (KRR1)
|
OTCMJ3K3
|
KRR1_HUMAN
|
Affects Response To Substance
|
[151] |
Phosphoribosylformylglycinamidine synthase (PFAS)
|
OTCOBYYK
|
PUR4_HUMAN
|
Affects Response To Substance
|
[180] |
Adhesion G protein-coupled receptor L2 (ADGRL2)
|
OTCXD2YR
|
AGRL2_HUMAN
|
Affects Response To Substance
|
[151] |
Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS)
|
OTCYYCAC
|
HGS_HUMAN
|
Affects Response To Substance
|
[151] |
RNA-binding motif, single-stranded-interacting protein 1 (RBMS1)
|
OTD13PJN
|
RBMS1_HUMAN
|
Affects Response To Substance
|
[151] |
Src kinase-associated phosphoprotein 1 (SKAP1)
|
OTD4ZKAL
|
SKAP1_HUMAN
|
Affects Response To Substance
|
[151] |
Battenin (CLN3)
|
OTDDKT8R
|
CLN3_HUMAN
|
Affects Response To Substance
|
[151] |
Integrin alpha-1 (ITGA1)
|
OTDITIST
|
ITA1_HUMAN
|
Increases Response To Substance
|
[152] |
Multiple epidermal growth factor-like domains protein 9 (MEGF9)
|
OTDQWTY4
|
MEGF9_HUMAN
|
Affects Response To Substance
|
[151] |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1)
|
OTDS5WAU
|
PIN1_HUMAN
|
Affects Response To Substance
|
[151] |
Cytoskeleton-associated protein 4 (CKAP4)
|
OTDUC9ME
|
CKAP4_HUMAN
|
Affects Response To Substance
|
[151] |
Transcription intermediary factor 1-beta (TRIM28)
|
OTE38OBF
|
TIF1B_HUMAN
|
Affects Response To Substance
|
[151] |
Cystatin-SN (CST1)
|
OTE4I83Q
|
CYTN_HUMAN
|
Affects Response To Substance
|
[151] |
Pseudouridine-5'-phosphatase (PUDP)
|
OTEPEJLX
|
HDHD1_HUMAN
|
Affects Response To Substance
|
[151] |
Rho GDP-dissociation inhibitor 1 (ARHGDIA)
|
OTEXWJDO
|
GDIR1_HUMAN
|
Affects Response To Substance
|
[151] |
Caveolin-1 (CAV1)
|
OTEZUR1L
|
CAV1_HUMAN
|
Decreases Response To Substance
|
[175] |
Methionine synthase (MTR)
|
OTF2K2TA
|
METH_HUMAN
|
Decreases Response To Substance
|
[180] |
CD151 antigen (CD151)
|
OTF3UZS7
|
CD151_HUMAN
|
Affects Response To Substance
|
[151] |
Paraneoplastic antigen Ma2 (PNMA2)
|
OTF5YBQG
|
PNMA2_HUMAN
|
Affects Response To Substance
|
[151] |
Endophilin-B2 (SH3GLB2)
|
OTF7BB9S
|
SHLB2_HUMAN
|
Affects Response To Substance
|
[151] |
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PPP2R5C)
|
OTF7CGO2
|
2A5G_HUMAN
|
Affects Response To Substance
|
[151] |
Dehydrogenase/reductase SDR family member 2, mitochondrial (DHRS2)
|
OTFHWIY8
|
DHRS2_HUMAN
|
Affects Response To Substance
|
[151] |
Cadherin-1 (CDH1)
|
OTFJMXPM
|
CADH1_HUMAN
|
Increases Response To Substance
|
[175] |
Laminin subunit alpha-2 (LAMA2)
|
OTFROQWE
|
LAMA2_HUMAN
|
Increases Response To Substance
|
[152] |
Heterogeneous nuclear ribonucleoprotein H (HNRNPH1)
|
OTFRWOLM
|
HNRH1_HUMAN
|
Affects Response To Substance
|
[151] |
m7GpppN-mRNA hydrolase (DCP2)
|
OTG3VKPS
|
DCP2_HUMAN
|
Affects Response To Substance
|
[151] |
Leucine-rich repeat transmembrane protein FLRT2 (FLRT2)
|
OTGD8TID
|
FLRT2_HUMAN
|
Affects Response To Substance
|
[151] |
Tomoregulin-1 (TMEFF1)
|
OTH6M3CH
|
TEFF1_HUMAN
|
Affects Response To Substance
|
[151] |
Phospholipid-transporting ATPase ABCA3 (ABCA3)
|
OTH6MSKQ
|
ABCA3_HUMAN
|
Decreases Response To Substance
|
[225] |
Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 (GNG11)
|
OTHIXBGW
|
GBG11_HUMAN
|
Affects Response To Substance
|
[151] |
Melanoma-associated antigen 6 (MAGEA6)
|
OTI8S0O2
|
MAGA6_HUMAN
|
Affects Response To Substance
|
[151] |
Nectin-2 (NECTIN2)
|
OTIE0W6O
|
NECT2_HUMAN
|
Affects Response To Substance
|
[151] |
Kallikrein-6 (KLK6)
|
OTIEA234
|
KLK6_HUMAN
|
Affects Response To Substance
|
[151] |
Laminin subunit gamma-1 (LAMC1)
|
OTIG527N
|
LAMC1_HUMAN
|
Affects Response To Substance
|
[151] |
Serine hydroxymethyltransferase, cytosolic (SHMT1)
|
OTIINA3J
|
GLYC_HUMAN
|
Affects Response To Substance
|
[226] |
Spartin (SPART)
|
OTIVOS2I
|
SPART_HUMAN
|
Affects Response To Substance
|
[151] |
Protein S100-P (S100P)
|
OTJCXNJG
|
S100P_HUMAN
|
Affects Response To Substance
|
[151] |
Polycomb protein EED (EED)
|
OTJFHCDF
|
EED_HUMAN
|
Affects Response To Substance
|
[151] |
Sulfate transporter (SLC26A2)
|
OTJNHNTO
|
S26A2_HUMAN
|
Affects Response To Substance
|
[151] |
Lysophosphatidic acid receptor 1 (LPAR1)
|
OTJNJQPF
|
LPAR1_HUMAN
|
Affects Response To Substance
|
[151] |
Unconventional myosin-VI (MYO6)
|
OTJQYRC7
|
MYO6_HUMAN
|
Affects Response To Substance
|
[151] |
Tetraspanin-4 (TSPAN4)
|
OTKFK57F
|
TSN4_HUMAN
|
Affects Response To Substance
|
[151] |
Interferon regulatory factor 6 (IRF6)
|
OTKJ44EV
|
IRF6_HUMAN
|
Affects Response To Substance
|
[151] |
SH3 domain-binding glutamic acid-rich-like protein 3 (SH3BGRL3)
|
OTKMW34I
|
SH3L3_HUMAN
|
Affects Response To Substance
|
[151] |
Ras-related protein Rab-1A (RAB1A)
|
OTKPHRD0
|
RAB1A_HUMAN
|
Affects Response To Substance
|
[151] |
5'-3' exonuclease PLD3 (PLD3)
|
OTL07SP2
|
PLD3_HUMAN
|
Affects Response To Substance
|
[151] |
Protein S100-A4 (S100A4)
|
OTLRGFSQ
|
S10A4_HUMAN
|
Decreases Response To Substance
|
[227] |
Death-associated protein kinase 3 (DAPK3)
|
OTLV7EKW
|
DAPK3_HUMAN
|
Affects Response To Substance
|
[151] |
Peroxiredoxin-2 (PRDX2)
|
OTLWCY9T
|
PRDX2_HUMAN
|
Decreases Response To Substance
|
[228] |
Hemicentin-1 (HMCN1)
|
OTLZAS0P
|
HMCN1_HUMAN
|
Increases Response To Substance
|
[152] |
Unconventional myosin-Ie (MYO1E)
|
OTM9YSIZ
|
MYO1E_HUMAN
|
Affects Response To Substance
|
[151] |
kinase isozyme 1, mitochondrial (PDK1)
|
OTMABK9Z
|
PDK1_HUMAN
|
Affects Response To Substance
|
[151] |
NADH dehydrogenase iron-sulfur protein 8, mitochondrial (NDUFS8)
|
OTMEAWKO
|
NDUS8_HUMAN
|
Affects Response To Substance
|
[151] |
C-1-tetrahydrofolate synthase, cytoplasmic (MTHFD1)
|
OTMKHVWC
|
C1TC_HUMAN
|
Affects Response To Substance
|
[229] |
Ubiquitin-conjugating enzyme E2 R1 (CDC34)
|
OTNBK390
|
UB2R1_HUMAN
|
Affects Response To Substance
|
[151] |
Glycine cleavage system H protein, mitochondrial (GCSH)
|
OTNC1OKA
|
GCSH_HUMAN
|
Affects Response To Substance
|
[151] |
Pulmonary surfactant-associated protein D (SFTPD)
|
OTNKPDJC
|
SFTPD_HUMAN
|
Increases ADR
|
[28] |
Hepatoma-derived growth factor-related protein 3 (HDGFL3)
|
OTNN7WYH
|
HDGR3_HUMAN
|
Affects Response To Substance
|
[151] |
Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE)
|
OTNONPMB
|
GLCNE_HUMAN
|
Affects Response To Substance
|
[151] |
Splicing factor 3B subunit 1 (SF3B1)
|
OTNTX2DG
|
SF3B1_HUMAN
|
Affects Response To Substance
|
[151] |
Protein Tob1 (TOB1)
|
OTNW949D
|
TOB1_HUMAN
|
Affects Response To Substance
|
[151] |
ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL6IP4)
|
OTOA8VAL
|
AR6P4_HUMAN
|
Affects Response To Substance
|
[151] |
Forkhead box protein N3 (FOXN3)
|
OTOJYJZP
|
FOXN3_HUMAN
|
Affects Response To Substance
|
[151] |
Glutathione S-transferase Mu 4 (GSTM4)
|
OTOTF8DU
|
GSTM4_HUMAN
|
Decreases Response To Substance
|
[230] |
Solute carrier family 52, riboflavin transporter, member 2 (SLC52A2)
|
OTPC6NXA
|
S52A2_HUMAN
|
Affects Response To Substance
|
[151] |
Poly(A) polymerase alpha (PAPOLA)
|
OTPHD65D
|
PAPOA_HUMAN
|
Affects Response To Substance
|
[151] |
Centrosomal protein of 57 kDa (CEP57)
|
OTPOHLIX
|
CEP57_HUMAN
|
Affects Response To Substance
|
[151] |
CD99 antigen (CD99)
|
OTPUZ5DE
|
CD99_HUMAN
|
Affects Response To Substance
|
[151] |
Large ribosomal subunit protein uL23 (RPL23A)
|
OTPYLCCX
|
RL23A_HUMAN
|
Affects Response To Substance
|
[151] |
Complement component 1 Q subcomponent-binding protein, mitochondrial (C1QBP)
|
OTPYQX3K
|
C1QBP_HUMAN
|
Decreases Response To Substance
|
[231] |
Bone morphogenetic protein 4 (BMP4)
|
OTPZMDFH
|
BMP4_HUMAN
|
Decreases Response To Substance
|
[191] |
Inosine triphosphate pyrophosphatase (ITPA)
|
OTQ47WVR
|
ITPA_HUMAN
|
Affects Response To Substance
|
[232] |
45 kDa calcium-binding protein (SDF4)
|
OTQ7WFYW
|
CAB45_HUMAN
|
Affects Response To Substance
|
[151] |
Eukaryotic translation initiation factor 5A-1 (EIF5A)
|
OTQ8DJX5
|
IF5A1_HUMAN
|
Affects Response To Substance
|
[151] |
Lactadherin (MFGE8)
|
OTQKE41R
|
MFGM_HUMAN
|
Affects Response To Substance
|
[151] |
Calsyntenin-1 (CLSTN1)
|
OTQN35G2
|
CSTN1_HUMAN
|
Affects Response To Substance
|
[151] |
Histone deacetylase 4 (HDAC4)
|
OTQNGD32
|
HDAC4_HUMAN
|
Affects Response To Substance
|
[151] |
Double-stranded RNA-specific adenosine deaminase (ADAR)
|
OTQNOHR8
|
DSRAD_HUMAN
|
Decreases Response To Substance
|
[233] |
Keratin, type I cytoskeletal 23 (KRT23)
|
OTQW6UAG
|
K1C23_HUMAN
|
Increases Response To Substance
|
[152] |
Transforming growth factor-beta-induced protein ig-h3 (TGFBI)
|
OTR443C5
|
BGH3_HUMAN
|
Decreases Response To Substance
|
[152] |
Cyclin-dependent kinase 2-associated protein 2 (CDK2AP2)
|
OTR99SJ8
|
CDKA2_HUMAN
|
Affects Response To Substance
|
[151] |
TNFAIP3-interacting protein 1 (TNIP1)
|
OTRAOTEW
|
TNIP1_HUMAN
|
Affects Response To Substance
|
[222] |
Diamine oxidase (AOC1)
|
OTRC220K
|
AOC1_HUMAN
|
Affects Response To Substance
|
[151] |
Dickkopf-related protein 1 (DKK1)
|
OTRDLUSP
|
DKK1_HUMAN
|
Decreases Response To Substance
|
[219] |
Methyl-CpG-binding domain protein 3 (MBD3)
|
OTRL76H5
|
MBD3_HUMAN
|
Affects Response To Substance
|
[151] |
Gamma-enolase (ENO2)
|
OTRODL0T
|
ENOG_HUMAN
|
Decreases Response To Substance
|
[175] |
Dr1-associated corepressor (DRAP1)
|
OTRWLF6D
|
NC2A_HUMAN
|
Affects Response To Substance
|
[151] |
Glutathione S-transferase Mu 1 (GSTM1)
|
OTSBF2MO
|
GSTM1_HUMAN
|
Decreases Response To Substance
|
[230] |
Protein kinase C delta type (PRKCD)
|
OTSEH90E
|
KPCD_HUMAN
|
Affects Response To Substance
|
[222] |
Formin-binding protein 1 (FNBP1)
|
OTSJ5KKA
|
FNBP1_HUMAN
|
Affects Response To Substance
|
[151] |
Lumican (LUM)
|
OTSRC874
|
LUM_HUMAN
|
Decreases Response To Substance
|
[152] |
Collagen alpha-1(III) chain (COL3A1)
|
OTT1EMLM
|
CO3A1_HUMAN
|
Decreases Response To Substance
|
[152] |
Mesothelin (MSLN)
|
OTT23UM3
|
MSLN_HUMAN
|
Affects Response To Substance
|
[151] |
NKG2-C type II integral membrane protein (KLRC2)
|
OTT4N86S
|
NKG2C_HUMAN
|
Affects Response To Substance
|
[151] |
Talin-1 (TLN1)
|
OTTD2YXM
|
TLN1_HUMAN
|
Affects Response To Substance
|
[151] |
Collagen alpha-1(XV) chain (COL15A1)
|
OTTFKK18
|
COFA1_HUMAN
|
Decreases Response To Substance
|
[152] |
Adipogenesis regulatory factor (ADIRF)
|
OTTJP8D4
|
ADIRF_HUMAN
|
Affects Response To Substance
|
[151] |
CASP8-associated protein 2 (CASP8AP2)
|
OTTWT68S
|
C8AP2_HUMAN
|
Increases Response To Substance
|
[222] |
Rab11 family-interacting protein 2 (RAB11FIP2)
|
OTTX9RWE
|
RFIP2_HUMAN
|
Affects Response To Substance
|
[151] |
Protein disulfide-isomerase (P4HB)
|
OTTYNYPF
|
PDIA1_HUMAN
|
Affects Response To Substance
|
[151] |
AMP deaminase 1 (AMPD1)
|
OTU17BCI
|
AMPD1_HUMAN
|
Affects Response To Substance
|
[232] |
Period circadian protein homolog 2 (PER2)
|
OTU2B1DJ
|
PER2_HUMAN
|
Affects Response To Substance
|
[151] |
Methylenetetrahydrofolate reductase (MTHFR)
|
OTUBJSR7
|
MTHR_HUMAN
|
Increases ADR
|
[234] |
Dual specificity mitogen-activated protein kinase kinase 2 (MAP2K2)
|
OTUE7Z91
|
MP2K2_HUMAN
|
Affects Response To Substance
|
[151] |
Prosaposin (PSAP)
|
OTUOEKY7
|
SAP_HUMAN
|
Affects Response To Substance
|
[151] |
AT-rich interactive domain-containing protein 5B (ARID5B)
|
OTUQ4CQY
|
ARI5B_HUMAN
|
Affects Abundance
|
[235] |
Acyl-CoA 6-desaturase (FADS2)
|
OTUX531P
|
FADS2_HUMAN
|
Affects Response To Substance
|
[151] |
Guanidinoacetate N-methyltransferase (GAMT)
|
OTVC87ES
|
GAMT_HUMAN
|
Affects Response To Substance
|
[151] |
Matrilin-2 (MATN2)
|
OTVDR68G
|
MATN2_HUMAN
|
Decreases Response To Substance
|
[152] |
Membralin (TMEM259)
|
OTVH9HD8
|
MBRL_HUMAN
|
Affects Response To Substance
|
[151] |
ATP-binding cassette sub-family C member 11 (ABCC11)
|
OTVHL7OR
|
MRP8_HUMAN
|
Decreases Abundance
|
[168] |
Nicotinamide phosphoribosyltransferase (NAMPT)
|
OTVJR3GL
|
NAMPT_HUMAN
|
Affects Response To Substance
|
[236] |
GTPase NRas (NRAS)
|
OTVQ1DG3
|
RASN_HUMAN
|
Increases Response To Substance
|
[223] |
Ensconsin (MAP7)
|
OTVSSJ33
|
MAP7_HUMAN
|
Affects Response To Substance
|
[151] |
ATP-binding cassette sub-family A member 2 (ABCA2)
|
OTVSYK0X
|
ABCA2_HUMAN
|
Decreases Response To Substance
|
[225] |
N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3)
|
OTVT1Q25
|
B3GN3_HUMAN
|
Affects Response To Substance
|
[151] |
E3 ubiquitin-protein ligase KCMF1 (KCMF1)
|
OTVTKFAU
|
KCMF1_HUMAN
|
Affects Response To Substance
|
[151] |
PHD finger protein 10 (PHF10)
|
OTWDR4EX
|
PHF10_HUMAN
|
Affects Response To Substance
|
[151] |
Decorin (DCN)
|
OTWLJL7K
|
PGS2_HUMAN
|
Decreases Response To Substance
|
[152] |
Phosphatase and actin regulator 2 (PHACTR2)
|
OTWMX2A8
|
PHAR2_HUMAN
|
Affects Response To Substance
|
[151] |
Periostin (POSTN)
|
OTWP62UA
|
POSTN_HUMAN
|
Decreases Response To Substance
|
[152] |
Bcl-2-related protein A1 (BCL2A1)
|
OTWRYSNA
|
B2LA1_HUMAN
|
Decreases Response To Substance
|
[222] |
Glypican-3 (GPC3)
|
OTWS8WSW
|
GPC3_HUMAN
|
Increases Response To Substance
|
[152] |
CD302 antigen (CD302)
|
OTX580VU
|
CD302_HUMAN
|
Affects Response To Substance
|
[151] |
Arfaptin-1 (ARFIP1)
|
OTXHWO6M
|
ARFP1_HUMAN
|
Affects Response To Substance
|
[151] |
Glutathione peroxidase 2 (GPX2)
|
OTXI2NTI
|
GPX2_HUMAN
|
Affects Response To Substance
|
[151] |
Bifunctional glutamate/proline--tRNA ligase (EPRS1)
|
OTXK0FLB
|
SYEP_HUMAN
|
Affects Response To Substance
|
[151] |
ATP synthase subunit delta, mitochondrial (ATP5F1D)
|
OTXTAG2V
|
ATPD_HUMAN
|
Affects Response To Substance
|
[151] |
Carbamoyl-phosphate synthase , mitochondrial (CPS1)
|
OTXV8NSR
|
CPSM_HUMAN
|
Affects Response To Substance
|
[151] |
Progranulin (GRN)
|
OTXXSJ53
|
GRN_HUMAN
|
Affects Response To Substance
|
[151] |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PIK3C2B)
|
OTY2PROB
|
P3C2B_HUMAN
|
Affects Response To Substance
|
[151] |
Thymidine kinase, cytosolic (TK1)
|
OTY5JFM1
|
KITH_HUMAN
|
Increases ADR
|
[28] |
Collagen alpha-2(I) chain (COL1A2)
|
OTY7G382
|
CO1A2_HUMAN
|
Increases Response To Substance
|
[152] |
Calreticulin (CALR)
|
OTYD2TR1
|
CALR_HUMAN
|
Affects Response To Substance
|
[151] |
Lysosome-associated membrane glycoprotein 1 (LAMP1)
|
OTYE92QY
|
LAMP1_HUMAN
|
Increases ADR
|
[28] |
BTB/POZ domain-containing protein 3 (BTBD3)
|
OTZ607YT
|
BTBD3_HUMAN
|
Affects Response To Substance
|
[151] |
Ena/VASP-like protein (EVL)
|
OTZ8ZDNY
|
EVL_HUMAN
|
Affects Response To Substance
|
[151] |
Protein BTG2 (BTG2)
|
OTZF6K1H
|
BTG2_HUMAN
|
Affects Response To Substance
|
[222] |
Aspartate aminotransferase, cytoplasmic (GOT1)
|
OTZLM5UB
|
AATC_HUMAN
|
Increases ADR
|
[28] |
Lysine-specific demethylase 6A (KDM6A)
|
OTZM3MJJ
|
KDM6A_HUMAN
|
Affects Response To Substance
|
[151] |
Alkaline phosphatase, placental type (ALPP)
|
OTZU4G9W
|
PPB1_HUMAN
|
Affects Response To Substance
|
[151] |
Drebrin (DBN1)
|
OTZVKG8A
|
DREB_HUMAN
|
Affects Response To Substance
|
[151] |
------------------------------------------------------------------------------------ |
|
|
|
|